Entries |
Document | Title | Date |
20080199542 | Use of Winter Savory (Satureja Montana) or the Extracts Thereof For the Preparation of Medicaments For the Treatment of the Premature Ejaculation - The use of Winter savory or its purified extracts rich in rosmarinic acid, the use of rosmarinic acid and the extracts containing it for the preparation of medicaments for the treatment of premature ejaculation. | 08-21-2008 |
20080199543 | Pharmaceutically Active Extracts of Vitex Leucoxylon, a Process of Extracting the Same and a Method of Treating Diabetes and Inflammatory Diseases Therewith - The present invention relates to pharmaceutically active extracts of | 08-21-2008 |
20080206365 | Diterpene compounds having an atisane framework, compositions thereof, and methods of production - Provided are a certain compounds and compositions useful for inhibiting or activating the production of various types of cytokines. Also provided are certain compounds and compositions for preventing or treating various diseases attributable to abnormal cytokine production or compromised immunity. | 08-28-2008 |
20080206366 | COSMETIC COMPOSITION COMPRISING EXTRACT FROM MALLOTUS JAPONICUS FOR IMPROVING SKIN WRINKLE - The present invention relates to compositions for inhibiting elastase activity, enhancing collagen biosynthesis and improving skin wrinkle, comprising | 08-28-2008 |
20080213404 | Hif Modulating Compounds and Methods of Use Thereof - A method is provided for treating subjects, including humans, with infection or virulence by pathogens. The method involves administering an agent in amounts effective to eradicate or reduce infections and/or an inflammatory response caused by pathogens. Methods for identifying compounds useful as anti-infectives that decrease the immune resistance, virulence, or growth of microbes are also provided. More particularly, there are provided methods for identifying compounds which increase accumulation or stability or activity, or alternatively decrease the degradation of HIF-1a protein. | 09-04-2008 |
20080213405 | Pharmaceutical compositions containing bulbophyllum and their use for treating illnesses - Described are pharmaceutical compositions containing | 09-04-2008 |
20080220096 | CYNARA SCOLYMUS EXTRACTS AND COMPOSITIONS CONTAINING THEM - The present invention relates to a | 09-11-2008 |
20080220097 | FORMULATIONS CONTAINING CYNARA SCOLYMUS AND PHASEOLUS VULGARIS EXTRACTS WHICH ARE USEFUL IN THE TREATMENT OF OBESITY - The present invention relates to a | 09-11-2008 |
20080220098 | FORMULATIONS OF ALPHA-AMYLASE INHIBITORS WITH ALPHA-GLUCOSIDASE INNHIBITORS USEFUL IN THE TREATMENT OF DIABETES AND OBESITY - This invention relates to the combination of α-amylase inhibitors prepared from | 09-11-2008 |
20080220099 | Nutritional composition - A dietary supplement for dogs is disclosed. The composition is a blend of methyl sulfonyl methane, glucosamine sulfate, chondroitin sulfate, ascorbic acid, phylloquinone, yucca powder and stabilized rice bran. The composition may be added to a variety of meat products for dogs, preferably beef and/or beef by-products. | 09-11-2008 |
20080226753 | Method of Reducing Insect Resistant Pests in Transgenic Crops - The present invention discloses Resistance Management (RM) practices that are critical to safeguarding | 09-18-2008 |
20080226754 | METHOD FOR TREATMENT OF CARTILAGE DISORDERS WITH CENTELLA EXTRACT - The invention is a method for the treatment of mammalian articular cartilage disorders, inflammatory joint disease, trauma-related cartilage injuries, and degenerative disc disease. The method involves treating the affected area with a composition containing a therapeutically effective dose of | 09-18-2008 |
20080226755 | Composition to enhance the bioavailability of curcumin - A composition for enhanced bioavailability of curcumin including purified curcuminoid and purified essential oil of turmeric. A method to prepare a composition for enhanced bioavailability of curcumin having purified curcuminoid and purified essential oil of turmeric. | 09-18-2008 |
20080233214 | Therapeutic Compounds Isolated from Calomeria Amaranthoides - The present invention relates to extracts and compounds which are isolated from Calomeria amaranthoides, and to derivatives and analogues of such compounds, which demonstrate cytotoxic activity against a variety of cell types exhibiting hyperproliferative cell division. | 09-25-2008 |
20080233215 | EXCIPIENT AND AN IMPROVED METHOD FOR MANUFACTURING EXTRACTED, EVAPORATED, GRANULATED BOTANICAL HERB PRODUCT - An excipient and a method for manufacturing concentrated Chinese herbs through using the excipient are provided. The manufacturing method includes the following steps: (a) providing a Chinese herb raw material; (b) obtaining an extract from the Chinese herb raw material; (c) collecting volatile oils in a separate bin, later reintroduced; (d) removing water from the extract, to get a concentrate; and (e) adding an excipient to the concentrate, and then granulating and drying, to get a Chinese herbal preparation, in which the excipient contains a capsule protective agent of 1-99 wt % with respect to the excipient and a decomposed product of starch of 1-99 wt % with respect to the excipient. Therefore, the amount of starch required to be used is reduced and the manufactured concentrated Chinese herbal preparation can be completely dissolved in water. | 09-25-2008 |
20080233216 | Composition Comprising the Extract of Siegesbeckiae Herba For Preventing and Treating Arthritis and the Use Thereof - The extract of Siegesbeckiae herba of the present invention showed potent inhibitory effect on the dissociation of proteoglycan and type II collagen in chondrocyte and cartilage tissue and protecting effect on cartilage due to the inhibition of MMP-1, MMP-3 and MMP-13 activity and the restoring effect on cartilage tissue, the anti-inflammatory and antiphlogistic effect in edema animal model, anti-inflammatory effect confirmed by the inhibition test on PGE | 09-25-2008 |
20080241280 | Usage of the Plant of Genus Ampelopsis and Extracts Thereof For Manufacture of Medicament and Functional Food - Usage of the plant of genus | 10-02-2008 |
20080241281 | Compositions & methods for activation and inhibition of Staphylococcus aureus biofilm development - Botanical extracts and derivative compositions are described for activating or inhibiting the formation and development of bacterial biofilms. Gymnemic acids and other associated saponins are isolated from botanical extractions of the | 10-02-2008 |
20080241282 | Sorghum Extract Compositions - Methods and compositions for preventing or treating various diseases or conditions in a patient with an alcohol extractable fraction of | 10-02-2008 |
20080241283 | Aqueous extracts of anoectochilus spp. kinsenoside-comprising pharmaceutical compositions useful for hepatoprotection and uses of the same - A pharmaceutical composition useful for hepatoprotection is provided. The composition comprises an effective amount of kinsenoside or a pharmaceutically acceptable salt or ester thereof. An aqueous extract of | 10-02-2008 |
20080248138 | TOPICAL OIL FOR TREATING PHYSICAL AILMENTS AND METHOD FOR MAKING AND APPLYING THE SAME - A method for making and applying a topical oil and composition thereof, combining the healing properties of the Noni plant with a topical application for treating physical ailments. The topical oil disclosed includes an oil derived from raw leaves, stems, and buds of a noni plant; a carrier oil; and vitamin E oil. | 10-09-2008 |
20080248139 | PROCESS FOR THE PREPARATION OF FERUTININE FROM FERULA GENUS PLANTS - The invention relates to a process for the preparation of ferutinine (Ia) from | 10-09-2008 |
20080254148 | HERBAL COMPOSITIONS FOR THE INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS - The invention provides a herbal composition for the inhibition of HIV, comprising an organic extract of | 10-16-2008 |
20080254149 | Recovery of Residual Plant Components After Distillation of Essential Oils - Methods for recovering valuable compounds and substances from plants after distillation of oils are disclosed. The methods involve various aqueous and non-aqueous solvent extraction of plant material from which oils have been distilled previously. | 10-16-2008 |
20080254150 | Management of dermatitic symptoms of mammalian integument with emollient disinfectant formulations - Botanically-sourced and botanically-derived emollient sanitation compositions for topical use are disclosed. Representative compositions generally aid reconstitution of the lipid profile of the stratum corneum by providing botanical lipids and/or lipid-derivatives that resemble human sebum—these components being ordinarily diminished with the use of conventional hand sanitizer products. Disclosed features and specifications may be variously controlled, adapted or optionally modified to realize, for example, improved hand sanitizer formulations. Representative embodiments of the present invention generally provide anti-microbial compositions blended with botanically sourced lipids and/or lipid-derivatives to control or otherwise improve dermatitic symptoms associated with frequent use of conventional hand sanitizer products. | 10-16-2008 |
20080254151 | HERBAL MIXTURE EXTRACT OF REHMANNIAE RADIX PREPARATA AND ACANTHOPANACIS CORTEX AND A COMPOSITION COMPRISING THE SAME FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS - The present invention relates to a herbal mixture extract of Rehmanniae Radix Preparata and Acanthopanacis Cortex and a composition comprising the same for the prevention and treatment of osteoporosis. | 10-16-2008 |
20080260866 | Method for decreasing inflammation and stress in a mammal - The present invention is directed to a method for decreasing inflammation and stress in a mammal comprising; administration to a mammal a composition comprising a glucose anti-metabolite; and wherein said composition comprises amounts of the glucose anti-metabolite sufficient to lower a level of a C-reactive protein in the blood of the mammal subsequent to administration of the glucose anti-metabolite. | 10-23-2008 |
20080268072 | Method of Improving Anticancer Effect of Pulsatillae Radix and a Composition Prepared by the Method - The present invention relates to a composition enriched with 3-0-[O-α-L-rhamnopyranosyl-(1→2)-[0-β-D-glucopyranosyl-(1-→4)]-α-L-arabinopyranosyl]hederagenin (Code No. SB 365) of which antitumor activity is very strong by enzyme-reacting and extracting Pulsatillac radix. | 10-30-2008 |
20080268073 | CERAMIDASE INHIBITOR - The present invention provides a ceramidase activity inhibitor which inhibits ceramidase activity, specifically neutral/alkaline ceramidase activity, characterized in that the inhibitor comprises, as an active ingredient, a processed product derived from at least one plant selected from the group consisting of plants belonging to Ginkgoaceae, plants belonging to Cucurbitaceae, plants belonging to Rutaceae, plants belonging to Laminariaceae, plants belonging to Myrtaceae and plants belonging to Compositae, and a medicament, a quasi-drug, cosmetics and a food, each comprising the inhibitor. | 10-30-2008 |
20080268074 | Cosmetic Compositions and Methods Comprising Rhodiola Rosea - A cosmetic composition comprising a UV-protective amount of at least one rosavin, preferably present in an extract of | 10-30-2008 |
20080274212 | Herbal Extract for Renal Disorders - The present invention relates to the use of standardized extract of | 11-06-2008 |
20080274213 | Drug for Ameliorating Male Climacteric Disorders - It is intended to provide a highly safe pharmaceutical drug or food that inhibits reduction in blood testosterone level and prevents or ameliorates symptoms and so on associated with male climacteric disorders. The present invention provides a drug for inhibiting reduction in blood testosterone level and a drug for ameliorating male climacteric disorders comprising a plant belonging to the genus | 11-06-2008 |
20080274214 | Medicament For The Prevention and Treatment Of Influenza - The invention relates to the use of an extract from plants of the genus | 11-06-2008 |
20080279966 | Branched-chain amino acid composition for improving skeletal muscle protein metabolism - The present invention relates to compositions and methods for improving skeletal muscle protein metabolism through encouraging skeletal muscle protein synthesis, reducing skeletal muscle protein degradation, and attenuating inflammatory signaling in exercising muscle. | 11-13-2008 |
20080279967 | Composition and method for increasing the metabolism of free fatty acids and facilitating a favorable blood lipid - A dietary supplement comprising at least an effective amount of | 11-13-2008 |
20080286384 | Topical Wound Care Product Containing Hyssop - A composition for treating wounds having an effective amount of hyssop extract, combined with glycerol, salt, saccharides, and water has been discovered to be effective in promoting healing of wounds. | 11-20-2008 |
20080286385 | Method of Obtaining Avocado Powder - The invention relates to avocado powder and to the method of obtaining the same. Avocado powder is a novel product which enables the avocado to be preserved for an extended period of time at ambient temperature, such as to conserve the characteristic properties of the product, with the additional advantage of being 100% natural and occupying less physical storage space, thereby eliminating the post-processing cold chain. The method of obtaining avocado powder comprises a series of operations or steps that terminate in the pulverization and packing of the end product. | 11-20-2008 |
20080286386 | Na+, K+-Atpase Expression in Cervical Dysplasia and Cancer - The present disclosure provides methods of diagnosing cervical dysplasia and cervical cancer by detecting Na | 11-20-2008 |
20080292732 | Plant and Plant Storage Organ Having Glp-1 Derivative Accumulated Therein and Method of Producing the Same - The present invention is to provide a plant and a plant storage organ thereof in which GLP-1 derivatives are accumulated, and a method of producing them in order to develop a method for ingesting orally GLP-1 derivatives at a low cost and to make use of it in diabetic treatment. A transgenic plant or a plant storage organ thereof in which GLP-1 derivatives are accumulated cleavable with a digestive enzyme is produced by a method comprising: integrating into a vector a linked GLP-1s-DNA which comprises tandem repeated “n” DNAs (“n” being an integer of 3 or more) encoding a GLP-1 derivative consisting of GLP-1 (7-36) or of an amino acid sequence of GLP-1 (7-36) in which one or a few amino acids are deleted, substituted and/or added, and C-terminal consists of Arg or Lys, and having GLP-1 activity; introducing the vector into a plant cell; and redifferentiating the obtained transformant. The transgenic plant and the plant storage organ are useful as a pharmaceutical composition or a food or drink for treating or preventing diabetes. | 11-27-2008 |
20080299229 | METHODS OF REDUCING BETA-AMYLOID POLYPEPTIDES - The invention features methods of reducing the level of a β-amyloid (Aβ) polypeptide using an | 12-04-2008 |
20080299230 | Oil formulations and methods of use - The invention generally relates to various oil formulations for protecting plants from nematodes and other pathogens. The invention provides specific formulations which do not require the use of chemical additives. These formulations have low phytotoxicity and low volatility. Also, methods of applying the formulations for agricultural use are disclosed. | 12-04-2008 |
20080299231 | HERBAL COMPOSITION FOR TREATMENT OF NEURODEGENERATION AND NEURONAL DYSFUNCTION - This invention provides methods of using various herbal compositions to treat neurodegenerative diseases and neuronal dysfunctions, said compositions comprise a combination of Radix angelica sinensis (DangGui), Ligusticum chuanxiong (ChuanXiong), Hirudo (ShuiZhi), Polygonatum sibiricum (HuangJing), Carthamus tinctorius (Hong Hua), Astragalus membranaceus (HuangQi), and Glycyrrhiza uralensis (Gancao). | 12-04-2008 |
20080317878 | Herbal Therapy for the Treatment of Food Allergy - The present invention provides herbal formulas, and compositions thereof, that can treat or reduce the severity, intensity, or duration of food allergy and food allergyrelated symptoms. The compositions may optionally include one or more adjuvants, cytokines, encapsulating materials, or pharmaceutically acceptable carriers or excipients, and may be administered prior to, during, or after the development of food allergy-related symptoms in a patient in need thereof. | 12-25-2008 |
20080317879 | Herb Composition for Asthma Maintenance Therapy and Manufacturing Method Thereof - The present invention relates to a herb composition for asthma maintenance therapy based on Chungsangboha-tang, which is known to be effective in asthma, capable of reducing the long-term suffering of asthma patients and improving their quality of lives and a manufacturing method thereof. The herbal composition of the present invention is characterized by comprising 5-18 parts by weight of | 12-25-2008 |
20080317880 | PLANT ISOFLAVONE AND ISOFLAVANONE O-METHYLTRANSFERASE GENES - The invention provides enzymes that encode O-methyltransferases (OMTs) from | 12-25-2008 |
20080317881 | METHOD FOR SUSTAINABLE TRANSGENE TRANSCRIPTION - The present invention relates to constructs and methods for improving expression of transgenes in plants, animals and humans. | 12-25-2008 |
20090004299 | Methods for Inhibiting a Decline in Learning and/or Memory in Animals - A method for inhibiting a decline in learning and/or memory in an animal comprising maintaining the animal on an antioxidant-fortified diet for a period of at least about 3 years. The diet comprises at least one antioxidant in a total antioxidant amount effective to achieve such inhibition. Suitable antioxidants include vitamin E, vitamin C, α-lipoic acid and antioxidant-containing plant meals. The methods are particularly useful for young adult canines such as dogs. | 01-01-2009 |
20090017140 | MAYTENUS ABENFOLIA EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 01-15-2009 |
20090017141 | TOPICAL COMPOSITION FOR THE TREATMENT OF HYPERPIGMENTED SKIN - The present invention relates to novel, topically applied, cosmetic/dermatological compositions for the treatment of hyperpigmentation disorders and photodamaged human skin. The subject compositions combat hyperpigmented skin. In addition, the compounds described can be used in the treatment of many other pathologies. Due to a high degree of gentleness, along with potent antioxidant and moisturizing effects, the present invention can be used safely in the treatment of many conditions, such as the prevention and/or treatment of melasma, freckles, age spots (lentigo senilis) and photodamaged skin. | 01-15-2009 |
20090017142 | Essential Oils Inhibit Mold on Wood - Methods of treating wood lumber to inhibit growth of mold fungi by surface treating the wood lumber with an essential oil, diluted or undiluted, being geranium Egyptian, thyme, dill weed or rosemary. Various surface treatments include dipping, spraying, brushing and vapor exposure. | 01-15-2009 |
20090017143 | Composition for treatment of alcoholism - A composition effective in the treatment of alcoholism comprising one or more alcohol craving blocker components such as Kudzu and Rhodiola Rosea, one or more antidepressant components such as St. John's Wort (Hypericin), 5-Hydroxytryptophanm SAMe, Melatonin and Taurine, and/or one or more anti-anxiety components such as Vitamin B complex, Glutamine, Niacin, SAMe, Hops, Melatonin and Rhodiola Rosea, the components chosen such that in combination they beneficially affect the nutritional, physiological and psychological deficiencies that combine to cause alcohol dependency. | 01-15-2009 |
20090022820 | COMPOSITIONS FOR STERILIZING SPORES OF SPORE -FORMING MICROORGANISMS COMPRISING THE EXTRACTS OF TORILIDIS FRUCTUS - Disclosed are a composition comprising an organic acid extract of Torilidis Fructus, which has a sterilization effect on spores of spore-forming microorganisms including fungi and bacteria, and a method of sterilizing spores and vegetative cells using the composition. | 01-22-2009 |
20090022821 | COMPOSITIONS FROM WAX MYRTLE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES - The present invention relates to the use of certain novel compositions from wax myrtle ( | 01-22-2009 |
20090028967 | FLUID KONJAK MATERIAL AND ITS PRODUCTION AND USE - A fluid konjak material, which can be mixed with any other edible material uniformly at a high concentration while sufficiently keeping the gelling power and the biological effect intrinsic to konjak mannan, is provided by swelling and dissolving konjak flour in water, treating the resultant with alkali at a pH of at least 10, lowering the pH to less than 8, heating the composition with forced stirring and enzymatically treating the forcedly-stirred composition. | 01-29-2009 |
20090035395 | SPONDIAS MOMBIN L. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 02-05-2009 |
20090035396 | Novel reference plant, a method for its production, extracts obtained therefrom and their use - The invention relates to a reference plant which has been selected to:
| 02-05-2009 |
20090041864 | Apparatus and Method for Cellular Extract Enhancement - An apparatus | 02-12-2009 |
20090041865 | Extract of the Family Dioscoreaceae and Composition for Preventing or Treating Peripheral Neuropathy Comprising the Same - An extract of the family Dioscoreaceae useful for preventing or treating the peripheral neuropathy; and a pharmaceutical composition or food composition comprising the extract are provided. In addition, a pharmaceutical composition or food composition useful for preventing or treating the peripheral neuropathy comprising a compound isolated from the extract of the family Dioscoreaceae is provided. | 02-12-2009 |
20090041866 | ABNORMAL PROTEIN REMOVING COMPOSITION - It is an object of the present invention to efficiently remove abnormal protein produced in living tissues, especially skin, due to exposure to UV light, etc. | 02-12-2009 |
20090041867 | ESTROGENIC EXTRACTS OF LIGUSTRUM LUCIDUM AIT. OF THE OLEACEAE FAMILY AND USES THEREOF - Extracts of various species of the Moraceae family have estrogenic properties. For example, aqueous and ethanolic extracts of | 02-12-2009 |
20090041868 | Binding and Rinse-Off of Quaternary Ammonium Compounds for Cosmetic and Personal Care Applications - The disclosed composition and method includes the use of non-polar unsaponifiable material and polar hydrophilic salts in conjunction with quaternary ammonium compounds to provide hair treatment preparations for cosmetic and personal care applications. Disclosed features and specifications may be variously controlled, adapted or otherwise optionally modified to improve substantivity and/or rinse-off characteristics. Exemplary embodiments of the present invention generally provide hair conditioners, shampoos, straighteners, permanent waves, color-fast dyes, non-color-fast dyes, and repair treatments with jojoba hydrolysates in combination with Quaternium 80 for increased substantivity and superior wash/rinse-off benefits. | 02-12-2009 |
20090041869 | METHOD OF REDUCING INSECT RESISTANT PESTS IN TRANSGENIC CROPS - The present invention discloses Resistance Management (RM) practices that are critical to safeguard | 02-12-2009 |
20090053330 | PROCESS FOR PREPARATION OF RHUS VERNICIFLUA EXTRACTS HAVING EXCELLENT ANTI-CANCER ACTIVITY AND ANTI-CANCER PHARMACEUTICAL COMPOSITION CONTAINING THE SAME - Provided is a process for preparation of a | 02-26-2009 |
20090053331 | Hands and feet sanitizing system - A sanitizing system is provided which includes an antibacterial liquid composition formulated to sanitize and deodorize the hands, feet, and other areas of the body. The antibacterial liquid composition is adapted to be dispensed from a pump dispenser as a topical spray. | 02-26-2009 |
20090053332 | Compositions for diabetes treatment and prophylaxis - Gurmarin containing compositions are useful for modulation of glucose metabolism and the treatment of diabetes. Glucose metabolism in a human patient is regulated by isolated gurmarin-containing dosage forms that optionally contain a non-metabolizable polysaccharide such as the exudate of | 02-26-2009 |
20090053333 | TREATMENT OF VEGETATION LIQUORS DERIVED FROM OIL-BEARING FRUIT - The present invention relates to processes for the treatment of liquors derived from oil-bearing fruit, for example from oil palm fruit, and to products therefrom. Typically a process involves removal of undissolved solids, oleaginous parts, colloids and higher weight molecules from the vegetation liquor to give an aqueous fraction containing phytochemicals, for example, flavonoids, phenolic acids and hydroxy acids. Subsequently, pH adjustment and solvent extraction upon said aqueous fraction realise an extract rich in hydroxy acids or phenolic acids or flavonoids or any combination thereof. Applications of the substances subject of this invention are to be found in drinks, edible products, tonics, health supplements, antioxidant additives, cosmetics, soaps, shampoos, detergents, drugs or medicinal products. | 02-26-2009 |
20090061025 | COMPOSITIONS AND METHODS FOR TREATING DEMODEX INFESTATIONS - Compositions containing about 0.6% to about 20% of tea tree oil are described. Some compositions are in the form of solutions, suspensions, spray, lotions, gels, pastes, medicated sticks, balms, cleansers (including shampoos and soaps), creams, or ointments. Also described are compositions and methods for use in treating ocular Demodex infestations and related conditions using such compositions. | 03-05-2009 |
20090061026 | NUTRACEUTIC PREPARATION IN POWDER FORM CONTAINING FREE PLANT STEROLS - The present invention relates to a nutraceutical preparation containing, in the same unit dose, a dried powder comprising free plant sterols in the global quantity of 0.5 to 3.0 g. The preparation preferably also contains red yeast rice, soluble natural fibres and natural antioxidant compounds, the latter generally being carried by products deriving from fruit and/or vegetables. The invention also relates to the process for its preparation, and the use of the preparation in foodstuffs to reduce and control the cholesterol level, mainly in the blood. | 03-05-2009 |
20090061027 | Composition For The Prevention and Treatment Of Common Cold Diseases - The invention relates to the use of Cistus for producing a composition for the prophylaxis and/or treatment of common cold diseases. In particular, the composition can be used for the prophylaxis and/or treatment of the symptoms of a head cold. | 03-05-2009 |
20090061028 | PESTICIDAL/OVICIDAL COMPOSITION AND PESTICIDAL/OVICIDAL METHOD - A pesticidal/ovicidal composition comprising: (a) 50-97.9 parts by mass of a triglyceride containing not less than 50% of oleic acid as a fatty acid component; (b) 0.1-20 parts by mass of a cationic surface active agent; and (c) 2-30 parts by mass of a glycerin derivative, and a pesticidal/ovicidal method using the same. The composition according to the invention has not only a pesticidal activity but also an ovicidal activity on crop pests, and provides a safe and high pesticidal/ovicidal effect. | 03-05-2009 |
20090068291 | Plant extracts and compositions comprising extracellular protease inhibitors - The present invention provides a plant derived extract comprising inhibitory activity against one or more extracellular proteases which degrade human tissue matrix. Moreover, the amount of inhibitory activity in an extract can be increased by stressing the plant prior to forming an extract. These extracts are each prepared by a standard process and demonstrate the ability to inhibit one or more extracellular proteases which degrade human tissue matrix. Libraries of extracts can be prepared from stressed and non-stressed plants, wherein each of the extracts demonstrate inhibitory activity against one or more extracellular protease inhibitors. Alternatively, semi-purified and purified inhibitory compounds can be isolated from the extracts following standard procedures. In one aspect, these extracts with inhibitory activity can be used during protein purification to minimize the degradation due to extracellular proteases. | 03-12-2009 |
20090068292 | Therapeutic herb cosmetic composition - The current invention discloses an herb composition to treat burn, sun burn, physical injury, dermatitis, or to promote skin stem cell proliferation, increase collagen synthesis, increase epidermal thickness, and increase desquamation of normal skin resulting in smoother, younger looking skin. The composition comprises of herb extract from | 03-12-2009 |
20090068293 | ESTROGENIC EXTRACTS OF Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family AND USES THEREOF - Estrogenic extracts of | 03-12-2009 |
20090068294 | ESTROGENIC EXTRACTS OF Rheum palmatum L of the Polygonaceae family AND USES THEREOF - Extracts of various species of the Polygonaceae family have estrogenic properties. For example, aqueous and ethanolic extracts of | 03-12-2009 |
20090074891 | COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 03-19-2009 |
20090087500 | GUAVA LEAF EXTRACT POWDER AND METHOD FOR PRODUCTION THEREOF - To provide a guava leaf extract powder which exhibits less deterioration in quality and functions after storage of the solution thereof for a long period of time. | 04-02-2009 |
20090092686 | PROCESS FOR THE RECOVERY OF A PHYTOLIPID COMPOSITION - Disclosed is a process for the recovery of a phytolipid composition from a vegetable oil by-product. The phytolipid composition produced comprises squalene, phytosterols, mixed tocopherols and tocotrieneols, and vegetable wax and is useful as an emollient. The phytochemical composition may be applied directly to the skin to provide emolliency. Alternatively, the phytolipid composition may be formulated in various aqueous or anhydrous cosmetic compositions such as creams, lotions, gels, ointments, lip balms, sticks, or pencils for treatment of the skin and lips. The phytolipid composition also may be incorporated into foods, beverages, and nutraceuticals to provide health benefits. | 04-09-2009 |
20090098220 | LIQUID PHARMACEUTICAL PREPARATION COMPRISING FORSKOLIN FOR PROMOTING LEAN BODY MASS - A liquid pharmaceutical preparation comprising forskolin in an amount of about 0.025 mg/ml to about 1 mg/ml of the liquid pharmaceutical preparation for promoting lean body mass in a human subject. Further, an effective amount of the liquid pharmaceutical preparation comprising forskolin is administered subcutaneously in the human subject. | 04-16-2009 |
20090098221 | Creatine ascorbyl derivatives and methods of use thereof - The present invention provides methods of treating creatine responsive states, such as a neurological disorder (i.e., Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis, muscular dystrophy, Charcot Marie Tooth syndrome, Alzheimer's disease, or creatine transporter defect) or a skin disorder, by administering a creatine-ascorbyl derivative. | 04-16-2009 |
20090098222 | Accelerating Agent of Calcium Absorption - The present invention provides an accelerating agent for calcium absorption comprising Gum Arabic, which is daily available while simultaneously taking dietary fiber. | 04-16-2009 |
20090098223 | NATURAL PLANT EXTRACT COMPOSITION FOR PREVENTION AND RECOVERY OF HYPERLIPIDEMIA AND STROKE, NATURAL TEA CONTAINING THE SAME AS ACTIVE INGREDIENT AND METHOD FOR PREPARING THE NATURAL TEA - A natural plant extract composition for the recovery and prevention of hyperlipidemia and stroke, a natural tea comprising the same as an active ingredient, and a method for preparing the natural tea. The natural plant extract composition contains a | 04-16-2009 |
20090104288 | Compositions and methods for inhibiting a honey bee pathogen infection or controlling a hive infestation - The present invention is directed to methods and compositions to prevent or treat a honey bee pathogen infection (e.g., | 04-23-2009 |
20090104289 | FORMULATION OF ANTIMICROBIAL FILM, COATINGS AND/OR SPRAYS CONTAINING PORTULACA OLERACEA EXTRACT AND FILM PREPARED THEREFROM - An antimicrobial film formulation is prepared by extracting | 04-23-2009 |
20090104290 | ENERGIZING FORMULATION - The present invention relates to a pre-mix and a pharmaceutical composition for oxygenating a subject's tissues, uses and methods of treatment thereof. | 04-23-2009 |
20090104291 | WATER-DISPERSIBLE NANOPARTICLE WHICH CONTAINS BLOOD CIRCULATION PROMOTER - It is an object of the present invention to provide a nanoparticle which comprises a blood circulation promoter and a biodegradable polymer, which is safe and excellent in terms of dispersion stability and has high transparency and good absorbability due to its small particle size. The present invention provides a water-dispersible nanoparticle which comprises a blood circulation promoter and a biodegradable polymer. | 04-23-2009 |
20090104292 | TOPICAL ARNICA TREATMENT FOR REDUCING BRUISING - A method of preventing post-surgery, post-laser treatment or post-traumatic bruising of the skin comprising applying topically to the affected area of the skin a treatment comprising at least 15% by weight | 04-23-2009 |
20090117209 | ANDROGRAPHIS PANICULATA EXTRACT - An extract of | 05-07-2009 |
20090117210 | ANDROGRAPHIS PANICULATA EXTRACT - An extract of | 05-07-2009 |
20090123572 | Method and Pharmaceutical Composition for Treating Psoriasis, Squamous Cell Carcinoma and/or Parakeratosis by Inhibiting Expression of Squamous Cell Carcinoma-Related Antigen - In a first aspect thereof, the present invention provides a method for treatment and/or prevention of a disease selected from the group consisting of psoriasis and squamous cell carcinoma by inhibiting the expression of squamous cell carcinoma antigen (SCCA) by cells. In another aspect thereof, the present invention provides a method for screening for substances that inhibit epidermal parakeratosis, wherein the activity of a candidate substance that inhibits cysteine protease inhibitory activity possessed by squamous cell carcinoma antigen 1 (SCCA-1) is used as an indicator. | 05-14-2009 |
20090123573 | ADMIXTURE OF EXTRACTS OF PLANTS OF THE GENUS ROSMARINUS AND CAROTENOIDS FOR TREATING CUTANEOUS SYMPTOMS OF AGING - Intimate admixtures of at least one carotenoid and at least one extract of at least one plant of the genus | 05-14-2009 |
20090130234 | Composition for the Treatment of Diabetic Periodontitis - The invention refers to the use of an extract of a part of a | 05-21-2009 |
20090130235 | METHOD FOR MARKETING VIBRATION MEDICINE PRODUCTS - It is disclosed a method for marketing vibration medicine products. The method includes getting an original liquid vibration medicine product, producing a powder vibration medicine product, providing that powder vibration medicine product for blending inside a food or drink entity to get a new entity, and marketing the new entity as an improved first entity. The original vibration medicine product includes essences, and is marketed as having properties associated with the essences. The production of the second product is done using the original vibration medicine product and an acceptable food carrier as raw materials. Consequently, the second product has some presence of the original essences. The second entity is improved over the first entity in its association with the first vibration medicine product. | 05-21-2009 |
20090130236 | ANTI-MICROBIAL AGENT AND ANTI-MICROBIAL COMPOSITION - The present invention relates to an anti-tetanic agent comprising a Sasa extract; an anti-fungal agent comprising a Sasa extract and an organic acid; an anti-viral agent comprising a Sasa extract; an anti-microbial agent comprising | 05-21-2009 |
20090136600 | METHOD FOR ALLEVIATING CHEMOTHERAPY SIDE EFFECTS USING EXTRACT OF DIOSCOREA SP. - Extract fractions of | 05-28-2009 |
20090142418 | ANTIVIRAL COMPOSITION COMPRISING ALNUS JAPONICA EXTRACTS - Antiviral compositions including | 06-04-2009 |
20090142419 | ANTI-INFLAMMATORY EXTRACT AND AGENT AND METHOD FOR THE PRODUCTION THEREOF - The invention relates to the pharmaceutical industry, in particular to producing herbal remedy for integrally treating various inflammatory diseases. The inventive remedy comprises a dry | 06-04-2009 |
20090142420 | Cosmetic Composition with Anti-Free Radical Activity - A cosmetic composition has an association of at least three of the following substances with anti-free radical activity, selected from: | 06-04-2009 |
20090142421 | ACTIVE FRACTION OF A POLAR SOLVENT EXTRACT FROM THE LATEX OF EUPHORBIACEAE PLANTS - The present invention generally refers to an active fraction of an extract of the latex of plants from the family Euphorbiaceae in a polar solvent, as well as of one or more compounds contained therein, as well as the use of said fraction and/or said compounds, particularly in the treatment of cancer. The invention also refers to compositions comprising said active fraction and/or said compounds, as well as their use for the treatment of diseases concerning cell proliferation/angiogenesis, particularly cancer. | 06-04-2009 |
20090142422 | Herbal compositions for the regression of chronic inflammatory skin disorders - Herbal compositions that, when used in an effective amount, are suitable for the regression of chronic inflammatory skin disorders, including eczema, psoriasis and seborrheic dermatitis. The compositions, formulated as ointments, oils and shampoos, are comprised of a non-aqueous extract of | 06-04-2009 |
20090142423 | Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same - The present invention relates to the use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition, and to a method for producing the same. | 06-04-2009 |
20090148542 | Composition comprising an extract of tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity - The present invention relates to a composition comprising an extract of | 06-11-2009 |
20090148543 | Method for protecting humans against superficial vasodilator flush syndrome, - Methods for protection of a human from SVFS comprise the administration of a flavonoid compound of the basic structures 2-phenyl-4H-1-benzopyran or 2-phenyl-4-keto-1-benzopyran or glycosides thereof, alone or, optionally, together with one or more of an olive kernel extract, a non-bovine sulfated proteoglycan, bitter willow extract, a D-hexosamine sulfate, S-adenosylmethionine, folic acid, vitamin B12 and a serotonin inhibitor. Such treatment prevents, reduces or eliminates SVFS in patients receiving as much as 300-3000 mg/day of niacin therapeutically, whether administered prior to, or along with, an anti-SVFS composition. | 06-11-2009 |
20090148544 | Cosmetic composition containing an extract from lotus and method of cosmetic care using said composition - The invention relates to a cosmetic composition containing at least one extract from at least one part of the Sacred Lotus plant ( | 06-11-2009 |
20090155392 | Methods and Systems for Sublingual Guarana Administration - Embodiments of the present invention relate generally to methods and systems for the sublingual and buccal administration of herbal supplements, and more particularly, to the sublingual and buccal administration of Guaraná, which allows for considerably reducing the therapeutic dose, with the additional advantage of increasing the quickness of the beneficial effects. | 06-18-2009 |
20090169650 | Food compositions incorporating stearidonic acid - The present invention relates to the improvement of food items through the increased utilization of plant-derived stearidonic acid. Many long chain fatty acids have been classified as being Omega 3 and have been shown to provide several health benefits, including heart health. According to the current invention plant-derived stearidonic acid (18:4ω3) has been incorporated into a wide range of food products by using either oil or flour processed from soybeans with enhanced levels of stearidonic acid. These foods range from oil-based products (salad dressing, mayonnaise) to dairy products (milk, cheese) to prepared foods (entrees, side dishes). In addition to improved health benefits the current invention provides food rich in Omega-3 fatty acids that have enhanced storage and/or shelf life characteristics. | 07-02-2009 |
20090175963 | ANTIVIRAL COMPOSITION COMPRISING LYCORIS SQUAMIGERA EXTRACTS - Antiviral compositions including | 07-09-2009 |
20090175964 | Composition for enhancing immunity - Disclosed is an edible composition for enhanced immunity comprising theanine or a source of theanine and a herb selected from Shankhpushpi, Shatavari, or a mixture thereof. | 07-09-2009 |
20090181110 | Compositions from Garcinia as Aromatase Inhibitors for Breast Cancer Chemoprevention and Chemotherapy - Aromatase inhibitors (AIs) are disclosed which are useful in the treatment and prevention of post-menopausal breast cancer. New AIs derived from natural products are disclosed that are evaluated for clinical utility for treating post-menopausal breast cancer and may also act as chemopreventive agents for preventing breast cancer. Several pure compounds demonstrated AI activity using a noncellular, enzyme-based microsomal and a cell-based aromatase assay. Correlations are made between structural classes with levels of aromatase inhibition. The disclosure may be utilized to direct synthetic modification of natural product scaffolds to enhance aromatase inhibition or to standardize botanical dietary supplements for increased aromatase inhibition activity. | 07-16-2009 |
20090181111 | Saponin And Preservative Compositions For Reduction of Protozoa - The invention is related to methods and compositions for reducing protozoa populations in animals. In an embodiment, the invention includes a method for reducing protozoal populations including administering a first composition comprising an effective amount of saponins to the animal, and administering a second composition comprising an effective amount of a preservative to the animal. In an embodiment, the invention includes a method for killing protozoa comprising contacting protozoa with a composition comprising an effective amount of saponins and an effective amount of ethoxyquin. Other embodiments are included herein. | 07-16-2009 |
20090181112 | TABLET COMPOSITION CONTAINING KAMPO EXTRACT - Provided is a tablet composition containing Kampo extract having more excellent disintegration and dissolution properties than ever before. The tablet composition containing Kampo extract contains a Kampo extract powder, croscarmellose sodium, and sodium hydrogen carbonate. The Kampo extract powder is preferably at least one extract powder selected from the group consisting of Kakkonto, Kakkontokasenkyushin'i, Shoseiryuto, Tokishakuyakusan, Kamishoyosan, Keishibukuryogan, Hochuekkito, Bofutushosan, Goshajinkigan, Maobushisaishinto, Keishikajutsubuto, Juzentaihoto, Sokeikakketsuto, Shakuyakukanzoto, Keishininjinto, Tokakujokito, Yokukansan, Goreisan, and Eppikajutsuto. | 07-16-2009 |
20090186100 | MEDICAMENT FOR ANTI-AGING SKIN CARE AND WOUND HEALING AND USE THEREOF - A composition comprising Semen Lactucae sativae, Fructus oryzae and Resina Boswelliae carterii for prophylaxis or treatment of skin-aging, increasing skin hydration, improving wrinkle; and facilitating wound healing rate and improving wound quality. | 07-23-2009 |
20090186101 | Use of Elderberry Extract - The present invention relates to the field of viral therapy. More specifically, the present invention relates to the use of elderberry extract in the preparation of a pharmaceutical formulation for the treatment of an influenza viral infection. It also relates to a novel method of treatment of the avian flu virus, through the administration of elderberry extract. | 07-23-2009 |
20090186102 | HERBAL MEDICINE FOR OSTEOPOROSIS AND RELATED CONDITIONS - A composition derived from six plant materials: ((i) Herba epimedii □□□ (Yin Yang Huo) (ii) Fructus Psoraleae ( | 07-23-2009 |
20090186103 | Process for obtaining dried plant material - A process for obtaining dried plant material of plants from the Apocynaceae family, also known as Asclepiadaceae family, which contain steroidal glycosides having appetite suppressant activity. Said process covers (after harvesting and removing the roots a comminution step, a holding step of 1-36 hours in which moisture loss is limited, and a drying step. | 07-23-2009 |
20090191286 | Binding and Rinse-Off of Quaternary Ammonium Compounds for Cosmetic and Personal Care Applications - The disclosed composition and method includes the use of non-polar unsaponifiable material and polar hydrophilic salts in conjunction with quaternary ammonium compounds to provide hair treatment preparations for cosmetic and personal care applications. Disclosed features and specifications may be variously controlled, adapted or otherwise optionally modified to improve substantivity and/or rinse-off characteristics. Exemplary embodiments of the present invention generally provide hair conditioners, shampoos, straighteners, permanent waves, color-fast dyes, non-color-fast dyes, and repair treatments with jojoba hydrolysates in combination with Quaternium 80 for increased substantivity and superior wash/rinse-off benefits. | 07-30-2009 |
20090196940 | COMPOSITIONS AND METHODS FOR SUPPORTING HEAT SHOCK FUNCTION - Compositions and methods for promoting or maintaining protein accretion in cells, particularly in skeletal muscle cells, by supporting heat shock protein function. The compositions comprise glutamine and additional components directed at enhancing the activity of heat shock proteins. | 08-06-2009 |
20090202663 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OTOMYCOSIS - Disclosed is a composition comprising betamethasone, griseofulvin and tea tree oil, for use in the treatment of ear fungal infections, particularly otomycosis, particularly infections caused by Aspergillus niger or Candida albicans. The composition may be in the form of ointment, cream, gel or liquid, e.g. ear drops. | 08-13-2009 |
20090208593 | PHYTO AROMA MICRO-NUTRITHERAPEUTIC COMPOSITIONS IN ORODIETOLOGY - The invention concerns a composition comprising at least a nutrient and at least a phytotherapeutic compound. The composition according to the invention is characterized in that it also comprises at least an essential oil and/or essence and it is in the form of a granule. The invention is used as a complement of a varied and balanced diet for indications such as aging, weight loss, discomfort related to hormonal changes of the pre-menopause and menopause, drainage, digestion, intestinal transit, relaxation, calm, microcirculation, appeasement of the bacterial flora, painful joints, physical and mental fatigue, protection of the immune system, or even whiten teeth and reduce urge to smoke. | 08-20-2009 |
20090208594 | Cosmetic and dermatological composition for psoriatic skin treatment - Cosmetic and dermatological composition for the treatment of psoriatic skin, comprising 5%-15% quince seeds; 10%-40% natural base cream; and 55%-75% mixture of anti-oxidants, skin softening agents, absorption aids, tissue regenerating and protecting agents, preservatives and thickening agents. | 08-20-2009 |
20090208595 | Extract of plant Dendrobii caulis and preparing process thereof - An extract of plant | 08-20-2009 |
20090214676 | METHOD FOR TREATING OCULAR DEMODEX - The present invention relates to a method for treating a disorder chosen from ocular | 08-27-2009 |
20090214677 | Pharmaceutical Composition Containing an Extract of a Solidago Species - An extract of a part of a | 08-27-2009 |
20090214678 | Herbal Formulation for the Prevention and Management of Diabetes Mellitus and Diabetic Micro-Vascular Complications - A novel herbal formulation for the prevention and management of diabetes mellitus and its significance in the prevention of diabetic micro-vascular complications. A novel herbal formulation for the prevention of endothelial dysfunction Diabetes Mellitus and Diabetic Micro-Vascular complications comprising: | 08-27-2009 |
20090220622 | USE OF MIMOSINE OR A DERIVATIVE THEREOF FOR TREATING THE CUTANEOUS EFFECTS OF PSORIASIS AND RELATED SKIN DISORDERS, AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING SAME - The present invention relates to the use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders. | 09-03-2009 |
20090232911 | Use of sericin for improving feeling in use of denture - The purpose is to prevent, ameliorate or relieve various conditions induced in the dried oral cavity or to improve the stability of a denture during use. A solution for treating a denture or a denture stabilizer comprising sericin can be used. | 09-17-2009 |
20090232912 | Method For Preparing Extract For The Prevention and Treatment Of Hyperlipidemia and Obesity From the Extract of Aster Spathulifolius Aerial Part and Composition Containing The Same - The present invention relates to a method for preparing an extract of the aerial part of | 09-17-2009 |
20090232913 | Composition for the Control of Cholesterol Levels - The present invention relates to a composition used to control cholesterol levels. In particular, the present invention relates to a method for the treatment or prevention of disorders or diseases mediated by hyperlipidemia, said method comprising administering to a mammalian subject in need thereof an effective amount of a composition comprising an extract from at least one plant from the genus | 09-17-2009 |
20090238899 | METHOD FOR RAPID IDENTIFICATION OF PHARMACOLOGICALLY ACTIVE CHEMICAL ENTITIES ASSOCIATED WITH THE EFFICACY OF ETHNOBOTANICAL SUBSTANCES - The method includes the steps of performing in-vitro liver, intestinal and/or expressed enzyme assays with selected ethnobotanical substances, for both humans and a variety of animal species, to produce an array of resulting chemical entities, such as metabolites, for the human and the animals. Comparisons are then made between the chemical entities from the human in-vitro studies and the animal in-vitro studies to determine the closest match. The animal with the closest match is then used for an in-vivo study. If a match is present between the animal in-vivo results and the human in-vitro results, the matched chemical entity is isolated or synthesized and then further tested to determine the suitability of the matched chemical entity as a treatment drug. | 09-24-2009 |
20090238900 | NOVEL ANTI-DIABETIC HERBAL COMPOSITION, METHOD FOR PREPARING THE SAME AND USE THEREOF - Disclosed is an herbal composition for the treatment of Type II diabetes and their associated secondary complications in humans, wherein said composition comprising extract of roots of | 09-24-2009 |
20090238901 | Method for Treatment of Constipation-Predominant Irritable Bowel Syndrome - The present invention provides methods for treating constipation-predominant irritable bowel syndrome comprising administering to a patient in need thereof, a polymeric proanthocyanidin composition from a | 09-24-2009 |
20090246299 | FAT COMPOSITION - The present invention relates to fat composition, more specifically relates to 60% to 99.9% by weight of diglyceride containing 0.1 to 89.9% by weight of conjugated linoleic acid; 0.001% to 0.2% by weight of banaba extracts fermented by microorganism such as | 10-01-2009 |
20090252817 | Methods for the treatment or prevention of Diabetes Mellitus and other metabolic imbalances - The invention relates to methods for treatment and prevention of a metabolic imbalance, including diabetes mellitus and other related diseases or disorders, using an extract from a fruit of genus | 10-08-2009 |
20090252818 | Curcuma longa (turmeric) based herbal compound formulations as dietary supplements - Herbal compound formulations using herbs | 10-08-2009 |
20090258093 | Use of a brassocattleya marcella koss orchid extract as an active agent to prevent or delay the appearance of signs of cutaneous aging - The present invention describes the use of an extract from the | 10-15-2009 |
20090263509 | ANTIBACTERIAL AGENT AND ANTIBACTERIAL COMPOSITION - The problems to be solved by the invention are to provide antibacterial agents originated from natural products that are safe for regular use with potent antibacterial activity, and antibacterial compositions containing said antibacterial agents. Antibacterial agents containing Eysenhardtia adenostylis extract or isoflavan compounds are a solution to the problem. Also antibacterial agents containing Eysenhardtia adenostylis extract or isoflavan compounds as active ingredients. The antibacterial agents can be applied to products such as cosmetics, including quasi-drugs, pharmaceuticals and foods. Further, antibacterial compositions containing these antibacterial agents, Eysenhardtia adenostylis extract or isoflavan compounds, and other compositions such as cosmetics, including quasi-drugs, pharmaceuticals and foods. | 10-22-2009 |
20090263510 | Process of making Hoodia plant extract with improved flavor - Processes of making extracts of | 10-22-2009 |
20090263511 | INSECTICIDAL COMPOSITION - The use of dill oil or a mixture of two or more components thereof as a potentiator for a pesticide, such as an insecticide and in particular a pyrethroid is described, together with compositions containing dill oil, and their use in agriculture and in veterinary applications. | 10-22-2009 |
20090263512 | COMPOSITION COMPRISING XANTHOCERAS SORBIFOLIA EXTRACTS, COMPOUNDS ISOLATED FROM SAME, METHODS FOR PREPARING SAME AND USES THEREOF - This invention provides compositions, methods and process of producing extracts from | 10-22-2009 |
20090269423 | Foot-bath Agent of Chinese Herbal Medicine for Regulating Blood pressure and Improving Sleep Quality - The present invention relates to a foot-bath agent of Chinese herbal medicine for regulating blood pressure and improving sleep quality, and the components of the formula thereof are as follows: fructus leonuri 20-25%, semen ziziphi spinosae 15-20%, calcined magnetitum 17-22%, spica prunellae 15-20%, ligusticum chuanxiong hort 18-23%, borneolum 0.7-1.2%; provided that, after the final product is prepared using the above raw materials and the blending ratios thereof, the sum of all components should be 100% by weight. The foot-bath agent prepared has advantages including an efficacious and healthy method thereof being highly consistent with healthy living habits of people, an effective regulation of blood pressure and improvement of sleep quality, no allergy and less side effects to human body, and thus obviously is worthy to be popularized and has market prospect. | 10-29-2009 |
20090269424 | Peripheral blood flow-improving composition - The present invention provides a composition that can effectively improve peripheral blood flow to thereby ameliorate cold sensation, numbness, pains and other skin symptoms, as well as frostbites, chilblains and chaps and other skin disorders associated with disturbed peripheral blood flow. This composition has no side effects. Specifically, the peripheral blood flow-improving composition contains, as an active ingredient, a extract of a plant of the genus | 10-29-2009 |
20090274777 | Dietetic composition - (Problems) To provide a highly safe dietetic composition originating in green coffee beans by which excellent dietetic effects can be obtained and which contributes to the prevention and treatment of life style-related diseases such as diabetes. | 11-05-2009 |
20090274778 | Compositions Exhibiting Inhibition Of Cyclooxygenase-2 - The invention provides a method of treating diabetes by administering to an individual having diabetes a composition containing a hops extract. In a particular embodiment, an individual having diabetes can be administered a composition comprising a first component selected from the group consisting of alpha acids and beta acids, essential oils, fats and waxed, with the proviso that the first component and second component are not the same compound. The invention additional provides a method of treating diabetes by administering to an individual having diabetes a composition comprising a first component selected from a curcuminoid and a second component selected from an alpha acid and a beta acid. | 11-05-2009 |
20090274779 | Use in the cosmetics field of an extract of an exsudate of the plant daniellia oliveri, in particular as an antiwrinkle agent - The invention relates to the use, in a cosmetic composition or for the production of a cosmetic composition, of an extract of an exsudate of the plant | 11-05-2009 |
20090280195 | Methods for the treatment of addictive disease and addiction to chemical substances and addictive behaviors using a formula containing the following formulation: Mucuna pruiens, N Acetyl L Cysteine, Magnesium Citrate - The invention is directed at the formulation of | 11-12-2009 |
20090280196 | CISSUS QUADRANGULARIS PLANT EXTRACTS FOR TREATING OSTEOPOROSIS AND THE EXTRACTION PROCESS THEREOF - The invention relates to compositions and methods for preventing, treating, or managing osteoporosis or conditions which are characterized by increased bone resorption, comprising administration of a prophylactically and therapeutically effective amount of | 11-12-2009 |
20090280197 | CELL ACTIVATOR, COLLAGEN PRODUCTION PROMOTER, SKIN WHITENING AGENT, ANTIOXIDANT AGENT, ANTIINFLAMMATORY AGENT, AROMATASE ACTIVITY PROMOTER, PROTEASE ACTIVITY PROMOTER, EXTERNAL PREPARATION FOR SKIN, AND FOOD - The present invention provides a cell activation agent, a collagen production accelerator, a whitening agent, an antioxidant, an anti-inflammatory agent, an aromatase activity accelerator, a protease activity accelerator, a skin external preparation, and food, which all contain an extract of | 11-12-2009 |
20090285910 | Composition Comprising the Extract of Dioscorea Opposita Thunb Showing Neuronal Cell-Protecting Activity for Preventing and Treating Brain Disease - The present invention relates to a composition comprising an extract of | 11-19-2009 |
20090285911 | Cynara scolymus extracts, the use thereof and formulations containing them - The present invention relates to the preparation of a | 11-19-2009 |
20090285912 | Food Supplement and Method for Enhancing Athletic Performance - Food supplements comprising | 11-19-2009 |
20090285914 | Composition Comprising Hovenia Dulcis Thunb. Extract, Lindera Obtusiloba Blume Extract, or Herbal Mixture Extract Thereof - The present invention relates to a method for treating or preventing fibrosis and improving kidney function comprising administering a | 11-19-2009 |
20090291153 | Health food, Method for producing the same and dried Product and Extract - Conophylline, contained in leaves of | 11-26-2009 |
20090291154 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF HYPERLIPIDEMIA, PROCESSES FOR PRODUCING THE SAME AND THE USE THEREOF - The present invention discloses a pharmaceutical composition comprising | 11-26-2009 |
20090291155 | Herbal Composition - The present invention relates to a novel herbal composition comprising extract of leaves of | 11-26-2009 |
20090297636 | SENSORIC IMPRINTING - The invention concerns a method for exposing an infant to multiple different tastes of food products and stimulating the consumption of e.g. vegetables and fruit later in life. | 12-03-2009 |
20090297637 | Estrogenic Extracts of Anemarrhena Asphodeloides Bge. from the Liliaceae Family and Uses Thereof - Estrogenic extracts of | 12-03-2009 |
20090297638 | ESTROGENIC EXTRACTS OF Anemarrhena asphodeloides Bge. from the Liliaceae Family and USES THEREOF - Estrogenic extracts of | 12-03-2009 |
20090297639 | Cosmetic treatement method for fighting against skin ageing effects - The present invention relates to a method of cosmetic treatment for combating the effects of skin ageing and to novel cosmetic compositions which are particularly suitable for carrying it out. | 12-03-2009 |
20090304822 | Extract of Polygonum multiflorum Thunb. ex Murray var. hypoleucum and compositions for improving metabolic syndrome - An extract of | 12-10-2009 |
20090304823 | NUTRITIONAL COMPOSITIONS FOR PROMOTION OF BONE GROWTH AND MAINTENANCE OF BONE HEALTH AND METHODS REGARDING SAME - Compositions and methods for maintenance of bone health or prevention, alleviation and/or treatment of bone disorders are presented. The present invention also provides the manufacture of a nutritional product, a supplement or a medicament for promoting bone growth or for the maintenance of bone health and methods regarding same. In an embodiment, the present invention provides a composition comprising an active ingredient having an effective amount of a plant or plant extract containing at least one phytochemical having the ability to induce bone morphogenic protein expression. | 12-10-2009 |
20090304824 | Rapid-Melt Compositions, Methods of Making Same and Methods of Using Same - A novel rapid-melt composition, including methods of making the same, and methods of using the same for the delivery of prophylactic and therapeutic active materials to a mammal. The rapid-melt compositions are formed by molding or compression, with an additional heating step being preferred. | 12-10-2009 |
20090304825 | ESTROGENIC EXTRACTS FOR USE IN TREATING VAGINAL AND VULVAR ATROPHY - Estrogenic extracts of | 12-10-2009 |
20090304826 | Method and composition for dermatoses - The invention provides a method and composition for treating dermatoses by topical application of a composition containing an antihistamine, an NSAID and optionally a botanical medicinal compound. The compositions are useful for skin conditions such as inflammatory skin conditions, including eczema, atopic dermatitis, non-allergic dermatitis, psoriasis and rosacea, or any inflammation of the skin. | 12-10-2009 |
20090304827 | Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects - Nutritional supplement compositions comprising selected herbs and/or herbal constituents thereof that provide synergistic anti-inflammatory effects are disclosed. | 12-10-2009 |
20090311349 | METHOD OF QUANTIFICATION OF MULTIPLE BIOACTIVES FROM BOTANICAL COMPOSITIONS - A method of quantifying multiple bioactive compounds is disclosed. | 12-17-2009 |
20090311350 | COMPOSITIONS FOR ALLEVIATING INFLAMMATION AND OXIDATIVE STRESS IN A MAMMAL - An antioxidant-promoting composition that increases antioxidant defense potential in a subject is disclosed comprising | 12-17-2009 |
20090317493 | Trehalose-containing topical drying composition and method of using same - A topical drying composition is providing containing trehalose as the effective moisture (sweat) removing ingredient. The composition may be used in aqueous form or preferably as a cream and in addition to trehalose it contains several ingredients such as sorbitan monolaurate, polysorbitan, a moisturizer, a thickener, a softener, an antibacterial agent and a pH adjusting component to adjust the pH of the composition between about 5.5 to about 7.5. Sterilized water is used as the carrier for the composition. | 12-24-2009 |
20090317494 | Herbal composition containing COX-2 and its manufacturing method - A herbal composition, containing natural COX-2, includes a powder of Labiatae plant, wherein the herbal composition is prepared by a method including the steps of dehydrating the Labiatae plant and grinding the dried Labiatae plant into a powdered form. The herbal composition is used for treatment of a disease including Nephritis, Lymphoma and colorectal cancer, Acute, chronic, and bile-reflux cholecystitis, and aphonia. The herbal composition is formed as an internal treatment having an administrative form selected from the group consisting of capsule, powder, solution, and syrup. The herbal composition is formed as an external treatment by mixing the powdered Labiatae plant with “Vaseline”. | 12-24-2009 |
20090324750 | PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF PSEUDOLYSIMACHION LONGIFOLIUM AND THE CATALPOL DERIVATIVES ISOLATED THEREFROM HAVING ANTIINFLAMMATORY, ANTIALLERGIC AND ANTIASTHMATIC ACTIVITY - The present invention relates to a composition comprising an extract of | 12-31-2009 |
20090324751 | CHINESE HERB EXTRACT FOR TREATING DEMENTIA AND PREPARATION METHOD THEREOF - The present invention relates to a | 12-31-2009 |
20090324752 | COSMETIC USE OF ACTIVE INGREDIENTS INCREASING THE PRODUCTION OF GROWTH FACTORS - The invention relates to a cosmetic skin care method, intended to prevent and/or treat at least one cutaneous sign of ageing, including topical application to the skin of a composition containing at least one botanical active ingredient which increases the production by keratinocytes of at least one growth factor chosen from bFGF and PDGF. | 12-31-2009 |
20090324753 | Product and composition for alleviating post-menstrual symptoms - The current invention relates to a natural composition for topical application to skin to alleviate post-menstrual symptoms of cramping, backache, and breast tenderness; and for other aches and pains including Rheumatic, muscular and articular pains; and local treatment such as tendinitises, tennis elbow, benign distorsions, arthritis, osteoarthritis, neuralgia, sciatic nerve, lumbago, back pains, migraine, stiff neck, and insect bites. In one embodiment, the composition of the cream or lotion includes active natural ingredients of Carapa procera and Calotropis procera with shea butter and soy oil. In one embodiment the composition includes, by weight percent, 30% to 80% Butyrospermum parkii (Shea butter); 10% to 30% Glycine poja (soy); 10% to 30% Carapa procera; 3% to 10% Calotropis procera; and 3% to 10% Menthol. | 12-31-2009 |
20100003351 | COMPOSITIONS COMPRISING RHODIOLA ROSEA AND METHODS OF USE THEREOF - The present invention relates to compositions and kits comprising an extract of | 01-07-2010 |
20100009016 | DEHYDROEPIANDROSTERONE PRODUCTION PROMOTER AND USE THEREOF - A new orally administerable DHEA production promoter is provided. A composition containing an extract of at least one selected from the group consisting of plants of | 01-14-2010 |
20100009017 | Anticancer Methods Using Extracts of Anemarrhena asphodeloides Bunge - Selective apoptotic extracts of | 01-14-2010 |
20100021567 | Peganine Isolated from Anisotes Trisulcus L. as a Smoking Deterrent and Anorxigenic Agent - This patent concerns the discovery of the effectiveness of an alcoholic total extract of the aerial parts of the plant | 01-28-2010 |
20100021568 | Anti-Obesity Product And Its Method Of Preparation - The present invention relates to compositions comprising one or more anthraquinones for use in the treatment of obesity and related metabolic and liver disease. More particularly it relates to a plant extract fraction rich in anthraquinones including both anthraquinone glycosides and anthraquinone aglycones obtainable from a member of the Leguminosae family, more particularly | 01-28-2010 |
20100021569 | Use of Extracts from AMTHS plants in Lowering Blood Glucose - The present invention discloses the use of extracts from the plants of the genus | 01-28-2010 |
20100028463 | EXTRACT OF STEWARTIA KOREANA AND USE THEREOF - The present invention relates to an extract of | 02-04-2010 |
20100028464 | USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATEITY AGENT FOR TREATMENT OF OBESITY - Use of saffron and its active ingredients, such as safranal and/or picrocrocin and/or crocin and/or derivatives thereof, for the production of an active satiation agent for the treatment of problems of overweight. | 02-04-2010 |
20100028465 | COMPOSITION FOR AMELIORATING CEREBRAL FUNCTION - Provided is a substance which is a safe material such as a food component and an extract of a natural product and has a stronger effect of ameliorating a cerebral function (effect of ameliorating a metabolism of monoamines as an intracerebral neurotransmitter and ameliorating deterioration in memory and learning due to hypofunction of a cholinergic neuron). The present invention provides a composition for ameliorating a cerebral function, comprising an alkali-stable lipid from an acetic acid bacterium, N-acylsphinganine or N-2′-hydroxypalmitoyl-sphinganine, as an active ingredient. | 02-04-2010 |
20100028466 | CAROTENOID COMPOSITIONS CONTAINING MODIFIED GUM ACACIA - The present invention relates to compositions containing modified gum acacia and carotenoids, wherein the gum acacia has been subjected to a heat-treatment at a temperature between 100° C. and 115° C. for 1 to 38 hours, wherein the composition comprises less than 40 weight-% oil. It has been found that the compositions according to the invention allow to produce emulsions having a very high color intensity, color stability. These compositions can be used for the enrichment, fortification and/or coloration of food beverages, animal feed, cosmetics or pharmaceutical compositions. The present invention also refers to the preparation of such compositions, wherein it has been found that the emulsification time in the manufacturing process of the compositions can be reduced when using a modified gum acacia in carotenoid compositions with less than 40 weight-% oil. The present ‘invention furthermore refers to a process for the manufacture of a beverage by mixing the compositions with ingredients of beverages. The present invention also refers to beverages obtainable by this process. | 02-04-2010 |
20100034903 | SHINYLEAF YELLOWHORN EXTRACT, METHODS FOR EXTRACTION AND USES THEREOF - An extract of | 02-11-2010 |
20100034904 | COMPOSITION COMPRISONG RUTIN AND POLYUNSATURATED FATTY ACID HAVING AN INHIBITORY ACTIVITY ON 5-ALPH REDUCTASE - The present invention relates to the use of selected active principles of a natural origin in substitution of extract from Boehmeria Nipononivea for regulating the trophism of hair follicles and the production of sebum on the skin and its use in alopecia, with considerable practical advantages and with respect to the safety profile. | 02-11-2010 |
20100034905 | Method of treating burns - In a first aspect, the present invention provides compositions for treating burns. The compositions, containing effective amounts of a processed | 02-11-2010 |
20100034906 | STEAM DISTILLATION OF CATMINT PLANTS - This invention provides processes for improved recovery of essential oil from the catmint (catnip) plant | 02-11-2010 |
20100040704 | Composition and method for weight reduction - Disclosed is a composition and method for facilitating weight loss in individuals. The composition is a physiologically effective amount of the herbal substance | 02-18-2010 |
20100040705 | PEST REPELLENT - A pest repellent is disclosed having long lasting and high repelling efficacy against sanitary insects such as mosquitoes and which is highly harmless to humans. In at lease one embodiment, the pest repellent contains copaiba oil and/or an extract thereof as well as DEET and/or bisabolol. | 02-18-2010 |
20100040706 | METHOD OF ANTI-AGEING COSMETIC CARE BY STIMULATION OF SURVIVIN EXPRESSION - The invention relates to a cosmetic care method comprising the delivery of an effective amount of at least one cosmetically acceptable agent that activates or stimulates survivin expression in the stem cells of the basal layer of the epidermis. The invention makes it possible in particular to prevent or delay the appearance of the signs of skin aging or to treat them. | 02-18-2010 |
20100040707 | INGESTIBLE COMPOSITIONS CONTAINING EXTRACTS - The present invention relates to ingestible compositions containing | 02-18-2010 |
20100047370 | PHARMACEUTICAL COMPOSITION WITH ANTIFUNGAL ACTIVITY CONTAINING CYMBOPOGON NARDUS, ITS PROCESS, AND USE - The present invention refers to the application of extracts of | 02-25-2010 |
20100055208 | Insecticidal Compositions and Uses Thereof - The present invention provides compositions and methods for controlling plant pests. In particular, the present invention provides plant extracts with insecticidal activity. | 03-04-2010 |
20100055209 | Standardized Extract And Its Use In The Manufacture Of A Medicament - The present invention refers to a medicament which activates gastrointestinal movement. The medicament consists essentially of Cucurbitacin D and one or more substances form the group including Cucurbitacin A, Cucurbitacin B, Cucurbitacin E, Isocucurbitacin B and Isocucurbitacin D. The medicament is made from an extract obtained from Muskmelon Base, the fruit stem of | 03-04-2010 |
20100055210 | COSMETIC COMPOSITION FOR PROTECTING SKIN AGAINST UV LIGHT AND WRINKLE IMPROVEMENT CONTAINING THE EXTRACT OF MAGNOLIA SIEBOLDII FLOWER EXTRACTS - Disclosed herein is a cosmetic composition for preventing photoaging, containing an extract of | 03-04-2010 |
20100055211 | PROCESS FOR PRODUCING REFINED NUTRACEUTIC EXTRACTS FROM ARTICHOKE WASTE AND FROM OTHER PLANTS OF THE CYNARA GENUS - Process for fractioning and refining natural products obtainable from waste vegetal material and particularly from artichoke ( | 03-04-2010 |
20100062083 | DERMAL FILM-FORMING LIQUID FORMULATIONS FOR DRUG RELEASE TO SKIN - The present invention is directed to liquid compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, forming a dermal film after application onto the skin, useful for delivery of actives onto the skin surface and in the stratum corneum. | 03-11-2010 |
20100062084 | Treatment Of Gastrointestinal Diseases - The present invention relates to compositions (including medicaments and nutritional products) for use in the prevention or treatment of gastrointestinal disease. Such compositions comprise a therapeutically effective amount of a less than or equal to 4 kDa soluble fraction derivable from potato juice. | 03-11-2010 |
20100062085 | TREATMENT OF DAMAGED SKIN - A medicament for treating skin is described. It comprises essentially of | 03-11-2010 |
20100062086 | Compositions and Methods of Their Use for Improving the Condition and Appearance of Skin - The present invention relates to compositions and methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, where the compositions include natural plant constituents, or synthetic equivalents thereof, which inhibit or decrease expression of C-reactive protein expression, production or secretion, thereby reducing, inhibiting, or ameliorating dermatological signs of aging. The compositions of the invention may be topically applied to the skin, or are delivered by directed means to a site in need thereof, in an amount effective in improving the condition and aesthetic appearance of skin. | 03-11-2010 |
20100068309 | METHOD OF EVALUATING SKIN BARRIER FUNCTION, METHOD OF SCREENING MATERIAL FOR ENHANCING SKIN BARRIER FUNCTION USING THE EVALUATING METHOD, THE MATERIAL FOR ENHANCING SKIN BARRIER FUNCTION, AND COSMETIC CONTAINING THE MATERIAL FOR ENHANCING SKIN BARRIER FUNCTION - A method for developing an excellent material for enhancing skin barrier function, and providing a cosmetic which is developed based on the method and has excellent ability to enhance skin barrier function is described. The method evaluates skin barrier function by the steps of 1) culturing normal human epidermal cells in wells having a semipermeable membrane with two sides, in presence and absence of a test substance; 2) adding a medium not containing metal ions to a first side of the semipermeable membrane in each well and a medium containing the metal ions to a second side of the semipermeable membrane in each well, provided that the cells are adhered to the first side of the semipermeable membrane; 3) culturing the cells; 4) measuring the concentration of the metal ions in each medium; and 5) calculating permeability of the metal ions in the epidermal cell layer based on the measured concentrations of the metal ions in each media. The test substance is effective for enhancing skin barrier function when the permeability is reduced in the medium in which the test substance is added compared to the permeability in the medium in which no test substance is added. The larger the level of reduced permeability, the higher the suitability of the test substance as a material for enhancing skin barrier function. | 03-18-2010 |
20100068310 | EXTERNAL COMPOSITION FOR SKIN CONTAINING SCROPHULARIA BUERGERIANA MIQ. EXTRACT AND THE USE THEREOF FOR THE SKIN MOISTURIZING COSMETICS - Disclosed herein is a skin external composition for alleviating dry skin symptoms, which contains an extract of | 03-18-2010 |
20100068311 | Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus - A medicinal preparation, a process, a nutritional composition and regenerative and insulin potentiating method for humans and also for mammals for prevention, treatment and management/glycemic control of diabetes mellitus by obtaining optimum glucose level in blood, by administering an extract of | 03-18-2010 |
20100068312 | FORMULATION FOR FEVER REDUCING TREATMENT AND A METHOD AND KIT FOR USING THEREOF - A fever reducing formulation comprising an aqueous solution of acetic acid, sweating inducing plant extracts and fragrant masking ingredients. The solution of acetic acid and the plant extract reduce fever while the fragrant masking ingredients mask the smell of the acetic acid. A kit for reducing fever comprising the above mentioned fever reducing formulation, as well as a container for mixing the formulation, an absorbing material for applying the formulation to the skin and an information and instruction sheet. A method for reducing fever comprising mixing the formulation, moistening an absorbing material with the formulation and applying the absorbing material to the skin. | 03-18-2010 |
20100074975 | Pharmaceutical composition for the prevention and treatment of liver disease comprising a lonicera caerulea L. Var. Edulis extract - Disclosed herein is a pharmaceutical composition having preventative and therapeutic effects on liver diseases, comprising an extract from | 03-25-2010 |
20100080861 | COSMETIC OR DERMATOLOGICAL COMPOSITIONS COMPRISING A MIXTURE OF ESSENTIAL OILS, AND ITS USES THEREOF, PARTICULARLY FOR THE CARE OF SENSITIVE OR SENSITIZED SKIN - The present invention relates to cosmetic or dermatological compositions comprising a combination of a cannabis essential oil substantially free of cannabinoids and a helichrysum essential oil, and to their uses thereof, particularly for the care of sensitive or sensitized skin. | 04-01-2010 |
20100080862 | COMPOSITIONS AND FOODS FOR IMPROVING LIPID METABOLISM - It is intended to provide compositions and foods for use in the treatment, prophylaxis, or amelioration of diseases or symptoms which can be treated, prevented or ameliorated by activating PPAR, in particular, insulin resistant diabetes and hyperlipidemia. Namely, medicinal compositions usable in treating, preventing or improving diseases or symptoms which can be treated, prevented or ameliorated by activation PPAR which contain humulones, isohumulones or lupulones or pharmaceutically acceptable salts or solvates thereof. | 04-01-2010 |
20100092581 | ANTIBACTERIAL COMPOSITIONS COMPRISING AN EXTRACT FROM ARCEUTHOBIUM - This application relates to an antibacterial composition comprising an extract from a plant belonging to the genus | 04-15-2010 |
20100098783 | APPETITE SUPPRESSANT COMPOSITION - A chewable appetite suppressant composition includes a | 04-22-2010 |
20100098784 | CAPSULE CONTAINING PLANT PREPARATIONS - The invention relates to a composition containing a lipophilic extract of | 04-22-2010 |
20100098785 | Composition of Ashwagandha and Indian Gooseberry - A therapeutic composition comprising extracts of the plant species ashwagandha ( | 04-22-2010 |
20100098786 | FORMULATION CONTAINING A CARBOXYLIC ACID OR AN ESTER THEREOF - A formulation comprising eicosapentaenoic acid, or an ester thereof, and a triterpene, or an ester thereof, and the use of such a formulation. | 04-22-2010 |
20100104668 | NUTRITIONAL SUPPLEMENT FOR HONEYBEES - A nutritional supplement for honeybees includes plant material chosen from a group comprised of plants known to provide nutrients to the honeybees, a beverage brewed from the plant material and a sugar base upon which the beverage is applied where, when the beverage has dried, the nutritional supplement is formed and can be distributed to supplement a normal honeybee feeding thereby providing a more balanced diet that at least in part helps to strengthen immune systems of the honeybees. The group includes plants known to, at least in part, stimulate a queen honeybee to lay eggs, stimulate hygienic behavior in a honeybee colony, provide a preventive maintenance against disease treat and reduce bacteria, fungus and viruses treat and reduce honeybee dysentery, reduce pests in a honeybee colony, such as tracheal and varroa mite and treat and reduce Deformed Wing Virus in a honeybee colony. | 04-29-2010 |
20100104669 | Method for preparing an aqueous solution containing triterpenic acid, aqueous solution containing triterpenic acid, and use thereof - A method for preparing an aqueous solution containing triterpenic acid, an aqueous solution containing triterpenic acid, and use thereof, includes preparation of a basic aqueous solution containing triterpenic acid and reduction of the pH of the basic aqueous solution containing triterpenic acid by adding an acidic aqueous solution in the presence of a stabilizing additive. The system may also provide an aqueous physiological solution of a plant extract containing triterpenic acid, a method for preparing same, and use thereof for therapeutic purposes that includes aqueous physiological solutions rich in triterpenic acid which includes pharmacologically effective amounts of triterpenic acids. | 04-29-2010 |
20100104670 | USE OF CHITOSANS FOR THE TREATMENT OF NAIL INFLAMMATORY DISEASES - Chitosan-based nail formulations are useful to treat nail inflammatory diseases like psoriasis, atopic dermatitis and | 04-29-2010 |
20100112096 | DRY EXTRACTS OF PELARGONIUM SIDOIDES AND PELARGONIUM RENIFORME - The invention relates to production methods for obtaining dry extracts from | 05-06-2010 |
20100112097 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER AND HEALTH FOOD CONTAINING THE SAME FOR PREVENTING AND TREATING CANCER - A pharmaceutical composition for treating and preventing cancer, and health food for ameliorating and preventing cancer containing the pharmaceutical composition are provided. The pharmaceutical composition includes | 05-06-2010 |
20100119627 | SPECIAL EXTRACT AND USE THEREOF FOR INHIBITING THE DEGRADATION OF CYCLIC GUANOSINE MONOPHOSPHATE (cGMP) - A process for the preparation of an extract from a plant of the Turneraceae family, comprising the steps of:
| 05-13-2010 |
20100119628 | Anti-aging cosmetic composition - The present invention relates to an anti-aging cosmetic composition, and more particularly, the present invention relates to an anti-aging cosmetic composition containing | 05-13-2010 |
20100129475 | ESSENTIAL OIL OF KUNZEA AMBIGUA AND METHODS OF USE - A method for treating disease includes the steps of obtaining the essential oil from the Kunzea ambigua plant and administering the essential oil obtained to a human to take internally. The essential oil of the Kunzea ambigua plant has been discovered to act positively against parasitic infestation of humans and animals, and also has been found to have high kill rates against various viral and bacterial infections. | 05-27-2010 |
20100136144 | COMPOSITION CONTAINING A QUINOA EXTRACT FOR DERMATOLOGICAL USE - The present invention relates to a composition containing a quinoa grain extract, said extract being a peptidic and osidic extract or a lipidic extract of quinoa grain, said lipid quinoa extract being itself chosen from a group comprising an oil concentrated into its non saponificable fraction, a non saponificable, or a refined oil. The invention also relates to methods for preparing these different extracts and to dermatological or neutraceutic applications of these extracts. | 06-03-2010 |
20100136145 | FORMULATIONS CONTAINING CYNARA SCOLYMUS AND PHASEOLUS VULGARIS EXTRACTS WHICH ARE USEFUL IN THE TREATMENT OF OBESITY | 06-03-2010 |
20100143508 | Limonene and yucca medical compound for treating human diseases and conditions - A medical compound for treating a wide variety of human diseases and conditions comprises a medically effective amount of a yucca extract, an effective delivery-enhancing amount of d-Limonene and an organic solvent as the active components. The inactive components include one or more inert solvents and an inert emulsifier. In the preferred embodiment, the yucca extract is Sarsasapogenin at 45% by volume, the d-Limonene is in an amount of 19.1% by volume and the organic solvent is 2-Butoxyethanol at 13.5% by volume. The inert components, making up the rest of the compound, are the inert solvent isoparaffinic fluid, the inert emulsifier sodium dodecylbenzene sulfonate and the inert solvent isopropylamine. The medical compound has a unique delivery system that readily enters the systemic circulation and rapidly reaches the target tissue and/or organs to quickly begin the process of restoring and healing the patient by boosting his or her immune system. | 06-10-2010 |
20100143509 | THERAPEUTIC COMPOSITIONS FROM JAMAICAN BITTER YAM AND METHODS OF MAKING AND USING SAME - The invention relates to therapeutic compositions, in particular to therapeutic compositions made from Jamaican bitter yam that are substantially free of tannins and alkaloids and comprise fiber, and methods of making and using such therapeutic compositions. | 06-10-2010 |
20100151057 | MEDICINAL HERBAL EXTRACT HAVING ANTI-OBESITY EFFECT - Disclosed is an anti-obesity active extract obtained from a medicinal plant. More specifically, the extract obtained from lysimachiae foenum-graeci herba (which is a medicinal plant traditionally used in the East) can be used as an active ingredient for a raw material, a functional food, cosmetic, a crude drug, etc. for an obesity preventing or therapeutic agent because the extract can suppress the adipocyte differentiation and decrease the body weight and body fat in an obese animal, thereby suppressing fat accumulation (that is, a factor for obesity). | 06-17-2010 |
20100151058 | COMPOSITIONS FOR PRODUCING SATIETY - Long term weight loss can be achieved and maintained with a formulation of over-the-counter life-enhancing dietary supplements. One or more supplements stimulate the release of serotonin within the brain and one or more supplements stimulate the release of cholecystokinin into the bloodstream. The combined potentiating effect of these two mechanisms on satiety enables greater weight loss than that previously achieved by the individual mechanisms acting alone. A third weight loss mechanism can be achieved with the addition of phenylethylamine. Even more effective weight loss formulations can be achieved with the addition of a blue-green algae, such as aphanizomenon flos aqua, to provide a longer lasting weight loss mechanism. | 06-17-2010 |
20100151059 | USE OF VITEX AGNUS CASTUS EXTRACTS FOR PREPARING A MEDICAMENT - The present invention relates to the use of fruit extract from | 06-17-2010 |
20100166890 | ANTITUSSIVE COMPOSITION AND METHOD FOR MAKING THE SAME - An antitussive composition is provided. A pharmaceutical composition for relieving, preventing and/or treating a cough includes a sufficient amount of the | 07-01-2010 |
20100166891 | Composition comprising hemp oil for treating topical diseases, especially hand-foot syndrome - The invention relates to a novel composition comprising hemp oil for treating topical diseases, in particular the hand-foot syndrome. | 07-01-2010 |
20100173022 | COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS AND METABOLIC SYNDROME - The invention relates to the field of pharmacology. More specifically, the invention relates to a composition for the treatment of diabetes mellitus and/or the metabolic syndrome. Even more specifically, the invention relates to a herbal composition for treating the same. In one of its embodiments, the invention provides a composition comprising a) an anti hyperglycaemic agent b) an anti inflammatory agent c) an anti hyperlipidemic agent d) an anti oxidant agent e) a gastro-intestinal agent, wherein said activities are provided by parts or extracts of | 07-08-2010 |
20100183750 | FORTIFICATION OF PLANTS WITH FOLATES BY METABOLIC ENGINEERING - The invention relates to a transgenic plant overexpressing a polynucleotide encoding a plant GTP cyclohydrolase I (GTPCHI) enzyme. The present invention also relates to a product comprising the transgenic plant of the invention or a harvestable part, plant organ, plant tissue, plant cell, seed, or a propagule of said plant. The present invention further elucidate the use of the plant of the invention to cross breed with other plants, as biofortification to enrich the quality of the food intake of an animal or human subject, for the manufacture of a medicament to prevent folate insufficiency, or, for the treatment of folate insufficiency or diseases or disorders resulting from said insufficiency in an animal or human subject. | 07-22-2010 |
20100189819 | NEURO-DEGENERATIVE INHIBITOR, NEURO-ENDOCRINE MODULATOR, AND NEURO-CEREBRAL METABOLISM ENHANCER - Neuro-metabolic and endocrine-function regulating/modulating compositions, are disclosed. The compositions of the present invention comprise Selegiline Hydrochloride, Procaine Hydrochloride, Vinpocetine, trimethylglycine, and an ingredient selected from a group consisting of N-nicotinoyl-gamma-aminobutyric acid (N-GABA), niacin, niacinamide, gamma-aminobutyric acid (GABA), and combinations thereof. Methods of using the compositions, compositions, and compositions of the present invention are also disclosed. | 07-29-2010 |
20100196518 | Method and Device for the Treatment of Water for Purposes Conducive to Good Health - This invention therefore presents a method and a device for the treatment of drinking water for purposes conducive to good health and the production of wellness and healthcare products. In this method the water to be treated is heavily swirled within a container ( | 08-05-2010 |
20100203174 | PET FOOD COMPOSITION FOR REGULATING BODY WEIGHT AND PREVENTING OBESITY AND RELATED DISORDERS IN PETS - The invention relates to a pet food composition for regulating body weight and preventing obesity and related disorders in pets, which comprises as an active ingredient at least one plant or plant extract having the ability to stimulate energy expenditure and/or fat burning. The invention also relates to a method for improving the health of pets, particularly by preventing obesity and metabolic disorders associated with obesity in pets. It also relates to a method for increasing energy expenditure, controlling the glucose homeostasis and improving activity or mobility of the pet. | 08-12-2010 |
20100209542 | Methods For Treating Withdrawal From Addictive Compounds | 08-19-2010 |
20100209543 | COMPOSITIONS AND METHODS OF USE - This invention relates to the use of plant extracts, compositions thereof, and compounds isolated from plant extracts or obtained from synthetic means thereof, for the treatment of diseases, disorders or symptoms thereof (e.g., proliferation disorders, cancer). | 08-19-2010 |
20100215778 | Method of Prophylaxis - The method of human prophylaxis comprising a number of steps is claim. First, the client is prepared for a steam bath, by applying a herbal paste on the skin, over at least one area of the client's body. The herbal paste is allowed to be absorbed into the client's body for an amount of time of at least five minutes and is followed with a massage the client's body. The client is then placed into a cedar steam barrel, connected to the steam generator, where the client's body is exposed to the steam. Following the stream procedure, the herbal paste is reapplied, the client's body is massaged, and the client to rests and drinks at least one cup of tea. | 08-26-2010 |
20100215779 | Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention - Methods for reducing the risk of or treating a disorder associated with fluid and/or salt retention in a patient are described. The methods include administering to the patient an agent selected from: a) an agent that reduces sodium absorption in the intestine; b) an agent that increases anion secretion in the intestine; or c) an agent that both reduces sodium absorption in the intestine and increases anion secretion in the intestine. | 08-26-2010 |
20100215780 | Method for treating onychoschizia - The present invention is directed to compositions containing a combination of a herb from the genus | 08-26-2010 |
20100221363 | PROCESS FOR THE PRODUCTION OF A STORAGE STABLE FUNGICIDAL EXTRACT OF GLYCYRRHIZA GLABRA FOR THE CONTROL OF PHYTOPATHOGENIC FUNGI AND OTHER PLANT DISEASES - Plant diseases of crops cause huge economic losses in agricultural and ornamental production as well as in public green. Effective management and control of the disease is a major problem and a big challenge for the agricultural production. Applications (in the form of sprays) of extracts derived preferably from the aboveground parts of the | 09-02-2010 |
20100221364 | COMPOSITIONS AND METHODS OF INDUCING HAIR GROWTH UTILIZING COTINUS COGGYGRIA - This application relates to compositions and methods for inducing hair growth and improving hair quality utilizing extracts of | 09-02-2010 |
20100227007 | DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF NELUMBO AND PROCESSES OF USING SAME - Materials derived from | 09-09-2010 |
20100233298 | COSMETIC USE OF PHYTOSPHINGOSINE AS SLIMMING AGENT AND COSMETIC COMPOSITIONS COMPRISING PHYTOSPHINGOSINE - The invention relates to novel cosmetic uses of phytosphingosine or of one of its cosmetically acceptable salts, particularly its hydrochloride, as a slimming agent and/or as an active agent which stimulates the synthesis of leptin by adipocytes, for preparing a cosmetic composition intended for reducing subcutaneous excess fat. | 09-16-2010 |
20100233299 | TOPICAL PHYTOTHERAPEUTIC COMPOUND FOR THE TREATMENT OF HERPES BASED ON UNCARIA TOMENTOSA AND EXTRACTION PROCESS FOR OBTAINING A VEGETAL EXTRACT FROM UNCARIA TOMENTOSA - The present invention concerns a phytotherapic compound for the treatment of herpes based on | 09-16-2010 |
20100233300 | BIO-DERIVED 1,3-PROPANEDIOL AND ITS CONJUGATE ESTERS AS NATURAL AND NON IRRITATING SOLVENTS FOR BIOMASS-DERIVED EXTRACTS, FRAGRANCE CONCENTRATES, AND OILS - Compositions comprising 1,3-propanediol and an extraction product are provided, and the 1,3-propanediol in the composition is biologically derived. Also provided are processes for extracting an extract from a source. These processes comprise providing an ester of 1,3-propanediol and mixing the 1,3-propanediol ester with the source. This serves to extract the extract from the source into the ester. The processes also include separating the source from the ester and extract. Also provided are compositions comprising an ester of 1,3-propanediol and an extraction product. In these compositions, the ester can have at least 3% biobased carbon. | 09-16-2010 |
20100239693 | CANNABINOID-CONTAINING PLANT EXTRACTS AS NEUROPROTECTIVE AGENTS - The invention relates to the use of cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration. In particular, the invention relates to use of one or more cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration, wherein the one or more cannabinoid-containing plant extracts comprise: i) a cannabinoid-containing fraction; and ii) a non-cannabinoid containing fraction. | 09-23-2010 |
20100247684 | SYNERGISTIC PESTICIDE COMPOSITIONS - The present invention relates to compositions that include a combination of one or more pesticides and one or more adjuvants. | 09-30-2010 |
20100255123 | SKIN MOISTURIZER, BLOOD CIRCULATION PROMOTER, AND EXTERNAL PREPARATIONS FOR THE SKIN CONTAINING THE SKIN MOISTURIZER AND THE BLOOD CIRCULATION PROMOTER - An object of the present invention is to provide a moisturizer having excellent moisturizing effects, and a blood circulation enhancer having blood circulation-promoting effects. A plant belonging to the genus | 10-07-2010 |
20100255124 | COMPOSITIONS OF VOLATILE ORGANIC COMPOUNDS AND METHODS OF USE THEREOF - The present invention provides compositions and methods for treating, inhibiting or preventing the developing of a plant pathogenic disease. The compositions comprise volatile organic compounds effective to inhibit the growth of, or kill pathogenic microbes, including | 10-07-2010 |
20100255125 | PROCESS FOR COSMETIC TREATMENT USING FERUTININE FROM FERULA GENUS PLANTS - The invention relates to a process for cosmetic treatment, including the reduction of superficial and deep wrinkles, using ferutinine from | 10-07-2010 |
20100266715 | COMPOSITION FOR TREATING AIDS AND ASSOCIATED CONDITIONS - An Aids and associated conditions related to Aids treating compositions is disclosed. The compositions comprise: a medicament selected from an extract of at least one of the following plant families: Apocynaceae (Pleioscarpa Bicarpellata); Annonaceae (Cleistopholis Patens); Dichapetalaceae (Dichapetehan Madagasca Riense); Annoceae (Uvaristrum Pierreanum); Cynocynaceae (Strophantus Gratus); Asclepiadaceae (Gongronema Latifolium); Combretaceae (Combretum Racemosum); Apocynaceae (Alostonia Boonei); Amaranthaceae (Alternanthera Pungens); Aroceae (Anchomanes Differmis); Cyperaceae (Seleria Voivinil); Anacardiaceae (Lannea Acida); Bignoniaceae (Kigelia Africana); Bombacaceae (Ceiba Pentanota); Anarcardiaceae (Antrocaryon Micraster); Bombacaceae (Bombax Bounopozense): Anarcardiaceae (Spondias Mombin); Caricaceae (Carica Papaya); a glyceryl ester of any of the foregoing extracts; a saponin of any of the foregoing extracts; an alkaloid of any of the foregoing extracts; a protein of any of the foregoing extracts; a fat of any of the foregoing extracts; a sugar of any of the foregoing extracts; and any mixture of any of the foregoing. | 10-21-2010 |
20100272831 | PROCESS FOR MANUFACTURING NANOCOMPOSITE MATERIALS FOR MULTISECTORAL APPLICATIONS - The present invention relates to a process for manufacturing intercalated nanocomposites with a layered structures, characterized in that they contain intercalated food, pharmaceutical or medical contact compliant organic materials and comprises the following steps:
| 10-28-2010 |
20100285153 | Lipolysis Stimulator - To provide a lipolysis agent, a slimming agent, and a cellulite-ameliorating agent, which stimulate decomposition of fat accumulated in the adipose tissue, to thereby exhibit body-slimming effect and which is effective for inhibition or prevention of obesity and amelioration of prone to obesity. The lipolysis stimulator of the invention contains, as effective ingredients, a plant Huang Hua Cai or an extract thereof, and a xanthine derivative. | 11-11-2010 |
20100285154 | USE OF LIGNAN COMPOUNDS FOR TREATING OR PREVENTING INFLAMMATORY DISEASE - The present invention relates to the use of lignan compounds for treating or preventing an inflammatory disease. More particularly, it relates to a method for preventing or treating an inflammatory disease, comprising administering to a subject in need thereof an effective amount of macelignan represented by Chemical Formula I or a pharmaceutically acceptable salt thereof. The lignan compound has the effect of inhibiting inflammatory reactions by inhibiting the production or expression of inflammation mediators NO, iNOS, PGE | 11-11-2010 |
20100285155 | CLEANSER COMPOSITION AND METHODS FOR USING THE SAME - The present invention is directed to anti-microbial cleanser compositions comprising linalool, hinokitiol and dipropylene glycol. The present invention further provides methods for using these compositions to maintain eyelid hygiene, to treat an ocular disorder or to clean a skin surface. The cleanser compositions of the present invention can be in the form of a foam, gel or liquid. | 11-11-2010 |
20100285156 | COMPOSITION FOR PREVENTING AND TREATING METABOLIC DISEASES COMPRISING THE EXTRACT OF LYSIMACHIAE FOENUM-GRAECI HERBA - Disclosed are raw material, functional foods, and herb medicines for preventing and treating metabolic diseases, which comprise a Lysimachiae Foenum-Graeci Herba extract as an effective ingredient. The Lysimachiae Foenum-Graeci Herba extract have an activity of reducing blood glucose levels, triglycerides and cholesterol levels, AST and ALT levels, and fat in the liver, and thus can be effectively used as a hepatic protector and a remedy for preventing and treating various metabolic diseases including diabetes, high blood pressure, fatty liver, cardiovascular diseases, and hyperlipidemia. | 11-11-2010 |
20100291241 | METHOD OF PRODUCTION OF EXTRACT DERIVED FROM Swinglea Glutinosa LEAVES - The invention of the present Application provides a standardized method to obtain an extract and the extract from leaves of | 11-18-2010 |
20100291242 | ANTAGONIST AGAINST TOLERANCE TO ANTICANCER DRUGS - An ABC transporter protein expression inhibitor comprising, as the active ingredient(s), 0.001 to 100 nM of one or more members selected from among steroid hormones, compounds having a female hormone function, analogous compounds thereof and antagonistic inhibitors therefor; an anticancer composition containing this ABC transporter protein expression inhibitor and an anticancer drug; and cells useful in the development of an anticancer drug. The present invention provides a drug which inhibits the expression of an ABC transporter to thereby overcome resistance to anticancer drugs; cancer cells useful in screening such drugs; and an anticancer drug efficacious even against such a cancer as having acquired resistance to anticancer drugs. | 11-18-2010 |
20100291243 | EXTRACTOR HAVING POTTERY WITH A DARK BROWN GLAZE AND THE METHOD FOR EXTRACTING USING THEREOF - Disclosed are an extractor having a “pottery with dark brown glaze” called “Onggi” in Korean, and a method of extracting using the same. The extractor includes a body, a body cover, a heating part, a pottery and a gas valve. The pottery is located within the body. The extractor extracts by injecting nitrogen gas, etc. into the body through a gas valve, thereby rendering the inside of the body to be high pressure state during extraction. Thus, the inside of the body is maintained under high pressure during extraction. Accordingly, an extract is located only within the pottery, and thus changes that can be caused while an extract contacts with the body can be prevented. | 11-18-2010 |
20100297266 | Preparations and methods for textile and or fiber surface finishing, surface finished articles prepared thereby, and uses therefor - Disclosed are food compositions, comprising aqueous extracts of | 11-25-2010 |
20100297267 | Compositions for diabetes treatment and prophylaxis - Gurmarin containing compositions are useful for modulation of glucose metabolism and the treatment of diabetes. Glucose metabolism in a human patient is regulated by isolated gurmarin-containing dosage forms that optionally contain a non-metabolizable polysaccharide such as the exudate of | 11-25-2010 |
20100297268 | AGENT FOR INCREASING BLOOD ADIPONECTIN QUANTITY - An agent for increasing blood adiponectin quantity is provided, the agent including: a pulverized product or extract of a plant of the genus | 11-25-2010 |
20100303933 | IMMUNOPOTENTIATING COMPOSITION FROM LABISIA PUMILA EXTRACT - The present invention relates to an immunopotentiating composition and to a composition accelerating the production of interferon-[gamma]. More particularly to a process for preparation of water-soluble | 12-02-2010 |
20100303934 | METHODS AND COMPOSITIONS FOR NERVE REGENERATION - A method of promoting nerve regeneration in a subject that includes administering to the subject a therapeutically effective amount of a composition that includes at least one therapeutically-active extract fraction of | 12-02-2010 |
20100316736 | APPETITE SUPPRESSANT - Provided is an extract of | 12-16-2010 |
20100316737 | HOMEOPATHIC COMPLEX - The present invention is directed to a homeopathic complex for use in the treatment of various diseases or disorders, including use as an anti-infective agent and/or in the regeneration of diseased or damaged tissue. Ideally, the anti-infective homeopathic complex of the invention may comprise a homeopathic tincture or dilutions thereof of Hepar sulphuris calcareum or other similar profiled Calcarea or Sulphur salt or acid, Lachesis muta or other remedy with a similar profile, Mercurius Solubilis or similar mercury containing remedy and Silica or other silica containing compounds. | 12-16-2010 |
20100316738 | METHODS OF INHIBITING, PREVENTING, KILLING AND/OR REPELLING INSECTS USING SIMULATED BLENDS OF CHENOPODIUM EXTRACTS - The present invention provides natural and/or simulated, synthetic, synergistic pesticidal compositions comprising terpenes, such as extracts from | 12-16-2010 |
20100316739 | Chitosan gel for dermatological use, production method therefor and use of same - Pharmaceutical compositions, based on chitosan, which are suitable to leave a protecting coating on the skin, as well as agents conferring curative, soothing and moisturizing properties to sore skins, are protected. | 12-16-2010 |
20100323038 | Pharmaceutical Compositions - The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects. | 12-23-2010 |
20100323039 | LABISIA PUMILA EXTRACTS FOR REDUCING THE RISK OF CARDIOVASCULAR DISEASES - There is disclosed a standardised aqueous extract of | 12-23-2010 |
20100330208 | APPARATUS AND PROCESS FOR EXTRACTION OF CONSTITUENTS FROM ALTERNATIVE MEDICINAL MATERIAL - An apparatus and process as a system for extraction of constituents from alternative medicinal material is provided. The apparatus includes an outer container containing a solvent liquid, an inner container mounted within the outer container containing an alternative medicinal material, a microwave generator for supplying microwaves to the solvent liquid and the alternative medicinal material, and a motor for rotating the inner container within the outer container. The inner container includes a perforated wall, such that the alternative medicinal material in the inner container can be fully or partially immersed in the solvent liquid. | 12-30-2010 |
20110003017 | Method for Preparation of Extract from Angelica Gigas Nakai and Composition Containing the Extract - Disclosed is | 01-06-2011 |
20110003018 | COMPOSITION FOR PREVENTING AND TREATING ARTHRITIC DISEASES - In some embodiments, a composition for the treatment and inhibition or prevention of arthritic diseases includes an extract of mixed herbs, the mixed herbs including an active ingredient with | 01-06-2011 |
20110008471 | SYNERGISTIC ANTIPARASITIC COMPOSITIONS AND SCREENING METHODS - Compositions for treating parasitic infections and methods of using the compositions to treat subjects with parasitic infections are provided. Methods of selecting compositions for use in treating parasitic infections are further provided. | 01-13-2011 |
20110008472 | ANTI-METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AGENT AND ANTI-VANCOMYCIN-RESISTANT ENTEROCOCCUS AGENT - An anti-methicillin-resistant | 01-13-2011 |
20110014305 | Extracts of eleutherococcus spp., preparation method thereof and use of the same - The present invention relates to extracts of | 01-20-2011 |
20110020476 | Composition based on vegetal extracts of ajuga reptans for preventing hair loss, stimulating the growth of hair, regulating the production of sebum - The present invention relates to preparations based on vegetal extracts of | 01-27-2011 |
20110033561 | USE OF PHYTOECDYSONES IN THE PREPARATION OF A COMPOSITION FOR ACTING ON THE METABOLIC SYNDROME - For reducing the negative effects of the metabolic syndrome on mammal organisms, it is proposed to use phytoecdysones for diminishing the fat body mass in individuals, notably with a weight excess. Phytoecdysones are advantageously incorporated into a food composition. The phytoecdysones can come from food plants, such as quinoa. | 02-10-2011 |
20110038957 | NOVEL NUTRACEUTICAL COMPOSITIONS CONTAINING STEVIA EXTRACT OR STEVIA EXTRACT CONSTITUENTS AND USES THEREOF - The invention relates to a novel nutraceutical composition containing | 02-17-2011 |
20110038958 | USE OF CANNABINOIDS IN COMBINATION WITH AN ANTI-PSYCHOTIC MEDICAMENT - The present invention relates to the use of one or more cannabinoids in combination with one or more anti-psychotic medicaments for use in the prevention or treatment of psychosis and psychotic disorders. Preferably the one or more cannabinoids are taken from the group: cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin acid (THCVA); cannabichromene (CBC); cannabichromenic acid (CBCA); cannabigerol (CBG) and cannabigerolic acid (CBGA). Preferably the anti-psychotic medication is an atypical anti-psychotic medication. | 02-17-2011 |
20110038959 | PLANT-ORIGIN DRUG FOR PREVENTING OR IMPROVING HYPERURICEMIA - This invention provides an agent for preventing or ameliorating hyperuricemia comprising, as an active ingredient, an extract of at least one type of plant raw material selected from the group consisting of | 02-17-2011 |
20110038960 | PREPARATION AND USE OF A PLANT EXTRACT FROM SOLANUM GLAUCOPHYLLUM WITH AN ENRICHED CONTENT OF 1,25-DIHYDROXYVITAMIN D3 GLYCOSIDES AND QUERCETIN GLYCOSIDES - The present invention relates to the preparation of an enriched and equilibrated plant extract from | 02-17-2011 |
20110045105 | COSMETIC USE OF AN OPHIOPOGON JAPONICUS ACTIVE PRINCIPLE - The use of at least one extract that is obtained from | 02-24-2011 |
20110045106 | COFFEE EXTRACT - The present invention relates to a method of producing a coffee extract with antioxidant and anti-inflammatory properties and uses of the extract of the invention. The coffee extract comprises caffeic acid and/or ferulic acid and can be produced by hydrolysing chlorogenic acids present in coffee extract, e.g. with a microorganism or an enzyme. The coffee extract of the invention may e.g. be used as an ingredient of a food or beverage product. | 02-24-2011 |
20110059190 | CISTUS EXTRACT CONTAINING ENRICHED SECONDARY PLANT INGREDIENTS - The invention relates to a method for producing an extract containing at least 40% (m/m) of polyphenols from | 03-10-2011 |
20110059191 | BCL-2 PROTEIN EXPRESSING AGENT, APOPTOSIS INHIBITING AGENT AND AGENT FOR PREVENTING ULTRAVIOLET DNA DAMAGE OF EPIDERMAL CELL - An object of the present invention is to provide an apoptosis inhibiting agent which inhibits apoptosis of a cell having a DNA which is directly or indirectly damaged with ultraviolet-rays or the like, enhances the tissue restoring property of a cell, can be added to various drugs, and can be expected to be widely applied. | 03-10-2011 |
20110091580 | EXTRACT OF ROSMARINUS OFFICINALIS L. LEAVES FOR PHARMACEUTICAL APPLICATIONS - Disclosed are methods of alleviating oxidative stress, regulating blood glucose levels, and controlling pancreatic lipase activity by administering a Rosemary extract. Such methods may be useful to help body weight and body fat, prevent obesity, and treat hyperglycemia, hyperinsulinemia, cardiovascular disease and Type-2 diabetes. Preferred extracts contain 20% or 50% carnosic acid. | 04-21-2011 |
20110091581 | New pharmaceutical function of dichroa febrifuga alkone derivative (DFAD) - A safe pharmaceutical composition for antioxidation, controlling oncoges, inhibiting tyrodine kinase activity and increasing immune function contains | 04-21-2011 |
20110091582 | Method for Obtaining Concentrated Polyphenol Extracts From a Stirring Process - The present invention proposes methods for obtaining concentrated polyphenol extracts resulting from the stirring process, through a step in which a partially purified beer is placed into contact with a resin that adsorbs the polyphenols, followed by a step in which the polyphenols adsorbed onto said resin are recovered. The invention also relates to the extracts thus obtained, which feature remarkable properties, as well as to several applications for these extracts. | 04-21-2011 |
20110091583 | ANTIALLERGIC MARINE BIOPOLYMERS - The present invention relates to pharmaceutical compositions based on carrageenan as an active ingredient, for use as a medicament in the prophylactic or therapeutic treatment of allergic conditions or diseases, with the proviso that the carrageenan comprises iota- and/or kappa-carrageenan and is substantially free of lambda carrageenan. Typically, the invention relates to liquid formulations, gels and dry powder compositions comprising iota- and/or kappa-carrageenan and, optionally, one or more non-carrageenan therapeutic agents for administration to the respiratory tract, the gastrointestinal tract or the eyes. The compositions of the invention have been found to be efficacious in the prevention and treatment of type I allergies and additionally, may exert an adjuvant function upon combined mucosal administration with non-carrageenan therapeutic agents. | 04-21-2011 |
20110104310 | Method of Manufacturing Magnoliidae Compounds - Magnoliidae compounds are made by obtaining parts of Magnoliidae plants. The parts of the Magnoliidae plants are mixed with alcohol and water. The mixture of the parts of the Magnoliidae plants, alcohol and water is heated and the parts of the Magnoliidae plants are removed so that a liquid mixture remains. The liquid mixture is drying to form a solid composition. Alcohol and water are added to the solid composition to reconstitute the solid composition into a liquid composition. The liquid composition is heated to form solid matter. The solid matter is dried to obtain a purified composition of the Magnoliidae compounds. A dose of Magnoliidae compounds promotes weight loss and can be administered in liquid form, sublingually, intravenously, in a pharmaceutically acceptable carrier, in combination with a metabolite detoxification agent, in combination with a nutritional or dietary supplement, or in chewing gum. | 05-05-2011 |
20110104311 | Performance Beverage - A performance beverage for underwater diving or other challenging physiological environments. | 05-05-2011 |
20110111063 | Extended Moisturization Cosmetic Compositions - A cosmetic composition providing a skin moisturizing effect over extended periods of time when applied to skin in need thereof is provided. The composition comprises a skin moisturizing sufficient amount of an extract of an air plant in combination with a cosmetically or dermatologically acceptable carrier. Also provided is a method for providing a skin moisturizing effect over extended periods of time. The method comprises applying to the skin in need of a skin moisturizing effect, a composition comprising a skin moisturizing sufficient amount of an extract of air plant in combination with a cosmetically or dermatologically acceptable carrier. | 05-12-2011 |
20110111064 | Anti-Influenza Virus Agent, Anti-RS Virus Agent, and Anti-Immunodeficiency Virus Agent - The present invention herein provides an anti-influenza virus agent, an anti-RS virus agent or an anti-immunodeficiency virus agent, which comprises components originated from plants and which has excellent infectivity-inhibitory effect and proliferation-inhibitory effect against influenza viruses, RS viruses and immunodeficiency viruses. The anti-influenza virus agent, anti-RS virus agent or anti-immunodeficiency virus agent of the present invention comprises an extract derived from, or dry powder of the leaves of a plant belonging to the family Betulaceae and/or a plant belonging to the family Meliaceae. | 05-12-2011 |
20110117216 | ANTI-TUMOURAL EFFECTS OF CANNABINOID COMBINATIONS - The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM). | 05-19-2011 |
20110117217 | METHOD OF USING GUAVA EXTRACT - A method of using guava extract is disclosed that includes administering guava extract to a mammal to inhibit, prevent or alleviate at least one of a headache, nausea, dry mouth, lack of appetite, shakiness, and fatigue. A composition is also disclosed that includes a pharmaceutically acceptable carrier and guava extract. | 05-19-2011 |
20110123646 | Extracts Obtained from Cell Line Cultures from Plants Belonging to the Oleaceae Family (e.g. Syringa Vulgaris), Their Preparation and Use - The present invention refers to the use of extracts from selected and stabilised cell lines comprising phenylpropanoids with high anti-oxidant capacity having a verbascoside titre of between 20% and 90% and a chromophore-free fraction of between 80% and 10%, in human and veterinary medicine, and for nutritional and cosmetic purposes. | 05-26-2011 |
20110123647 | USE OF EXTRACTS OF CAPRARIA BIFLORA IN THE PREVENTION AND/OR TREATMENT OF SENILE CATARACTS - The invention provides methods for treating and/or preventing the recurrence of a senile cataract, and/or for inhibiting the development of a senile cataract and/or an incipient senile cataract, in a human or animal subject. The invention further provides nutraceutical compositions suited for the same, derived from an extract of the plant | 05-26-2011 |
20110129552 | Acne Treatment - A kit and method for a two-step acne treatment regimen. The kit comprises a wash composition and a cream treatment composition. The method comprising the steps of: using a wash composition to clean acne affected skin of an individual; and applying a cream treatment composition to the acne affected skin. | 06-02-2011 |
20110142964 | Increasing athletic performance in humans with ruta chalepensis extract - The present invention relates to increasing the athletic performance of humans, using ruta chalepensis extract as an oral supplement or medicine. Use of the invention provides increased muscle strength, muscle power, endurance, muscle protein content, and/or reduced fatigue following exercise or competition. | 06-16-2011 |
20110142965 | SKIN MOISTURIZER AND WASHING FORMULATION - Disclosed is a liquid skin cleansing and moisturizing composition comprising a skin moisturizing agent, a cationic guar gum, an anionic surfactant, a zwitterionic surfactant, and a non-lipid structuring agent, wherein the composition is dermatologically acceptable and formulated as a rinse-off composition. | 06-16-2011 |
20110142966 | AQUEOUS EXTRACTS OF ANOECTOCHILUS SPP. KINSENOSIDE AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR HEPATOPROTECTION - A pharmaceutical composition useful for hepatoprotection is provided. The composition comprises an effective amount of kinsenoside or a pharmaceutically acceptable salt or ester thereof. An aqueous extract of | 06-16-2011 |
20110142967 | METHOD OF REDUCING BLOOD CHOLESTEROL AND TRIGLYCERIDE LEVELS USING COMBINATIONS OF VASOPROTECTIVE AGENT - Combinations of vasoprotective agents useful for the treatment of reducing blood cholesterol and triglyceride levels induced by an excess of plasma lipids. The agents include polycosanols, tocotriends and/or lycopene, procyanidole oligomers and vegetable oil rich in insaturated fatty acids. | 06-16-2011 |
20110151028 | Topical vaginal preparation - A topical pharmacological preparation in the form of cream, suppositories or drops delivered topically to the vagina in order to contract the smooth muscle of the vaginal wall. The preparation contains a smooth muscle contracting agent such as oxytocin capable of constrict the vaginal tube reducing its overall diameter for a more pleasurable sexual experience for the female subject and his partner alike. The smooth muscle contracting agent can be associated with a systemic absorption retardant such as a mixture of Benzyl Alcohol, Acetone and Isopropanol. Such a formulation achieves high local tissue concentration of the smooth muscle contraction substance such as oxytocin in vicinity to the site of application, via minimization of systemic absorption of the smooth muscle contraction inducing substance and at the same time via promotion of its submucosal absorption across the mucosal barrier. As a result of the use of such formulation an increased local smooth muscle contraction activity is expected to occur in the muscularis mucosae. | 06-23-2011 |
20110151029 | Paxillin Stimulating Compositions and Cosmetic Uses Thereof - Cosmetic compositions comprising one or more paxillin stimulators and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The paxillin stimulators and combinations thereof are believed to have modulatory activity against at least one biochemical pathway implicated in skin aging. | 06-23-2011 |
20110151030 | COMPOSITIONS FOR ALLEVIATING INFLAMMATION AND OXIDATIVE STRESS IN A MAMMAL - An antioxidant-promoting composition that increases antioxidant defense potential in a subject is disclosed comprising | 06-23-2011 |
20110159118 | Screening Method (Metabolite Grid) for Therapeutic Extracts and Molecules for Diabetes - The present invention provides therapeutic compositions derived from plants useful for treating diabetes. The present invention also provides methods for screening plant metabolites and constituents to identify therapeutic agents and/or dietary supplements for treating diabetes. The therapeutic compositions can be derived from plants such as | 06-30-2011 |
20110159119 | COMPOSITIONS AND METHODS FOR ARACHNID CONTROL - The invention provides compositions and methods for treating or preventing infestation of a site with a spider. | 06-30-2011 |
20110159120 | SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACTS - The present invention discloses synergistic nutraceutical or pharmaceutical or dietary supplement anti-inflammatory compositions comprising therapeutically effective combination of an extract selectively enriched in 3-O-acetyl-11-keto-β-boswellic acid (AKBA) derived from | 06-30-2011 |
20110165270 | Environmentally-friendly substratum composition for a variety of personal products - A substratum composition derived entirely from naturally occurring ingredients chosen for their detoxifying, cleansing, and rejuvenating properties, and blended in effective proportions. Additionally, composition constituents are scrutinized and screened for environmental neutrality, thereby eliminating traditional impacts on community watersheds. The all-natural composition may serve as a substratum for a variety of personal hygiene, haircare, skincare, and cosmetic products. | 07-07-2011 |
20110165271 | ANTITUMORAL TERPENOID PHARMACEUTICAL COMPOSITION 'ABISILIN' EXHIBITING ANGIOGENESIS-INHIBITING ACTION - The invention relates to medicine and the chemical and pharmaceutical industry and to agent for treating diseases caused by angiogenesis regulation disorders, in particular to a method for treating oncological diseases of different genesis by inducing angiogenesis inhibition which is secondary to the direct antitumoral, anti-reccurant and anti-metastatic action as well as by the associated activation of the apoptosis endogenous system. The invention uses a novel peroral medicinal form ‘Abisilin’, comprising ingredients relating to the class of natural terpene compounds (isoprenoids), produced from coniferous threes of a Pinaceue family, which medicinal form contains: sesquiterpenoids (3-6%), neutral diterpenoids (11-15%), diterpene acids (22-28%), triterpene acids (8-16%), unsaturated and saturated fatty acids (0.1-0.3%), phenolic compounds (0.1-0.2%), monoterpenoids being the rest, wherein the bornyl acetate content is equal to not less that 10.0% of the total terpene composition. It is expected that the use of the novel peroral medicinal form ‘Abisilin’, the substance of which exhibits immunomodulating, antibacterial, antiinfiammatory, anesthetic, wound-healing and other pharmacologically-significant actions, is free of contra-indications and toxic effects and can be used together with different agents, provides a novel therapeutic approach and enhances the efficiency of treatment of oncological and many other diseases caused by angiogenesis process disorders. | 07-07-2011 |
20110165272 | ANTIALLERGIC COMPOSITION - An antiallergic composition that is moderate for the human body and skin, and has reduced side-effects that comprises a cold-water extract from hop tissue or flavonoid glucosides separated from the cold-water extract from hop tissue. | 07-07-2011 |
20110171326 | Pharmaceutical material for psoriasis treatment - One embodiment of a pharmaceutical material for psoriasis treatment includes a liquid preparation by extracting herbs selected from the group consisting of | 07-14-2011 |
20110171327 | GUAVA PULP COMPOSITION - The present invention discloses a guava pulp (also referred to as pulp composition) of a particle size not greater than 0.25 mm which does not contain seeds and peels from the guava and has a lycopene concentration which is 1 to 2 folds higher than the lycopene concentration in the guavas from which the pulp is obtained. The invention further discloses uses of the pulp composition as starting material for obtaining guava oleoresin and lycopene, and as antioxidant. | 07-14-2011 |
20110177174 | Fruit chocolate - An intimately incorporated meltaway confection highlighting a fruit/fruit blend whose primary fat constituent is cocoa butter, having anhydrous, powdered freeze-dried fruit/fruit juices, and other fruit essences and oils, along with dairy and nutritive carbohydrate sweeteners. Additional flavorings, emulsifiers and fruit based acids may be added to further enhance palatability. Fruit/botanical blends would be achieved by adding an anhydrous powdered botanical component prior to conching. The conching process would employ a constant conching pressure for all aforementioned components of the present invention in order to create a smooth texture and mouth-feel. Further optional components comprise inclusions and coatings typical of other chocolate confections, in addition to metabolic compounds and medicinals for further health benefits. | 07-21-2011 |
20110177175 | DIETARY FIBER COMPOSITIONS - The present invention relates to dietary fiber compositions comprising fenugreek dietary fibers. The present invention also relates to use of these compositions as dietary supplements, functional foods or pharmaceutical preparations for promoting satiety and weight loss, lowering cholesterol, controlling blood glucose, maintaining colon health and modulating inflammation. | 07-21-2011 |
20110183014 | PRODUCT CONTAINING EXTRACT FROM ZANTHOXYLUM AVICENNAE (LAM.) DC., AND PREPARATION PROCESS AND USE THEREOF - Disclosed herein are a product containing an extract from | 07-28-2011 |
20110189311 | Highly Absorbable Drug Composition and Method of Producing the Same - Provided is a highly absorbable drug composition including one or more water-soluble compound (A) selected from an enzyme-treated hesperidin, a stevia extract, or an enzyme-treated stevia and a poorly water-soluble drug (B) selected from flurbiprofen or probucol. | 08-04-2011 |
20110189312 | Compositions and Methods for Supporting Heat Shock Protein Function - Compositions and methods for promoting or maintaining protein accretion in cells, particularly in skeletal muscle cells, by supporting heat shock protein function. The compositions comprise glutamine and additional components directed at enhancing the activity of heat shock proteins. | 08-04-2011 |
20110189313 | Method of using a green coffee bean extract to promote carnitine palmitoyltransferase activity - (Problems) To provide a highly safe dietetic composition originating in green coffee beans by which excellent dietetic effects can be obtained and which contributes to the prevention and treatment of life style-related diseases such as diabetes. | 08-04-2011 |
20110195135 | ANTI-AVIAN INFLUENZA VIRUS AGENT, AND PRODUCT CONTAINING ANTI-AVIAN INFLUENZA VIRUS AGENT - An anti-avian influenza virus agent containing, as an active ingredient, a component obtained when a guava extract extracted from a guava with an extraction solvent consisting primarily of at least one of water and a hydrophilic organic solvent is subjected to fractionation by HPLC under specific conditions. The specific conditions include the use of an ODS column, the use of a water-methanol mixture having a methanol concentration of 20% as a mobile phase during a period until 15 minutes after applying the guava extract to the column, and the use of a water-methanol mixture having a methanol concentration of 40% as a mobile phase during a subsequent period of 15 to 30 minutes. Alternatively, the specific conditions further include the use of a water-methanol mixture having a methanol concentration of 60% as a mobile phase during a period of 30 to 45 minutes after applying the guava extract to the column. The component contained in the anti-avian influenza virus agent is eluted from the column in a period until 20 minutes after applying the guava extract to the column or in a subsequent period of 20 to 35 minutes. | 08-11-2011 |
20110206784 | COMPOSITION FOR THE PREVENTION AND TREATMENT OF POSTMENOPAUSAL SYNDROME CONTAINING EXTRACTS OR FRACTIONS OF ACERIPHYLLUM ROSSII AS AN EFFECTIVE INGREDIENT - The present invention relates to a method for the prevention and treatment of postmenopausal syndrome containing the step of administering a pharmaceutically effective dose of the | 08-25-2011 |
20110206785 | EXTRACT OF POLYGONUM MULTIFLORUM THUNB. EX MURRAY VAR. HYPOLEUCUM AND COMPOSITIONS FOR IMPROVING METABOLIC SYNDROME - An extract of | 08-25-2011 |
20110217391 | MATRIX METALLOPROTEASE (MMP) PRODUCTION INHIBITOR - It is an object of the present invention to provide a method for inhibiting the production of matrix metalloprotease (MMP), wherein skin aging is suppressed and a highly stable and safe component from plants is used. The present invention provides a method for inhibiting the production of matrix metalloprotease (MMP), which comprises administering a | 09-08-2011 |
20110223262 | Method of Enhancing Biological Activity of Plant Extracts - The present invention relates to a method of modulating a selected biological activity of a naturally occurring material having one or more biological activities in an extract of the naturally occurring material, the method comprising incubating the extract in a medium in the presence of an aerobically metabolizing microorganism, under suitable aerobic conditions, for a period of time sufficient to modulate the selected activity with respect to baseline activity of the unincubated extract. The invention also relates to the bioconverted material so prepared, and the use of same in cosmetic or pharmaceutical compositions. | 09-15-2011 |
20110223263 | ANTIOXIDANT COSMETIC COMPOSITION CONTAINING EXTRACT OF PROCESSED PEONY, POLYGONATI RHIZOMA OR LILY - The present invention relates to an antioxidant cosmetic composition, and more particularly to an antioxidant cosmetic composition containing, as an active ingredient, either an extract of at least one of peony, Polygonati rhizoma and lily, processed using a medicinal herb processing technique, or a mixture of said extract and an extract of at least one of unprocessed peony, Polygonati rhizoma and lily. | 09-15-2011 |
20110236509 | TOPICAL COMPOSITION COMPRISING EXTRACTS OF A. INDICA AND M. CHARANTIA OR S. INDICUM - The invention relates to a topical composition and a method for reducing or preventing occurrence of acne on the skin. It is an object of the present invention to provide for a combination of herbal extracts that interact synergistically to provide a cosmetic composition for prevention, reduction or treatment of acne. The present invention provides for a topical composition comprising (i) an extract of a first active which is | 09-29-2011 |
20110244060 | CARDIOPROTECTIVE EFFECTS OF NUTRACEUTICALS ISOLATED FROM NIGELLA SATIVA SEEDS - This invention relates to a rich antioxidant nutraceuticals prepared from | 10-06-2011 |
20110256245 | METHODS AND COMPOSITIONS OF CANNABIS EXTRACTS - In one embodiment, a method is provided for obtaining an extract from a cannabis plant for medical uses. In one embodiment, a method for obtaining an extract from a cannabis plant for medical uses is provided. The method comprises (a) providing cannabis flower trimmings with trichome material, (b) providing clean, cold water to at least cover cannabis the cannabis flower trimmings, (c) agitating the mixture of cannabis flower trimmings and water (d) soaking the cannabis flower trimming in cold water for at least one minute, (e) removing cannabis flower trimmings from the water, (f) removing the trichome material from the water and (g) drying the trichome material to contain no more than 10% total water weight. | 10-20-2011 |
20110256246 | ESSENTIAL OIL OF KUNZEA AMBIGUA AND METHODS OF USE - A method for treating such ailments as, or otherwise reducing the effects of, irritable bowel syndrome, hemorrhoids, symptoms of the common cold, improving the condition of lesions and ulcers of the type often attendant certain cancers, such as cancer of the jaw and mouth scrub typhus (tick fever), certain sinus infections, whooping cough, tooth abscesses and inflammation, including the inflammatory effects associated with auto-immune diseases, particularly, Crohn's disease, which method includes the steps of obtaining an essential oil of Kunzea ambigua and internally administering the essential oil of Kunzea ambigua via inhalation, ingestion or via application to an infected area, if feasible. | 10-20-2011 |
20110262567 | COMPOSITION FOR TREATING GOUT, CONTAINING ANGELICA GIGAS EXTRACT HAVING A XANTHINE OXIDASE-INHIBITING EFFECT AND AN INFLAMMATION-INDUCING ENZYME-INHIBITING EFFECT - The present invention relates to a composition for the treatment of gout, comprising an Angelica gigas Nakai extract which inhibits xanthine oxidase to reduce uric acid in the blood or urine, thereby being effective in the treatment of gout. | 10-27-2011 |
20110268821 | EXTRACTING AN EXTRACT SUBSTANCE FROM A RAW MATERIAL - The present invention relates broadly to the extraction of an extract substance from a raw material. The extract substance may have application in the food, cosmetics, insecticide or other industries. The raw material may be in the form of vegetable or fruit matter or waste. The extract substance is to be in the form of a concentrated food (for humans or animals) or cosmetic including but not limited to aromatic substances. | 11-03-2011 |
20110268822 | METHODS FOR SYNTHESIZING KOTALANOL AND STEREOISOMERS AND ANALOGUES THEREOF, AND NOVEL COMPOUNDS PRODUCED THEREBY - Compounds having the general formula (I): wherein X is S, Se or NH, and stereoisomers thereof, and de-O-sulfonated analogues of all of the foregoing, but excluding naturally occurring kotalanol and de-O-sulfonated kotalanol, and methods for synthesizing same. The compounds are useful as glycosidase inhibitors, and may be used in the treatment of diabetes. The synthetic compounds may also be used as standards in the calibration or grading of natural or herbal remedies produced from natural sources of glycosidase inhibitors such as kotalanol. | 11-03-2011 |
20110280968 | NATURAL EXTRACT CONTAINING XANTHOHUMOL, METHOD FOR THE PRODUCTION THEREOF AND PRODUCTS PRODUCED THEREFROM - The invention relates to a method for producing an extract containing xanthohumol (XN), which is obtained from toasted cereal products, cereal malt, coffee or cocoa. The XN-content in said extract is in the region of 10 mg/kg-2 g/kg xanthohumol. The use of XN-toasted extracts enables the XN-content of foodstuffs and pharmaceutical products to be increased in a natural manner. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way. | 11-17-2011 |
20110293751 | Composition for Treatment of Skin - The present invention provides a composition comprising stearidonic acid (or an ester thereof) derived for example from | 12-01-2011 |
20110293752 | Inhibition of Angiogenesis and Destruction of Angiogenic Vessels with Extracts of Noni Juice (Morinda Citrifolia) - Noni juice and a protein-free, alcohol precipitate of Noni juice inhibited angiogenesis in in vitro human angiogenesis models. When growth medium contained Noni juice at least over the range from about 2.5% to about 33% (by volume), angiogenesis was blocked. Moreover, Noni juice and an ethanol precipitate were able to destroy a pre-existing angiogenic response as well as prevent the development of new vessels. Noni juice was effective in inhibiting the growth of angiogenic vessels from breast cancer explants. It will also be effective in treating cancers and non-cancerous diseases whose response includes an increase in angiogenesis, e.g., retinopathy of prematurity, neovascular glaucoma, diabetic retinopathy, and psoriasis. In an initial experiment, Noni juice was effective in treating lesions associated with psoriasis. The primary antiangiogenic component is believed to be a carbohydrate with a molecular weight less than about 6000 Daltons. In an initial experiment, oral administration of Noni juice appeared to adversely affect the antiangiogenic component(s) in the juice. | 12-01-2011 |
20110300240 | CAJANUS EXTRACTS AND GLUCOSAMINE FOR INFLAMMATORY DISORDERS - The present invention relates to novel compositions comprising | 12-08-2011 |
20110311655 | Further preparations of silk proteins, seed oils, monosaccharide, natural botanicals and polysaccharide mixtures in compositions for hair care or hair repair, and skin care and topical treatments - The present invention intends to provide a composition for hair and skin treatment containing a combination consisting of silk amino acid and protein complexes, seed oils, polysaccharides, polyol, monosaccharide, and botanicals. The composition for hair and skin treatment containing the combination consisting of silk amino acid and protein complexes, seed oils, polysaccharides, and botanicals has excellent improvement effects on the condition of the hair follicle and cuticle, imparts moisture to dry hair; thereby reducing the damaging effects of psoriasis, eczema, alopecia, and seborrheic dermatitis. Furthermore, it imparts retention of moisture to the skin resulting in an improved appearance and diminished appearance of lines on the skin. This invention relates to the manufacture of personal care products to be applied to the hair and skin. The compositions may be in the form of hair conditioners, hair growth treatments, shampoos, skin care, skin cleansing, or anti-wrinkle products, and ointments. | 12-22-2011 |
20110318433 | SOOTHING PHARMACEUTICAL OR COSMETIC COMPOSITION COMPRISING A PEPTIDE THAT ACTIVATES HMG-COA REDUCTASE - The present invention relates to a soothing cosmetic or pharmaceutical composition comprising at least one peptide that activates human HMG-CoA reductase of general formula (I): | 12-29-2011 |
20120003331 | Use of Tiliacora Triandra in Cosmetics and Compositions Thereof - The present disclosure relates to compositions and methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, where the compositions include natural plant constituents which increase expression levels genes, collagen replacement and retention, and cell proliferation of epidermis and dermis associated with the dermatological signs of aging. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof, once daily in an amount effective in improving the condition and aesthetic appearance of skin. | 01-05-2012 |
20120003332 | Compositions and Methods for Stimulation MAGP-1 to Improve the Appearance of Skin - The present disclosure relates to methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, by application of one or a combination of natural compounds or extracts that stimulate MAGP-1 expression and which improves the appearance of aged and/or photodamaged skin. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof in an amount effective to improve the condition and aesthetic appearance of skin. | 01-05-2012 |
20120003333 | Method of Removing Ticks from the Skin and Reducing the Risk of Bites - Compositions and method of using the same for the removal of ticks embedded in the skin or tissue of a human or animal host and for preventing ticks from attaching themselves to and biting humans or other animals. | 01-05-2012 |
20120009281 | PLANT EXTRACTS FOR TREATING SKIN DISORDERS AND ENHANCING HEALING OF WOUNDS FOR DIABETIC PATIENTS - The present invention provides a pharmaceutical composition for treating skin disorders, including enhancing the healing of wounds for diabetic patients. Specifically, this invention relates to the use of the extracts of | 01-12-2012 |
20120015053 | TREATMENT OF PSORIASIS - This invention relates to compositions, and methods of use thereof, for treating conditions associated with elevated arginase levels and/or activity comprising administering to a subject in need thereof, certain polyphenols such as flavanols, procyanidins, or pharmaceutically acceptable salts or derivatives thereof. | 01-19-2012 |
20120015054 | EXTRACT OF EUODIA SUAVEOLENS SCHEFF, REPELLENT COMPOSITIONS AND USE THEREOF - The invention relates to an extract of | 01-19-2012 |
20120021075 | DUAL-CHAMBER PACKAGING SYSTEMS FOR CANNABIS-INFUSED PRODUCTS SYSTEMS - A dual-chamber packaging for medical marijuana-infused products and edibles providing individuals who are suffering from various health problems and diseases with an effective method for ingesting and/or topically applying medical marijuana. The invention may comprise a dual-compartmental containment device made from high-density polyethylene. The two chambers may be separate but are encased in one outer container. Professionally manufactured goods, such as lotions or oils with THC and CBD enhancers and carriers and other beneficial properties, can be kept in the first compartment, while cannabinoid fluid may be contained in the second compartment. For use in transdermal delivery of cannabinoids, an individual may first dispense the professionally-developed material and rub it onto his/her skin. Dispensaries may customize the materials used in this device to satisfy the needs dictated by their patients' specific conditions or diseases. The device provides for the possibility of transporting partially professionally produced products not only within the state, but also to the states where medical marijuana is legal (while they are not filled with cannabinoids.) | 01-26-2012 |
20120027878 | NATURAL LYCOPENE CONCENTRATE AND METHOD FOR PRODUCTION THEREOF - Natural lycopene concentrate obtained from a plant structure after alkalinization, solid-liquid separation, acidification and a second solid-liquid separation. The concentrate obtained is highly bioavailable and water-soluble at room temperature. | 02-02-2012 |
20120034322 | INTESTINAL BACTERIAL FLORA DISTRIBUTION RATIO REGULATOR - A food or pharmaceutical capable of regulating an intestinal bacterial flora distribution ratio, which is safe and has few side effects, is provided. | 02-09-2012 |
20120040025 | Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention - Methods for reducing the risk of or treating a disorder associated with fluid and/or salt retention in a patient are described. The methods include administering to the patient an agent selected from: a) an agent that reduces sodium absorption in the intestine; b) an agent that increases anion secretion in the intestine; or c) an agent that both reduces sodium absorption in the intestine and increases anion secretion in the intestine. | 02-16-2012 |
20120040026 | AROMATASE INHIBITOR - A substance is disclosed that can inhibit the activity of aromatase (an enzyme capable of converting androgen into estrogen) to thereby effectively treat and/or prevent a sex hormone-dependent disease such as breast cancer occurring in a female person after menopause, as well as a climacteric disorder in a male person and metabolic syndrome caused by the accumulation of a visceral fat. Specifically, a therapeutic and/or prophylactic agent for a sex hormone-dependent disease comprises at least one herbal extract selected from the group consisting of “Kokeiten,” prunella spike, sweet hydrangea leaf, milk thistle, a jasmine tea, “Bokusoku,” “Tencha,” “Karensou,” “Youbaihi,” French maritime pine, betel palm, asparagus, “Rouro,” “Ryoukyou,” rooibos tea, rhubarb, pu-erh tea, green tea, “Ougon,” St. John's wort, licorice, “Senrikou,” wintergreen, “Kashi,” “Yagotou,” polygnum root, barrenwort, guarana, “Ouhi,” Argy's wormwood, sticky rehmannia, Japanese cornel, Asiasarum root, cinnamon, peony root, pine needle and amla fruit. | 02-16-2012 |
20120040027 | FOOD OR BEVERAGE COMPOSITION COMPRISING UNROASTED COFFEE SOLIDS - The present invention relates to a food or beverage composition comprising unroasted coffee solids and arabinogalactans, for example a ready-to-drink beverage. | 02-16-2012 |
20120058206 | ANTIALLERGIC MARINE BIOPOLYMERS - The present invention relates to pharmaceutical compositions for administration to the respiratory tract, the gastrointestinal tract or the eyes. In particular, the invention relates to liquid formulations and dry powder compositions comprising carrageenan, and in particular iota and kappa carrageenan, and one or more therapeutic agents. These sprays, powders, and the gel that forms when they are administered to the respiratory tract, the gastrointestinal tract or the eyes, have now surprisingly been found to be a very effective way of prevention and treatment of type I allergies and intranasal administration of therapeutic agents. | 03-08-2012 |
20120070514 | AROMATASE INHIBITOR - A substance is disclosed that can inhibit the activity of aromatase (an enzyme capable of converting androgen into estrogen) to thereby effectively treat and/or prevent a sex hormone-dependent disease such as breast cancer occurring in a female person after menopause, as well as a climacteric disorder in a male person and metabolic syndrome caused by the accumulation of a visceral fat. Specifically, a therapeutic and/or prophylactic agent for a sex hormone-dependent disease comprises at least one herbal extract selected from the group consisting of “Kokeiten,” prunella spike, sweet hydrangea leaf, milk thistle, a jasmine tea, “Bokusoku,” “Tencha,” “Karensou,” “Youbaihi,” French maritime pine, betel palm, asparagus, “Rouro,” “Ryoukyou,” rooibos tea, rhubarb, pu-erh tea, green tea, “Ougon,” St. John's wort, licorice, “Senrikou,” wintergreen, “Kashi,” “Yagotou,” polygnum root, barrenwort, guarana, “Ouhi,” Argy's wormwood, sticky rehmannia, Japanese cornel, Asiasarum root, cinnamon, peony root, pine needle and amla fruit. | 03-22-2012 |
20120070515 | Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder - The present invention relates to a composition comprising an extract of | 03-22-2012 |
20120076873 | Health Food - The object of the present invention is to consume raw food cultivated in appropriate soil. | 03-29-2012 |
20120076874 | COMPOSITION WITH IMPROVED BIOAVAILABILITY OF SAPONIN AND METHOD FOR IMPROVING THE BIOAVAILABILITY OF SAPONIN (AS AMENDED) - The present invention relates to a | 03-29-2012 |
20120082737 | Topical Skin Care Formulations Comprising Plant Extracts - Disclosed are compositions and corresponding methods of their use that include extracts from a | 04-05-2012 |
20120087995 | NFAT Signal Inhibitor and Calcineurin Inhibitor - To provide a drug, an external use composition, and a cosmetic composition, which exhibit an NFAT signal inhibitory action, a calcineurin inhibitory action, and a hair growth-promoting effect. | 04-12-2012 |
20120107424 | ANTI DENGUE ACTIVITY OF CISSAMPELOS PAREIRA EXTRACTS - The present invention relates to the anti dengue activity of the | 05-03-2012 |
20120107425 | USE OF RHODIOLA CRENULATA EXTRACT VIA THE TOPICAL ROUTE - The invention relates to the use of a | 05-03-2012 |
20120128796 | Extracts and Compounds from Ficus Benghalensis for Increasing Hair Growth and Decreasing Hair Loss - This application discloses natural product extracts and compounds from an aerial root of a | 05-24-2012 |
20120128797 | METHOD FOR TREATMENT OF CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME - The present invention provides methods for treating constipation-predominant irritable bowel syndrome comprising administering to a patient in need thereof, a polymeric proanthocyanidin composition from a | 05-24-2012 |
20120128798 | Method of Treating Neurological Conditions with Extract of Nerium Species or Thevetia Species - A method of treating neurological condition in a subject by administration of an extract, or fraction or sub-fraction thereof, of | 05-24-2012 |
20120128799 | Soft Dried Marshmallow and Method of Preparation - Dried soft aerated confections and methods of their preparation are provided having a water activity of about 0.1 to 0.4 and a glass transition temperature of less than 20° C. The confections comprise sugars, a foaming and a structuring ingredient, preferably each gelatin, and about 5 to 15% softening agent. Preferred softening agents include glycerin, polyglycerols and mixtures thereof. The confections are aerated to densities of about 0.1 to 0.5 g/cc. The soft dried aerated confections are particularly suited for addition to children's Ready-To-Eat cereals in the form of pieces weighing about 0.1 to 2 g each. The dried confection pieces maintain their soft texture over time without causing moisture migration to the cereal. | 05-24-2012 |
20120141609 | Melt-Blended Protein Composition - A melt-processed protein composition formed from a protein, plasticizer, and an electrophilic reagent is provided. The electrophilic reagent, for instance, may be selected to undergo a nucleophilic addition reaction with free sulfhydryl and/or thiyl radicals to help minimize the formation of disulfide crosslinking bonds that could otherwise lead to protein aggregation during melt processing. To enhance the degree to which the electrophilic reagent can limit crosslinking, a plasticizer is also employed that helps to mediate the adsorption of the electrophilic reagent into the internal structure of the protein, where it can be more stably retained. Furthermore, the temperature and shear rate employed during melt blending may also be selected to be relatively low to help limit polypeptide dissociation, thereby minimizing the impact of aggregation and embrittlement. | 06-07-2012 |
20120141610 | Novel Topical Composition Of Sarracenia Purpurea (Pitcher Plant) - A composition having a pitcher plant component and a fatty acid component, wherein the pitcher plant component is an alcohol extract, the pitcher plant component further comprises a preservative component, the pitcher plant component is prepared through a soak and press technique and prepared through steam distillation, the composition of claim | 06-07-2012 |
20120156314 | 11 beta, 13-DIHYDROHELENALIN DERIVATIVES AND USES THEREOF AS BOMBESIN RECEPTOR SUBTYPE 3 AGNOISTS - The present invention relates to compounds of formual (I): | 06-21-2012 |
20120156315 | Composition for Treating Vitiligo or Canities Comprising Extract from Sophora Japonica as Active Ingredient - Disclosed is a composition for treating or preventing vitiligo or canities comprising | 06-21-2012 |
20120164240 | ENRICHED A. BLITOIDES COMPOSITIONS AND USES THEREOF - Embodiments of the inventions described herein provide, among other things, enriched | 06-28-2012 |
20120164241 | BOEHMERIA EXTRACT AND ITS USE IN TREATING LIVER DISEASES - A pharmaceutical composition prepared from a | 06-28-2012 |
20120164242 | NOVEL METHODS FOR MODULATING MELANIN PRODUCTION - Methods are provided for modulating pigmentation and melanin production by administering an extract of | 06-28-2012 |
20120164243 | Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders - Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and/or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress. | 06-28-2012 |
20120164244 | COMBINATION OF PROANTHOCYANIDINS AND CENTELLA ASIATICA FOR THE TREATMENT OF ATHEROSCLEROSIS - The invention relates to a preparation for medical purposes and more specifically to a preparation consisting of the combination of proanthocyanidins such as Pycnogenol or grape seeds and | 06-28-2012 |
20120164245 | METHOD OF TREATMENT OF NEURODEGENERATIVE OR NEURO-MUSCULAR DEGENERATIVE DISEASES AND THERAPEUTIC AGENT TO TREAT THE SAME - Use of high doses above 1 gm per day of ascorbic acid or the derivatives thereof for the treatment of neurodegenerative and neuro-muscular degenerative diseases and disorders, in particular amytrophic lateral sclerosis, multiple sclerosis, alzheimer's disease, parkinson's disease, and muscular dystrophy is disclosed. Preferably the dose includes mannitol which facilitates the delivery of ascorbic acid to the target cells in the brain. Still further the said dose includes zinc citrate for preventing formation of kidney stones. Dose compositions for various routes of application such as oral, intravenous, intramuscular, nasal and in the form of transdermal patches are discussed. | 06-28-2012 |
20120171308 | Antioxidant Complex, Cosmetic and Pharmaceutical Compositions Containing Said Complex, and Use of Said Complex - The present application describes an antioxidant complex having a synergistic effect between its ingredients. Said mixture comprises: a) vitamin E and/or derivatives thereof; b) green tea extract and/or derivatives thereof; and c) cacao extract. Examples of cosmetic and pharmaceutical compositions comprising said antioxidant complex and a physiologically acceptable carrier are also described. The antioxidant complex of the present invention, as well as the aforementioned compositions, aid in preventing and protecting against cell and skin damages resulting from the action of free radicals, and also provide DNA, protein and cell membrane protection. | 07-05-2012 |
20120171309 | FORMULATIONS AND METHODS FOR INCREASING EFFICACIES AND IMPROVING FLAVORS OF FORMULATIONS CONTAINING GYNOSTEMMA PLANT - Formulations and methods for increasing efficacies and flavors of jiaogulan ( | 07-05-2012 |
20120177754 | INHIBITOR OF INFLAMMATORY CONDITIONS - The invention relates to | 07-12-2012 |
20120183631 | INGREDIENT EXTRACTED FROM POUZOLZIA ZEYLANICA (L.) BENN AND ITS ANTI-ACNE FORMULA - An ingredient extracted from | 07-19-2012 |
20120183632 | PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF PSEUDOLYSIMACHION LONGIFOLIUM AND THE CATALPOL DERIVATIVES ISOLATED THEREFROM HAVING ANTIINFLAMMATORY, ANTIALLERGIC AND ANTIASTHMATIC ACTIVITY - The present invention relates to a composition comprising an extract of | 07-19-2012 |
20120183633 | COMPOSITIONS AND FUNCTIONAL FOODS FOR TREATING AND PREVENTING OBESITY USING POLYGONUM CUSPIDATUM BUTANOL FRACTION AND ETHYL ACETATE FRACTION - The present invention relates to the obesity-curative or obesity-preventive effect of a | 07-19-2012 |
20120189719 | SCHISANDRAE FRUCTUS EXTRACTS FOR INHIBITION OR PREVENTION OF H1N1 INFLUENZA VIRUS INFECTION AND ITS APPLICATION THEREOF - Disclosed are an Schisandrae fructus extract for inhibition or prevention of influenza and its application, wherein the Schisandrae fructus extract is obtained by water, methanol, or ethanol extraction process and the extract comprises compounds such as schisandrone, benzoylgomisin P, wulignan A1, epigomisin O, epiwulignan A1, and tigloylgomisin P. The extracts and purified compounds of Schisandrae fructus has anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities, therefore the extracts and the purified compounds of Schisandrae fructus can be applied as an inhitibory agent of a pharmaceutical composition for treatment or prevention agent for influenza infection. | 07-26-2012 |
20120189720 | METHOD FOR TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME - The present invention provides methods for treating diarrhea-predominant irritable bowel syndrome comprising administering to a patient in need thereof, an inhibitor of chloride-ion transport in an amount sufficient to treat diarrhea-predominant irritable bowel syndrome (d-IBS). Treatment of d-IBS includes the treatment of the diarrhea component of d-IBS as well as the pain, abdominal discomfort and other symptoms associated with d-IBS. In one embodiment, the inhibitor of chloride-ion transport is crofelemer. | 07-26-2012 |
20120189721 | METHODS AND COMPOSITIONS FOR HEAVY METAL DETOXIFICATION - Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity. | 07-26-2012 |
20120195986 | PREVENTING OR TREATING PERIODONTAL DISEASES BY HERBAL EXTRACT - A use an extract of Coptidis Rhizoma or a combined extract of Coptidis Rhizoma and Pharbitidis Semen as an active ingredient for preventing and/or treating periodontal disease is provided. The extract of Coptidis Rhizoma or a combined extract of Coptidis Rhizoma and Pharbitidis Semen has activities to stimulate anti-inflammation, osteoblast differentiation and alveolar bone regeneration, and to prevent the alveolar bone destruction, thereby being effective for the prevention and/or treatment of periodontal disease. | 08-02-2012 |
20120213868 | OIL-EXTRACTED PRODUCT OF INDIGO NATURALIS, AND PREPARATION PROCESS AND USES THEREOF - Disclosed herein are an oil-extracted product of indigo naturalis, and the preparation process thereof. Also disclosed are a pharmaceutical composition containing the oil-extracted product of indigo naturalis and a method for treating a human subject having or suspected to have a psoriatic disease such as skin psoriasis and nail psoriasis. | 08-23-2012 |
20120219643 | ANTI-NEOPLASTIC COMPOSITIONS COMPRISING EXTRACTS OF BLACK COHOSH - A method for treating, preventing or ameliorating breast cancer is provided by administering a synergistic amount of digitoxin and either actein or an extract of black cohosh comprising triterpene glycosides, and optionally another chemopreventive agent which may be paclitaxel. Methods for treating or preventing a neoplasia using a synergistic combination, and compositions of a synergistic combination of a cardiac glycoside and either actein or an extract of black cohosh comprising triterpene glycosides, and optionally another chemopreventive agent which may be a taxane are also provided. The compositions may also be used in a method for modulating Na | 08-30-2012 |
20120225136 | INHIBITION OF TUMOUR CELL MIGRATION - The invention relates to the use of a cannabis plant extract or a cannabinoid as a pharmaceutically active agent in the inhibition of tumour cell migration. | 09-06-2012 |
20120231093 | METHOD FOR PREPARING NANO-SCALE OR AMORPHOUS PARTICLE USING SOLID FAT AS A SOLVENT - The present invention relates to a method for preparing nanoscale or amorphous particles using solid fat as a solvent. According to the present invention, nanoscale or amorphous particles of active ingredients are prepared by using fat as a solvent, wherein the fat is in solid phase at room temperature. The nanoscale or amorphous particles of active ingredients can be advantageously used in medicine, cosmetics, functional foods or the like. | 09-13-2012 |
20120231094 | Hair Shape Susceptibility Gene - A genetic polymorphism and a hair shape susceptibility gene that are related to hair shape, and a method for determining the genetic susceptibility to hair shape in individual test subjects are provided. Disclosed is a hair shape susceptibility gene, which overlaps with a haplotype block in the 1q32.1 to 1q32.2 region (D1S249 to D1S2891) of human chromosome 1 and comprises a portion or the entirety of the base sequence of the haplotype block, wherein the haplotype block is determined by a linkage disequilibrium analysis conducted on a single nucleotide polymorphism (SNP) marker whose allele frequency differs statistically significantly between a group having a curly hair trait and a group having a non-curly hair trait, and consists of a base sequence set forth in any one of SEQ ID NO:1 to NO:3. | 09-13-2012 |
20120237619 | COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 09-20-2012 |
20120244234 | NIGELLA EXTRACTS FOR THE TREATMENT OF SYMPTOMS CONNECTED TO IMPAIRED OR IMBALANCED NEUROTRANSMISSION - The present invention relates to the use of | 09-27-2012 |
20120258182 | SYNERGISTIC COMPOSITIONS AND METHODS - Pharmaceutical compositions for oral administration comprising a therapeutically effective amount of a synergistic combination of lycopene and at least one phytosterol wherein the ratio of said lycopene to said phytosterol in said pharmaceutical composition is a maximum of about 5:1 and wherein said composition produces a synergistic inhibition of cell growth are disclosed. | 10-11-2012 |
20120263804 | Essential element extractor - A Mobile Extractor for extracting essential elements from plant material and for transporting low concentrations of essential elements in a solution of solvent includes a clean tank, a hopper, one or more pumps, a plurality of valves, and a dirty tank. Plant material may be soaked or rinsed with a solvent that extracts essential elements from the plant material where the solvent washes the essential elements from the plant material into a dirty tank. When the operation is complete the dirty tank will contain a solution of solvent infused with essential elements from the plant material. The best mode of the invention extracts cannabinoid or | 10-18-2012 |
20120263805 | Detergent, Cleaning Agent or Disinfectant Containing Hydrolyzates Made of Plant Extracts - The invention relates to a detergent, cleaning agent or disinfectant containing at least one plant hydrolyzate, in particular selected from the group including | 10-18-2012 |
20120269908 | CARRIER IN OIL-IN-WATER EMULSION FORM, PARTICULARLY FOR COSMETIC OR DERMATOLOGICAL USE - The present invention relates to a carrier in oil-in-water emulsion form, containing a very small amount of a surface-active agent so that the emulsion is stable, well-tolerated, and nonirritating. The present invention also relates to a method for preparing a carrier according to the invention and to the use of such a carrier as a base for compositions to be applied onto sensitive human or animal body tissue, particularly in dermatological or dermocosmetic compositions. | 10-25-2012 |
20120276223 | COMPOSITION FOR PREVENTING AND TREATING INFLUENZA-VIRUS-INDUCED DISEASES - The present invention relates to a medicinal extract useful for preventing and treating influenza-virus-induced diseases, and to a pharmaceutical composition and health food including same. Derived from natural ingredients, the medicinal extract of the present invention is safe for humans, and can be used to prevent, treat, and alleviate symptoms of diseases induced by various strains of influenza viruses. | 11-01-2012 |
20120276224 | COMPOUND COMPRISING EXTRACTS OR FRACTIONS OF CHRYSANTHEMUM BOREALE MAKINO HAVING ANTI-INFLAMMATION ACTIVITY - The present invention relates to a composition having an anti-inflammatory activity, comprising extracts or fractions of | 11-01-2012 |
20120282354 | COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY INFLUENZA VIRUSES - The present invention relates to herbal medicine extracts useful in the prevention or treatment of diseases caused by influenza viruses, and to a pharmaceutical composition or health food comprising the extracts. The herbal medicine extracts of the present invention are derived from natural materials, and are safe for the human body, and can be used in preventing and treating and in relieving symptoms of diseases caused by various types of influenza viruses. | 11-08-2012 |
20120288574 | METHOD OF PREVENTING PHOTO-AGING WITH ASHWAGANDHA AND INDIAN GOOSEBERRY - A method of preventing photo-aging and its related causes includes administering a therapeutic composition comprising extracts of the plant species ashwagandha ( | 11-15-2012 |
20120288575 | CLEANSER COMPOSITIONS AND METHODS FOR USING THE SAME - The present invention is directed to anti-microbial cleanser compositions comprising linalool, hinokitiol and dipropylene glycol. The present invention further provides methods for using these compositions to maintain eyelid hygiene, to treat an ocular disorder or to clean a skin surface. The cleanser compositions of the present invention can be in the form of a foam, gel or liquid. | 11-15-2012 |
20120321726 | Berberine-containing pharmaceutical composition for inhibiting cancer stem cell growth or carcinoma metastasis and application thereof - A pharmaceutical composition for inhibiting cancer stem cells growth or carcinoma metastasis and an application thereof are disclosed. The pharmaceutical composition includes: a berberine compound; and a pharmaceutically acceptable carrier. The application is the use of the berberine compound in the manufacture of a medicament for the inhibition of cancer stem cell growth or carcinoma metastasis. | 12-20-2012 |
20120328718 | PHARMACEUTICAL COMPOSITIONS - The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects. | 12-27-2012 |
20130004595 | Compositions and Methods for Treating Skin Conditions - Provided are skin treatment compositions comprising an | 01-03-2013 |
20130004596 | PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES CONTAINING QUAMOCLIT ANGULATA EXTRACT - The present invention relates to a pharmaceutical composition for treating diabetes and its complications, containing a | 01-03-2013 |
20130004597 | HERBAL MEDICINAL COMPOSITION AND EXTRACT THEREOF FOR INHIBITING GROWTH OF CANCER CELLS - The present invention relates to herbal medicinal compositions and extracts thereof for inhibiting growth of cancer cells. One of the examples described in the present invention comprises | 01-03-2013 |
20130028991 | DIETARY SUPPLEMENT FOR USE IN A WEIGHT LOSS PROGRAM - This invention relates to a dietary supplement for use in a weight loss program, which alleviates insulin resistance in the presence of the metabolic syndrome. The dietary supplement includes, in combination, berberine, banaba leaf extract, and inositol. Also provided is a method of treatment in a weight loss program. | 01-31-2013 |
20130028992 | Herbal-Based Solution for Treating Symptoms of Nasal Conditions - An herbal-based solution includes a first amount of wasabi comprising at least an allyl isothiocyanate component, and a second amount of saline solution. The saline solution and the organic material are combined to substantially dilute the wasabi in the saline solution to produce the herbal-based solution. The herbal-based solution further has anti-inflammatory, anti-microbial and anti-coagulative properties. The wasabi may include | 01-31-2013 |
20130028993 | Composition and Manufacturing Processes of a Toxicity Free Botanical Drug for Curative Treatment of Chronic Diseases - This invention discloses composition and manufacturing processes of a toxicity free botanical drug formulation for curative treatment of chronic diseases. It is manufactured from plants | 01-31-2013 |
20130028994 | POMEGRANATE EXTRACT HAVING A HIGH ELLAGIC ACID CONTENT, AND USE OF THE POMEGRANATE EXTRACT - A pomegranate pulp extract is disclosed. The pomegranate pulp extract is effective in relieving women's menopausal symptoms, anxiety disorders, depression or attention deficit disorders due to the presence of a large amount of ellagic acid. Further disclosed is a method for further improving the relieving effect of the pomegranate extract on women's menopausal symptoms, anxiety disorders, depression or attention deficit disorders. The method includes increasing the content of ellagic acid in the pomegranate extract. | 01-31-2013 |
20130040001 | METHOD OF PROCESSING ANIMAL SKIN - The present invention provides a method of processing animal skin, comprising the steps of: 1) providing dry animal skin containing 7-38 wt % water; 2) rehydrating and softening the said dry animal skin, and obtaining softened wet skin; 3) mixing the said softened wet skin with water, and grinding the mixture to a slurry; 4) obtaining a solid product through a crosslink of collagen proteins in the said slurry; wherein, rehydrating the said dry animal skin is performed through soaking the dry animal skin in 0-55° C. water till the animal skin contains 40-50 wt % water; and softening the said dry animal skin comprises a step of heating the rehydrated dry animal skin. | 02-14-2013 |
20130059018 | PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER - This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon. | 03-07-2013 |
20130064905 | Method for Enhancing the Growth and Fullness of Hair - New fibroblast growth factor receptor 1 (FGFR1) inhibitors have been identified which are useful for promoting the retention and/or growth of keratin fibers, such as hair of the scalp, hair of the face (moustache, beard, etc.), eyebrows, eyelashes, and the like. The FGFR1 inhibitors may be formulated in effective amounts in a variety of cosmetic and personal care products. | 03-14-2013 |
20130064906 | HERBAL SKIN CARE COMPOSITION - A topical skin care composition containing an extract solution of | 03-14-2013 |
20130064907 | COMBINATIONS OF ANTIFUNGAL COMPOUNDS AND TEA TREE OIL - There is disclosed a method for treating a plant infection caused by a fungus of the class ascomycetes, comprising applying to the plant a combination of tea tree oil (TTO) and a synthetic fungicidal compound. Other embodiments are also disclosed. | 03-14-2013 |
20130071497 | Formulations and Methods for Preventing Eyebrow Hair Loss - Compositions comprising from about 0.5 to about 40 percent by weight of black cohosh extract, from about 0.5 to about 20 percent by weight of nonionic surfactant, and from about to 40 about 99 percent by weight of hydroxylated solvent are effective in reducing and preventing eyebrow hair loss in patients undergoing chemotherapy. | 03-21-2013 |
20130071498 | Insecticidal Compositions and Uses Thereof - The present invention provides compositions and methods for controlling plant pests. In particular, the present invention provides plant extracts with insecticidal activity. | 03-21-2013 |
20130101687 | INSECTICIDAL COMPOSITIONS AND METHODS OF USING THE SAME - Insecticidal compositions have at least one active agent and at least one insecticide. The active agent can include | 04-25-2013 |
20130101688 | HERBAL COMPOSITION PHY906 AND ITS USE IN CHEMOTHERAPY - This invention provides herbal compositions useful for increasing the therapeutic index of chemotherapeutic compounds. This invention also provides methods useful for improving the quality of life of an individual undergoing chemotherapy. Furthermore, this invention improves the treatment of disease by increasing the therapeutic index of chemotherapy drugs by administering the herbal composition PHY906 to a mammal undergoing such chemotherapy. | 04-25-2013 |
20130101689 | COMPOSITION CONTAINING PAPER MULBERRY EXTRACTS - The present invention relates to a composition containing a paper mulberry extract, and more particularly to a composition containing, as an active ingredient, a paper mulberry extract which has effects on enhancement of skin moisturization, inhibition of skin aging, alleviation of inflammation, antibacterial activity, pore size reduction, sebum control, skin complexion improvement, decomposition of subcutaneous fat, stimulation of melanin synthesis, and gray hair prevention. | 04-25-2013 |
20130108716 | Jatropha Curcas Processing Method and Products | 05-02-2013 |
20130108717 | COMPOSITIONS FOR THE TREATMENT OF GYNAECOLOGICAL DISORDERS | 05-02-2013 |
20130108718 | EXTRACTION METHOD FOR PROVIDING AN ORGANIC CERTIFIABLE STEVIA REBAUDIANA EXTRACT | 05-02-2013 |
20130115316 | INDOLEALKYLAMINO-WITHASTEROID CONJUGATES AND METHOD OF USE - A group of indolealkylamino-withasteroid conjugates, isolated and purified from | 05-09-2013 |
20130115317 | Method for Identifying Pre-Biotics and Compositions Containing the Same - A method for indentifying test agents that exhibit prebiotic activity on companion animal skin commensal microorganisms and dermatological compositions that include such agents. The method includes providing a test culture of a test agent, a companion animal skin commensal microorganism and a minimal carbon medium. The method provides a time efficient and cost effective way to predict in vivo prebiotic activity of a test agent on skin commensal microorganisms. | 05-09-2013 |
20130122118 | METHOD AND APPARATUS FOR TREATING PESTS - A device for treating pests and method for using the same. The device comprises an effective amount of endod. The device can be placed in a body of water wherein the endod treats the pests. Additionally the device can be placed in a pipe whereby a combination of the endod and the mechanical force of the water removes the pests in the pipe. | 05-16-2013 |
20130122119 | PHYLLANTHUS AMARUS COMPOSITIONS AND METHOD OF EXTRACTING SAME - An enriched hydrolyzable tannin blend derived from | 05-16-2013 |
20130122120 | INSECTICIDAL COMPOSITIONS AND METHODS - The present invention provides compositions that may be an aqueous insecticide containing at least one surfactant, such as for instance, sodium lauryl sulfate, at least one preservative, such as for instance, a potassium salt or sodium chloride, a nutrient source, such as for instance a yeast, an organic acid capable of lowering the pH of the aqueous insecticide, such as for instance citric acid, a fragrance, such as for instance geranium oil, and water. The aqueous insecticide may be designed to more efficiently kill and thereby control populations of species of | 05-16-2013 |
20130122121 | METHOD OF USE OF AN ANTI-METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AGENT AND AN ANTI-VANCOMYCIN-RESISTANT ENTEROCOCCUS AGENT - Methods of use of an anti-methicillin-resistant | 05-16-2013 |
20130136807 | INSECT PROOF AND INSECTICIDAL COMPOSITION FOR THE CONSERVATION OF CULTURAL PROPERTY COMPRISING Asarum sieboldii EXTRACT OR A FRACTION THEREOF AS AN ACTIVE INGREDIENT - Disclosed herein is an insect proof or insecticidal composition for the conservation of cultural properties against termites, comprising an extract of | 05-30-2013 |
20130136808 | PLANT-DERIVED FORMULATIONS FOR TREATMENT OF HIV - Disclosed herein are methods for treating mammals with HIV/AIDS comprising administering a therapeutically effective amount of a composition comprising an extract of | 05-30-2013 |
20130142889 | COMPOSITION COMPRISING THE EXTRACT OF PHYSALIS ALKEKENGI VAR. FRANCHETI HORT AS AN ACTIVE INGREDIENT FOR PREVENTING AND TREATING INFLAMMATORY DISEASES - The present invention is related to the inventive compositions comprising the extract of Physalis alkekengi var francheti Hort showing potent anti-inflammatory effect through various experiments, therefore, it can be used as the effective and safe therapeutics or health food for treating and preventing inflammatory diseases | 06-06-2013 |
20130149397 | Modulation of Thymosin Beta-4 in Skin - Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin. | 06-13-2013 |
20130171274 | COSMETIC COMPOSITION FOR IMPROVING SKIN ELASTICITY - Provided is a cosmetic composition for improving skin elasticity containing | 07-04-2013 |
20130177661 | Saussurea Involucrate Extract, Pharmaceutical Composition and Use for Anti-Fatigue and Anti-Aging - Disclosed are a | 07-11-2013 |
20130183390 | SYNERGISTIC PESTICIDE COMPOSITIONS - The present invention relates to compositions that include a combination of one or more pesticides and one or more adjuvants. | 07-18-2013 |
20130196003 | CLASS OF ANTI-ADHESION HYDROGELS WITH HEALING ASPECTS - Disclosed are hydrogels polymerized with a biofunctional moiety, biodegradable and permanent, designed to be implantable in a mammalian body and intended to block or mitigate the formation of tissue adhesions. The hydrogels of the present invention are characterized by comprising four structural elements: a) a polymeric backbone which defines the overall polymeric morphology, b) linkage groups, c) side chains, and d) biofunctional end groups. The hydrophobicity of the various structural elements are chosen to reduce tissue adhesion and enhance the biofunctional aspect of the end groups. The morphology of these polymers are typically of high molecular weight and have shape to encourage entanglement. Useful structures include branching chains, comb or brush, and dendritic morphologies. | 08-01-2013 |
20130202722 | Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof - A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof. | 08-08-2013 |
20130209587 | METHODS FOR ADMINISTERING TUBE FEED FORMULATIONS - Nutritional compositions that mimic whole foods and methods of using the nutritional compositions are provided. The nutritional compositions may include an increased number and variety of fruits and vegetables, an increased variety of macronutrient sources and an increased amount of other components that are found in whole foods. Methods of administering such nutritional compositions to patients in need of same are also provided. The methods may include administering tube feed formulations to a patient at typical meal times such as, for example, breakfast, lunch and dinner. | 08-15-2013 |
20130209588 | AGAVE SYRUP EXTRACT HAVING ANTICANCER ACTIVITY - The present invention comprises an | 08-15-2013 |
20130216632 | Method for Controlling Hair Growth, Method for Selecting or Evaluating Hair Growth Control Agent, and Hair Growth Suppression Agent - The present invention provides a method for controlling hair growth, a method for selecting or evaluating a hair growth control agent, and a hair growth suppression agent. The present invention provides a method for selecting or evaluating a hair growth control agent, including the steps of administering a test substance to a cell capable of expressing DnaJC6; measuring the expression of DnaJC6 in the cell; and evaluating the controlling effect of the test substance on hair growth based on the expression. The present invention also provides a hair growth suppression agent containing funabarasou ( | 08-22-2013 |
20130216633 | Articles and Compositions for Enhancing Sports Scores - Methods and compositions for enhancing the score of an individual in a sport activity are disclosed. | 08-22-2013 |
20130224315 | Compositions of Volatile Organic Compounds and Methods of User Thereof - The present invention provides compositions and methods for treating, inhibiting or preventing the developing of a plant pathogenic disease. The compositions comprise volatile organic compounds effective to inhibit the growth of, or kill pathogenic microbes, including | 08-29-2013 |
20130224316 | Melt-Blended Protein Composition - A melt-processed protein composition formed from a protein, plasticizer, and an electrophilic reagent is provided. The electrophilic reagent, for instance, may be selected to undergo a nucleophilic addition reaction with free sulfhydryl and/or thiyl radicals to help minimize the formation of disulfide crosslinking bonds that could otherwise lead to protein aggregation during melt processing. To enhance the degree to which the electrophilic reagent can limit crosslinking, a plasticizer is also employed that helps to mediate the adsorption of the electrophilic reagent into the internal structure of the protein, where it can be more stably retained. Furthermore, the temperature and shear rate employed during melt blending may also be selected to be relatively low to help limit polypeptide dissociation, thereby minimizing the impact of aggregation and embrittlement. | 08-29-2013 |
20130230607 | Method for Enhancing Sports Scores - Methods and compositions for enhancing the score of an individual in a sport activity are disclosed. | 09-05-2013 |
20130230608 | METHODS OF IMPROVING MENTAL OR PHYSICAL HEALTH CONDITIONS IN AN INDIVIDUAL - Methods of improving mental or physical health conditions of an individual are provided. In a general embodiment, the method provides administering to an individual in need of an improved mental or physical health condition a decaffeinated coffee product comprising an unroasted coffee. The mental or physical health condition can be, for example, sustained attention in the individual, improvement in the individual's mood or alertness, reduced headaches in the individual, and/or improved relaxation in the individual. | 09-05-2013 |
20130243889 | METHOD OF TREATING EAR INFECTIONS - The present invention relates generally to a methods of treating ear infections and clearing excess fluid from Eustachian tubes. | 09-19-2013 |
20130243890 | MEDICINAL OROBANCHEACE EXTRACTS - Pharmaceutical extracts from Egyptian broomrape have proven efficacy against HCV and NAFLD. Compositions and method of making and using same are provided. | 09-19-2013 |
20130251824 | Recycling cannabinoid extractor - A process and apparatus for extracting cannabinoids from | 09-26-2013 |
20130251825 | Compositions and methods for treatment of mammalian skin - Compositions useful for treatment of a wide range of skin disorders including: pre-cancerous lesions, keratotic lesions, superficial basal cell carcinomae; squamous cell carcinomae; malignant melanoma, and radiation-induced burns. In some embodiments the treatments comprise contacting human or other mammalian skin with a composition according to the disclosure. In other embodiments, administration of compositions provided is by injection. Some embodiments provide for preventive use of compositions provided towards preventing some forms of skin cancer and skin cancer-related disorders by repeated application to healthy-looking skin. Methods for providing the compositions are disclosed. | 09-26-2013 |
20130266669 | METHODS OF REMOVING MICROBES FROM SURFACES - A method has been found for the inhibition of microbial biofilm on surfaces in contact with systems, such as aqueous systems. In accordance with the method, an effective amount of a modified tannin biofilm control agent is fed to the system water. The modified tannin biofilm control agent comprises a reaction product of an amine, an aldehyde and tannin and provides a good environmental profile. | 10-10-2013 |
20130266670 | Fungicidal Bactericidal and/or Antioxidant Treatment of Foodstuffs Via Application of Formulations Comprising an Essential Oil and a Dialkylene Glycol - The present invention relates to the fungicidal, bactericidal and/or antioxidative treatment of foodstuffs, by means of formulations of essential oil in a dialkylene glycol. | 10-10-2013 |
20130280350 | HERBAL TOPICAL FORMULATION - A topical herbal composition comprising aqueous extract of leaf of | 10-24-2013 |
20130280351 | PREPARATION AND USE OF A PLANT EXTRACT FROM SOLANUM GLAUCOPHYLLUM WITH AN ENRICHED CONTENT OF 1,25 DIHDROCYVITAMIN D3 GLYCOSIDES AND QUERCETIN GLYCOSIDES - The present invention relates to the preparation of an enriched and equilibrated plant extract from | 10-24-2013 |
20130280352 | Pet Food Compositions for Inducing a Satiety Response - The invention relates to pet food compositions designed to induce the animal to cease feeding upon consumption of the appropriate nutritional amount. The invention further provides methods of inducing satiety response in animals and methods of controlling the amount of food intake in animals. | 10-24-2013 |
20130280353 | PHYTOTHERAPIC PHARMACEUTICAL COMBINATION OF LIPPIA SALVIIFOLIA AND LIPPIA SIDOIDES, PHYTOTHERAPIC PHARMACEUTICAL COMPOSITION, PROCESS FOR PREPARING A PHYTOTHERAPIC PHARMACEUTICAL COMPOSITION AND VETERINARY USES THEREOF - Phytotherapic pharmaceutical forms with antimicrobial activity, comprising a mixture of essential oils of | 10-24-2013 |
20130287868 | Pharmaceutical composition on the basis of Stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo - This invention generally refers to the process to obtain a compound and a standard pharmaceutical product from one or more parts of plants of the | 10-31-2013 |
20130295204 | FORMULATIONS COMPRISING SAPONINS AND USES THEREOF - Provided is a formulation including various natural extracts for a variety of human applications. | 11-07-2013 |
20130302448 | PHYTIN AQUEOUS SOLUTION AND USE OF SAID SOLUTION FOR THE PREPARATION OF A LIQUID NUTRITIONAL SUPPLEMENT OR A COSMETIC COMPOSITION - A phytin aqueous solution including at least one alpha-hydroxylated carboxylic acid and phytin in a solubilized form, preferably in a concentration ranging from 70 g/L to 270 g/L, and in that it has a pH value ranging from 3 to 5. The phytin aqueous solution may be used in the preparation of a liquid nutritional supplement and in the preparation of a cosmetic composition. | 11-14-2013 |
20130302449 | Method of Treating Neurological Conditions with Oleandrin-Containing Extract - A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of cardiac glycoside to a subject. The cardiac glycoside can be present in a dosage form. | 11-14-2013 |
20130302450 | HAIR GROWTH AND FOSTERING AGENT - Provided is a hair growth agent/hair tonic capable of improving the hair generation and growth effects and achieving the anti-canities effects. Specifically, the hair growth agent/hair tonic comprises, as an active ingredient, the extract obtained from the whole part of a plant belonging to the genus | 11-14-2013 |
20130309331 | Compositions and Methods for Treating the Symptoms Associated for Alcohol Based Hangovers - Compositions and methods that are effective relieving the symptoms of an alcoholic induced hangover, comprising of an acidified, protonated and mechanical excited pre-mix blended with a sweet, pleasant tasting mixture of vitamins, minerals, spices and natural herbsin an enriched aqueous composition. | 11-21-2013 |
20130309332 | New Use Of An Extract Of Plant Origin Of Globularia And Method For Obtaining Said Extract By In Vitro Plant Culture - According to the present invention the extract of plant origin of the | 11-21-2013 |
20130316023 | HOP OXIDATION-REACTION PRODUCT, PREPARING METHOD THEREOF AND USE THEREOF - The present invention relates to a food product and food additive comprising a hop oxidation-reaction product or an extract thereof, as well as to a fat accumulation suppressing agent and a weight gain suppressing agent having it as an active ingredient. | 11-28-2013 |
20130323329 | Method Of Using Rhein For Treating Fibrotic Conditions And Tumors - The present invention relates to a method of using an anthraquinone derivative namely 9,10-Dihyro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, or known as Rhein, for treating chronic pancreatitis induced fibrosis of the pancreas. More particularly, the present invention relates to a method of using Rhein, its derivatives and/or chemical variants as an anti-fibrotic agent. The present invention particularly relates to the suppression of pancreatic stellate cell activation for the management of chronic inflammatory, fibrotic and tumorigenic pathologies in the pancreas. | 12-05-2013 |
20130323330 | METHODS FOR INHIBITING PROSTATE CANCER BY KINASES AND ANGIOGENESIS INHIBITORY MECHANISMS OF BALL MOSS EXTRACT - A method of treating prostate cancer by administering a pharmaceutically-acceptable amount of a crude extract of the indigenous Jamaican plant Ball Moss ( | 12-05-2013 |
20130330425 | Plant retinol formulations and associated method - Nutritional formulations and methods to produce safe vitamin A/retinol are described. In particular, methods and formulations containing plant pro-vitamin A carotenoids from momordica cochinchinensis spreng are disclosed. The formulations and associated method are characterized by high concentration of provitaminA carotenoids in a water soluble form with enhanced stability and absorption. This invention describes methods to produce water-soluble provitamin A powder from “gac” and formulas to enhance absorption of plant provitamin A carotenoids to a subject. The method described herein requires no chemical solvents, nor involves genetic modification, also delivers other nutrients to improve nutritional status of subjects. This method provides a safe source of vitamin A to be used in pharmaceuticals, cosmeceuticals, nutraceuticals and food supplements for humans and animals. | 12-12-2013 |
20130330426 | TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS - Disclosed are compositions that include extracts from a | 12-12-2013 |
20130330427 | Lip Balm - A lip balm product having a synthetic ceramide, an anti-irritant compound, sodium hyaluronate, cosmetic wax, boswellic acids and/or esters and/or salts thereof, extract of the | 12-12-2013 |
20130337087 | METHODS AND MODELS FOR ASSESSING ANTI-AGING BENEFITS OF AGENTS - A screening method for identifying an agent as effective for providing an anti-aging skin benefit is provided. The screening method includes culturing first and second human skin samples from about 3 days to about 19 days, wherein the first and second human skin samples are derived from a human skin surgical waste tissue. The first human skin sample is contacted with at least one test agent. The second human skin sample is contacted with a positive control. Transcriptional profiles are generated from the first and second human skin samples, and the at least one test agent is identified as effective for providing an anti-aging skin benefit when the transcriptional profiles of at least two genes show a similar directional change in comparison to one or more untreated control tissue samples. | 12-19-2013 |
20130337088 | METHODS FOR TREATING SCARS AND AGING SKIN - Beneficial topical compositions for treating scar or aging skin are provided. In one embodiment, the compositions include | 12-19-2013 |
20130337089 | COMPOSITION FOR PREVENTING OR TREATING HEARING LOSS - Disclosed is a pharmaceutical composition for preventing or treating hearing loss, comprising | 12-19-2013 |
20130344173 | MODULATING DISEASE THROUGH GENETIC ENGINEERING OF PLANTS - In certain embodiments transgenic plants (e.g., transgenic tomatoes) are provided that comprise cells that express a peptide one or more domains of which comprise the amino acid sequence of an apolipoprotein or apolipoprotein mimetic peptide where the peptide has biological activity (e.g., lowers SAA, and/or increases paroxonase activity, and/or improves HDL inflammatory index, etc.) when the plant and/or the peptide is fed to a mammal. | 12-26-2013 |
20130344174 | Bioactive Fractions and Compounds from Polygonum genus, their Use in Anti-diarrhea and the Method of Preparation - The present invention discloses the utility of factions and compounds from | 12-26-2013 |
20130344175 | PREPARATION USED FOR ANTI-TACHYARRHYTHMIA AND ITS PREPARATION METHOD - A kind of Corydalis extract for anti-tachyarrhythmia, the extract prepared by the following method: Corydalis crude powder 100 parts by weight, is extracted by 60-80% ethanol 600-1000 parts by volume in 1-3 times, combined filtrate, concentrated under reduced pressure to a fluidextract of the relative density of 0.2-0.5 g/mL; take the processed D101 resin, and the fluidextract prepared through the resin column with the flow rate of 0.2-0.5 mL/min, impurity of deionized water with the flow rate of 0.2-0.5 mL/min, 60-90% ethanol elution, flow rate 0.4-0.8 mL/min, and recover ethanol, concentrate to Corydalis extract dry paste. According to the conventional method of adding conventional accessories, made into clinically acceptable pills, capsules, granules, tablets, oral liquid or injection. The extract has obvious effect on anti-arrhythmia. | 12-26-2013 |
20130344176 | METHODS AND COMPOSITIONS FOR TREATMENT OF ADD/ADHD, DEPRESSION, MEMORY PROBLEMS AND OTHER CONDITIONS - Disclosed herein are compositions and methods for treating a variety of mood and behavioral disorders, including attention deficit hyperactivity disorder (ADHD), anxiety, depression, memory loss, as well as other conditions. Also disclosed herein are methods for diagnosing certain conditions, such as ADHD, using these compositions. | 12-26-2013 |
20140004210 | DEGRADATION INHIBITOR OF HYALURONIC ACID, COMPRISING ROSEMARY EXTRACT AND RETINOL ACETATE | 01-02-2014 |
20140004211 | RAT-EYE BEAN EXTRACT IMPROVING BLOOD GLUCOSE CONTROL AND BIOACTIVITY AND METHOD OF PRODUCING THE SAME | 01-02-2014 |
20140004212 | ANDROGRAPHIS PANICULATA EXTRACT | 01-02-2014 |
20140017343 | METHOD FOR MANUFACTURING DRUGS THAT ENHANCE BRAIN FUNCTION - A method for manufacturing drugs that enhance brain function, includes the steps of: dip a predetermined amount of | 01-16-2014 |
20140017344 | USE OF A STANDARDISED DRY EXTRACT OF LEAVES OF BUDDLEJA GLOBOSA HOPE, BG-126, FOR THE TREATMENT AND PREVENTION OF GASTROINTESTINAL DISORDERS CAUSED BY TREATMENT WITH NITROFURANTOIN AND OTHER ANTIMICROBIALS - The invention relates to the use of a composition comprising extract of | 01-16-2014 |
20140017345 | COMPOSITION COMPRISING THE EXTRACT OF HERBAL COMBINATION FOR PREVENTING OR TREATING DIABETIC PERIPHERAL NEUROPATHY - Disclosed are a pharmaceutical composition and a health functional food for the prevention and treatment of diabetic peripheral neuropathy, comprising an herb extract of a mixture of 3.5:1 | 01-16-2014 |
20140023731 | COMPOSITION FOR TREATING AIDS AND ASSOCIATED CONDITIONS - An Aids and associated conditions related to Aids treating compositions is disclosed. The compositions comprise: a medicament selected from an extract of at least one of the following plant families: Apocynaceae ( | 01-23-2014 |
20140030364 | ANTIVIRAL COMPOSITIONS COMPRISING ETHANOL EXTRACT OF TETRACERA SCANDENS AND USE THEREOF - A composition for preventing or treating a viral infection, which includes an ethanol extract of | 01-30-2014 |
20140037761 | METHOD FOR PREVENTING OR TREATING AN ALLERGIC DISEASE USING EXTRACT FROM ILLICIUM VERUM - The present invention provides a method for preventing or treating an allergic disease, comprising administering to a subject a composition comprising an extract from | 02-06-2014 |
20140037762 | ADIPONECTIN PRODUCTION PROMOTER, AND MEDICINAL COMPOSITION, FOOD, DRINK AND FEED CONTAINING ADIPONECTIN PRODUCTION PROMOTER - Provided is an adiponectin production-promoting agent comprising Botanbouhu as an active component. Such an adiponectin production-promoting agent is able to be used for prevention or treatment of hypoadiponectinemia. Further provided are a pharmaceutical composition, food and drink, and feed comprising such an adiponectin production-promoting agent. | 02-06-2014 |
20140044807 | Method of Obtaining Hemp Plant Juice and Use of Same for the Production of Beverages - The present invention relates to a method for producing beverages on the basis of juice from the hemp plant. The invention relates to a method for obtaining juice suitable for human consumption from the hemp plant, wherein the complete hemp stem is pressed after harvest without prior drying or retting. The invention further provides a method for obtaining juice from the hemp plant, wherein the upper leafy part of the hemp plant is cut, the leaves are stripped of the remaining stem, fibres and shives being separated from each other at the stem, the leafy part of the stem, the fibres and the shives being pressed individually under pressure and the so obtained pressed juices are being mixed in a controlled manner. In a yet further aspect, the invention relates to a method for the manufacturing of beverages on the basis of juice from the hemp plant, wherein the hemp juice is mixed with yeast and than fermented. | 02-13-2014 |
20140044808 | DIETETIC OR PHARMACEUTICAL PREPARATION CONTAINING TARTARY BUCKWHEAT - The invention relates to a method for preparing a dietetic or pharmaceutical composition, comprising the following steps: a) a preparation containing rutin, in particular ground tatary buckwheat, is mixed with a protein solution in a weight ratio protein solution/buckwheat from 1 to 100 (or vice versa), wherein before the addition of buckwheat, the protein solution has been heated above room temperature, b) the mixture from step a) is held for a period of at least 10 to 1,000 s at a temperature >50° C., and c) subsequently to step b), the mixture is cooled down to a temperature below 45° C. The invention further relates to thus obtainable preparations and to the uses thereof. | 02-13-2014 |
20140057002 | ANTI-FATIGUE COMPOSITION OF PLANT MATERIAL AND PREPARATION METHOD, USE AND PRODUCTS THEREOF - The present invention provides a composition of a plant material with anti-fatigue activity, its preparation method, usage and related products. The said composition is manufactured from the following plant materials: 20-80% from the genus | 02-27-2014 |
20140057003 | Augmenting Cleaning Chemicals - Device, system and method for electrochemical generation of a liquid soap by electrolyzing a surfactant in an aqueous carrier in a cathode compartment of an electrolytic cell and electrolyzing an antimicrobial agent in an aqueous carrier in an anode compartment of the electrolytic cell with the compartments separated by a semipermeable membrane. Portions of the electrolyzed surfactant solution and portions of the electrolyzed antimicrobial solution are withdrawn from the cathode compartment and the anode compartment and combined to form the liquid soap. Skin benefiting agents such as vitamins may be added to the liquid soap with the surfactant and/or antimicrobial agent. | 02-27-2014 |
20140057004 | HERBAL POLYPHARMACEUTICAL FOR PREVENTING AND TREATING ATHEROSCLEROSIS - Herbal MDR for the prevention and treatment of atherosclerosis which includes a summary of the genus | 02-27-2014 |
20140057005 | DEVELOPMENT OF A PYTOESTROGEN PRODUCT FOR THE PREVENTION OR TREATMENT OF OSTEOPOROSIS USING RED CLOVER - A phytoestrogen blend was developed using a pharmaceutical platform technology to identify the time course of active components and effect time course of these components in the biophase after administration of a red clover extract. This phytoestrogen blend consists of biochanin A, daidzein, equol and genistein. The recommended daily dosage ranges from 5 to 200 mg of total isoflavone. | 02-27-2014 |
20140072659 | DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF NELUMBO AND METHODS OF USING SAME - Materials derived from | 03-13-2014 |
20140079817 | COMPOSITION FOR ENHANCING MEMORY AND MITIGATING NEURODEGENERATION AND METHOD THEREOF - The present invention provides a composition for enhancing memory and mitigating neurodegeneration comprising an effective amount of a | 03-20-2014 |
20140079818 | BOEHMERIA EXTRACT AND ITS USE IN TREATING LIVER DISEASES - A method for treating liver fibrosis. The method includes administering to a subject suffering from liver fibrosis a pharmaceutically active extract obtained from a | 03-20-2014 |
20140087008 | COMPOSITION FOR PREVENTING OR TREATING DEMENTIA COMPRISING EXTRACTS OF MONSONIA SPECIES - The present invention relates to a pharmaceutical composition for preventing and/or treating dementia comprising extracts of | 03-27-2014 |
20140087009 | Composition of Beta-Glucan and Ashwagandha - Compositions including combinations of β-glucan and | 03-27-2014 |
20140099388 | DELIVERY OF FUNCTIONAL INGREDIENTS - A primary composition comprising all essential nutrients of a fruit or a plant material, which has an increased stability, bio-availability and miscibility, and a process of forming same are provided. An oral composition containing the primary composition in a foodstuff, food supplement, cosmetic preparation or a pharmaceutical preparation is also provided. | 04-10-2014 |
20140113010 | Essential Element Management - The invention extends the utility of apparatus used to extract medicinal cannabis compounds into an eluate by separating a portion of medicinal cannabis compounds contained within a portion of eluate at a first extraction target level providing enough clean solvent to continue extraction operations. A high efficiency concentrator such as a rotary evaporator or a wiped film evaporator processes eluate from one or more tanks or extraction vessels creating clean solvent when extraction targets are met or when clean solvent is exhausted. This manages eluate concentration levels and limits the quantity of concentrated medicinal cannabis compounds on site at any moment in time. The invention enables a business model for keeping medicinal cannabis compounds within a legal system, and reduces pollution because law enforcement would no longer have to burn large quantities of cannabis plant matter. | 04-24-2014 |
20140120186 | INSECTICIDAL COMPOSITIONS AND METHODS OF USING THE SAME - Insecticidal compositions have at least one active agent and at least one insecticide. The active agent can include | 05-01-2014 |
20140134280 | EXTRACTS OF CYNANCHUM SP. AND ACTIVE INGREDIENTS CONTAINED THEREIN IN USE OF ARTHRITIS TREATMENT - An extract of | 05-15-2014 |
20140134281 | FUNCTIONAL FORMULATION - Nutraceutical gum or functional food compositions comprise Ashwagandha ( | 05-15-2014 |
20140147522 | GASTRIC HEALTH SUPPLEMENT AND METHODS THEREOF - The invention provides novel compositions that can be used as a supplement (e.g. feed supplement) to animals such as, horses. In certain embodiments, the composition comprises an effective amount of a preparation obtained from sea buckthorn and an effective amount of an amino acid. In other embodiments, the composition includes specific combinations of components selected from the group of a preparation obtained from sea buckthorn, glutamine, aloe vera extract, pectin, and lecithin. The invention also provides methods and uses of the composition for alleviating, treating or preventing an ulcer-related condition in a subject identified in need thereof. | 05-29-2014 |
20140147523 | EXTRACTS OF SOLANUM ESURIALE AND SOLANUM GLAUCOPHYLLUM AND METHODS OF TREATING SKIN - The present invention relates to compositions comprising extracts of | 05-29-2014 |
20140154343 | Modulation of Thymosin Beta-4 in Skin - Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin. | 06-05-2014 |
20140161909 | Medemia Nobilis Extracts and Methods of Use - The present invention describes methods for improving the appearance of skin, particularly, treating, ameliorating, preventing, delaying, and/or improving one or more signs of aging, by topically applying compositions comprising an extract of | 06-12-2014 |
20140161910 | Serissa Japonica Extracts and Methods of Use - Methods of using extracts of | 06-12-2014 |
20140161911 | Hoya Carnosa Extracts and Methods of Use - Methods of using extracts of | 06-12-2014 |
20140178506 | COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 06-26-2014 |
20140193529 | Modulation of Thymosin Beta-4 in Skin - Methods for preventing, ameliorating, or reducing dermatological signs of inflammation are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin and inhibit production of pro-inflammatory chemokines and/or cytokines. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin. | 07-10-2014 |
20140193530 | PHARMACEUTICAL COMPOSITION CONTAINING HONEYSUCKLE EXTRACT AND ANTIBIOTICS, PHARMACEUTICAL KIT, AND USE OF HONEYSUCKLE EXTRACT FOR PREPARATION OF DRUG - Provided is a pharmaceutical composition useful for prevention and/or treatment of diseases caused by bacteria, wherein the pharmaceutical composition comprising a honeysuckle extract containing iridoid compounds and an antibiotic. Also provided is a pharmaceutical kit comprising the honeysuckle extract containing the iridoid compounds and the antibiotics which are separately placed. The honeysuckle extract is used in combination with the antibiotics, the responsiveness of multi-drug resistant bacteria to antibiotics is improved, a clinical application prospect is presented, especially the current status of the refractory bacterial infection diseases caused by the pathogenic bacteria resistant to the antibiotics can be improved. Also provided is a use of the pharmaceutical composition and pharmaceutical kit in the preparation of drugs for prevention and/or treatment a diseases caused by bacteria. In addition, also provided is a use of the honeysuckle extract in the preparation of drugs for reversing bacterial resistance. | 07-10-2014 |
20140205686 | INHIBITORS OF EXTRACELLULAR PROTEASES - Provided is a plant derived extract including inhibitory activity against one or more extracellular proteases which degrade human tissue matrix. Moreover, the amount of inhibitory activity in an extract can be increased by stressing the plant prior to forming an extract. These extracts are each prepared by a process and demonstrate the ability to inhibit one or more extracellular proteases which degrade human tissue matrix. Libraries of extracts can be prepared from stressed and non-stressed plants, where each of the extracts demonstrate inhibitory activity against on or more extracellular protease inhibitors. Alternatively, semi-purified and purified inhibitory compounds can be isolated from the extracts. In one aspect, these extracts with inhibitory activity can be used during protein purification to minimize degradation due to extracellular proteases | 07-24-2014 |
20140212517 | VAPOR TRAP - A method of capturing a vaporized component or components, and apparatus for same is provided. The method involves vaporization of desired components, and capture of the vaporized components in a material using a vapor trap device. Once captured, the material with the component stored therein may be used for any number of purposes including ingestion, topical administration, and/or aromatization. | 07-31-2014 |
20140242196 | METHOD OF TREATING VENOMOUS BITES - The method of treating venomous bites, such as those from snakes and scorpions, involves treatment by the administration of a therapeutically effective amount of an aqueous extract of the fruit of | 08-28-2014 |
20140248379 | PROCESS FOR PRODUCING AN EXTRACT CONTAINING TETRAHYDROCANNABINOL AND CANNABIDIOL FROM CANNABIS PLANT MATERIAL, AND CANNABIS EXTRACTS - The invention relates to a method for producing an extract from | 09-04-2014 |
20140255521 | TOPICAL COMPOSITIONS AND METHODS OF TREATMENT OF TOPICAL DISORDERS - A topical composition includes at least one film forming ingredient; at least one surfactant; at least one non-polar volatile siloxane solvent; at least 15% (w/w) water; and a therapeutically effective concentration of at least one pharmaceutical agent, wherein the composition is sufficiently designed to dry within 60 seconds after application to a body surface to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time. | 09-11-2014 |
20140255522 | TOPICAL COMPOSITIONS AND METHODS OF TREATMENT OF ANORECTAL AND GENITAL DISORDERS - A topical anorectal or genital composition includes at least one film forming ingredient; at least one surfactant; at least one non-polar volatile siloxane solvent; at least 15% (w/w) water, and a therapeutically effective concentration of at least one pharmaceutical agent, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal or genital surface to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time. | 09-11-2014 |
20140255523 | Use of Tiliacora Triandra in Cosmetics and Compositions Thereof - The present disclosure relates to compositions for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, where the compositions include natural plant constituents which increase expression levels genes, collagen replacement and retention, and cell proliferation of epidermis and dermis associated with the dermatological signs of aging. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof, once daily in an amount effective in improving the condition and aesthetic appearance of skin. | 09-11-2014 |
20140271940 | BIOACTIVE CONCENTRATES AND USES THEREOF - The present invention relates to concentrates obtained from extraction from | 09-18-2014 |
20140271941 | Method For Producing Dry Extracts - The invention relates to a method for producing dry extracts of plants and to pharmaceutical preparations containing the same, more particularly phytopharmaceuticals, which contain at least one ethanolic/aqueous extract of a plant (drug), the plants being selected from the group consisting of: | 09-18-2014 |
20140287067 | ANTI-TUMOURAL EFFECTS OF CANNABINOID COMBINATIONS - The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM). | 09-25-2014 |
20140287068 | BREEDING, PRODUCTION, PROCESSING AND USE OF SPECIALTY CANNABIS - The invention provides compositions and methods for the breeding, production, processing and use of specialty | 09-25-2014 |
20140287069 | Apparatus and Method for Cellular Extract Enhancement - The invention discloses a method of increasing extracts | 09-25-2014 |
20140302180 | COMPOSITION COMPRISING CHICORY EXTRACT - The present invention relates to a chicory extract for allowing reduction or control of body weight or limitation of body weight gain, reduction or limitation of increase of fat storage, of fatty liver, of liver triglycerides level, of hypertriglyceridemia, of glycemia level, of insulinemia level, of insulin resistance, and/or of different factors of metabolic syndrome, and to a composition comprising such an extract. | 10-09-2014 |
20140308372 | JOJOBA EXTRACT USEFUL IN IMPROVING SKIN BARRIER FUNCTIONS - The present invention provides compositions comprising extracts of Jojoba ( | 10-16-2014 |
20140322363 | TREATMENT OF WITHDRAWAL SYMPTOMS TO AID IN NICOTINE USE CESSATION WITH PASSIFLORA INCARNATA - The present invention relates to the treatment of withdrawal and craving symptoms as an aid in smoking cessation by administration of one or more dosages of a medication containing | 10-30-2014 |
20140322364 | BODY TYPE SELF-ASSESSMENT AND TREATMENTS - Methods are provided for the self-assessment and treatment of medical conditions by an untrained layperson. Such methods may comprise determining the layperson's body type by self-assessment, selecting a mixture of herbs based upon the layperson's body type, and ingesting the mixture of herbs. | 10-30-2014 |
20140328950 | MORUS EXTRACTS RICH IN N-ACIDS OF IMINO SUGARS AND OR PIPECOLIC ACIDS - This invention relates to extracts rich in N-acids of imino sugars (as opposed to neutral and basic imino sugars) and/or pipecolic acids obtainable from the plant leaves of mulberry ( | 11-06-2014 |
20140335208 | TETRAHYDROCANNABIVARIN (THCV) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS - The present invention relates to the phytocannabinoid tetrahydrocannabivarin (THCV) for use in the protection of pancreatic islet cells. Preferably the pancreatic islet cells to be protected are beta cells. More preferably the protection of the pancreatic islet cells maintains insulin production at levels which are able to substantially control or improve control of blood glucose levels in a patient. | 11-13-2014 |
20140348957 | Therapeutic and Method of Use - The present invention is a compound comprising an NSAID portion and at least one of a progestin portion and a progesterone portion. The compound may take for instance the form of a pill or pellet (for oral internal use or for subdermal implantation), an injectable solution, or a suppository. The compound is intended for use in treating subjects having or being at increased risk—especially genetically determined risk—of developing endometriosis. The compound may also be used for treating other disorders or as a contraceptive. | 11-27-2014 |
20140348958 | Anticancer Active Ingredient From Guiera Senegalensis - A compound of formula (I), a positional or structural isomer thereof, or a pharmaceutically acceptable base addition salt or acid addition salt thereof, use thereof as a medicament, in particular an anticancer medicament. | 11-27-2014 |
20140348959 | Formulations and Methods for Treating Ear Conditions - Compositions and methods for treatment of conditions such as ear pain are disclosed. | 11-27-2014 |
20140363526 | SYNERGISTIC FORMULATION OF PLANT EXTRACTS FOR HEPATIC AND ADRENAL DISORDERS - A composition of matter comprising a synergistic formulation of plant extracts for hepatic and adrenal disorders is provided. In an implementation, an example extraction method for concentrating pharmacologically active fractions of plants provides a synergistically active compound containing approximately 5%-25% extract of | 12-11-2014 |
20140370126 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES OR ASTHMA, CONTAINING LAGERSTROEMIA OVALIFOLIA EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT - The present invention relates to a pharmaceutical composition for preventing or treating inflammatory diseases or asthma comprising a | 12-18-2014 |
20140370127 | ANTIVIRAL COMPOSITIONS COMPRISING ETHANOL EXTRACT OF TETRACERA SCANDENS AND USE THEREOF - A composition for preventing or treating a viral infection, which includes an ethanol extract of | 12-18-2014 |
20140377382 | CANNABINOID-CONTAINING PLANT EXTRACTS AS NEUROPROTECTIVE AGENTS - The invention relates to the use of cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration. In particular, the invention relates to use of one or more cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration, wherein the one or more cannabinoid-containing plant extracts comprise:
| 12-25-2014 |
20140377383 | USE OF HUMULUS JAPONICUS EXTRACT FOR PREVENTING OR TREATING METABOLIC DISORDERS OR FATTY LIVER - A functional health food containing | 12-25-2014 |
20150024072 | METHODS OF TREATING A SKIN CONDITION WITH MALVA NEGLECTA - The present invention relates to a method of treating a skin condition, particularly improving skin barrier function, improving the appearance of at least one sign of aging in skin, and/or lightening skin, by applying to the skin an extract of | 01-22-2015 |
20150024073 | COMPOSITIONS CONTAINING EXTRACTS OF MALVA NEGLECTA - The present invention relates to a skin care composition comprising an extract of | 01-22-2015 |
20150024074 | METHODS FOR TREATING SKIN BARRIER AND REDUCING ACNE - A method of treating acne by applying to the skin an extract of | 01-22-2015 |
20150030705 | TECHNIQUE AND METHOD FOR PRODUCING FUNCTIONAL MATERIAL ORIGINATED FROM ICE PLANT, AND FUNCTIONAL COMPONENT - The present invention provides a method for producing an ice plant having increased contents of pinitol, β-carotene, vitamin K and proline, said method being characterized by adding a stress to an ice plant during the cultivation of the ice plant; a method for increasing the contents of pinitol, β-carotene, vitamin K and proline, which are functional components contained in an ice plant, said method being characterized by adding a stress to the ice plant during the cultivation of the ice plant; and others. | 01-29-2015 |
20150037439 | PHYTOGENIC NUTRACEUTICAL COMPOSITION AND METHODS OF USE THEREOF - A nutraceutical composition including as a functional ingredient an effective amount of a substance extracted from dry, fresh or ensilaged phytomass of genus | 02-05-2015 |
20150050362 | Essential Oil of Kunzea Ambigua and Methods of Use - A method for treating disease includes the steps of obtaining the essential oil from the | 02-19-2015 |
20150050363 | Novel autophagy enhancer for treatment of neurodegenerative diseases - Use and application of Onjisaponin B derived and isolated from Radix Polygalae as novel autophagy enhancer are provided. A method of preventing, treating and/or delaying the onset of neurodegenerative diseases comprising administering an effective amount of Onjisaponin B is also provided. | 02-19-2015 |
20150050364 | COMPOSITION FOR TREATING OR PREVENTING TINNITUS - The present invention provides a pharmaceutical composition for treating or preventing tinnitus, comprising the extract of | 02-19-2015 |
20150056309 | Composition and Method for the Safe and Effective Inhibition of Pancreatic Lipase in Mammals - Provided are a composition and method for the safe and effective inhibition of pancreatic lipase in humans and other mammals. Provided is a composition which contains extracts of one or more of | 02-26-2015 |
20150056310 | COSMETIC METHOD FOR INCREASING COLLAGEN EXPRESSION IN SKIN COMPRISING TOPICALLY APPLYING AN EXTRACT OF QUASSIA AMARA - The present invention relates to a cosmetic method for increasing collagen gene and/or protein expression comprising topically applying an effective amount of an extract of the plant | 02-26-2015 |
20150064287 | METHOD FOR TREATING ABNORMAL POLYGLUTAMINE-MEDIATED DISEASES - The present invention relates to a method for treating abnormal polyglutamine-mediated diseases comprising: administering a pharmaceutical composition comprising one or more selected from the group consisting of a | 03-05-2015 |
20150064288 | Anti-Microbial Composition - The present invention relates to an anti-microbial composition and method of use thereof. In particular, the present invention relates to an anti-microbial composition comprising farnesol and cetrimide. | 03-05-2015 |
20150072027 | METHOD AND APPARATUS FOR TREATING PEST - A device for treating pests and method for using the same. The device comprises an effective amount of endod. The device can be placed in a body of water wherein the endod treats the pests. Additionally the device can be placed in a pipe whereby a combination of the endod and the mechanical force of the water removes the pests in the pipe. | 03-12-2015 |
20150072028 | EXTRACTS AND ISOLATED COMPOUNDS FROM CAKILE ARABICA FOR TREATMENT OF ULCER - The present invention relates to extracts, compounds isolated from | 03-12-2015 |
20150072029 | MATERIALS AND METHODS FOR REDUCTION OF PROTEIN TAU AND TREATMENT OF NEURODEGENERATIVE DISEASES - The subject invention provides a myricanol compound that is in predominant form of (+)-αR,11S-myricanol as compared to (−)-αS,11R-myricanol. In one embodiment, the (+)-αR,11S-myricanol is isolated from | 03-12-2015 |
20150086653 | PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER - This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon. | 03-26-2015 |
20150093455 | COMPOSITIONS AND METHODS FOR INCREASING TELOMERASE ACTIVITY - The present invention relates to methods and compositions for increasing telomerase activity in cells. Such compositions include pharmaceutical, including topical, and nutraceutical formulations. The methods and compositions are useful for treating diseases subject to treatment by an increase in telomerase activity in cells or tissue of a patient, such as, for example, HIV infection, various degenerative diseases, and acute or chronic skin ailments. They are also useful for enhancing replicative capacity of cells in culture, as in ex vivo cell therapy and proliferation of stem cells. | 04-02-2015 |
20150093456 | PHARMACEUTICAL COMPOSITION FOR TREATING WOUNDS OR REVITALIZING SKIN COMPRISING EUPHORBIA KANSUI EXTRACTS, FRACTIONS THEREOF OR DITERPENE COMPOUNDS SEPARATED FROM THE FRACTIONS AS ACTIVE INGREDIENT - The present invention relates to a pharmaceutical composition for treating wounds or revitalizing skin comprising the | 04-02-2015 |
20150110900 | CELLULOSE POWDER - This cellulose powder has: an average degree of polymerization of 100 to 350; a weight average particle size of over 30 gm, but less than 250 μm; an apparent specific volume of 2 to less than 15 cm | 04-23-2015 |
20150110901 | SESQUITERPENOID-BASED COMPOUNDS, EXTRACTS OF CYPERUS ROTUNDUS COMPRISING THE SAME, AND USE THEREOF - The present invention relates to a novel use of sesquiterpenoid compounds, the pharmaceutically acceptable salts thereof, or the extracts of | 04-23-2015 |
20150110902 | THERAPEUTIC USES OF MASTIC GUM FRACTIONS - The invention relates to therapeutic uses of gum mastic, and compounds found therein including polymeric myrcene. More particularly, the invention relates to methods of treating impaired neurological function using compositions comprising polymeric myrcene. | 04-23-2015 |
20150118328 | COMPOSITION FOR SKIN HYGIENE AND/OR HYDRATION - The present invention relates to a composition for cleansing and/or moisturizing skin. The compositions of the invention which provide a cosmetic or dermatological composition for cleansing and/or moisturizing skin, preferably compositions used for showering or bathing, comprise:
| 04-30-2015 |
20150118329 | METHOD FOR PROMOTING ADIPONECTIN PRODUCTION, PREVENTION AND TREATMENT OF HYPOADIPONECTINEMIA - Provided is an adiponectin production-promoting agent comprising Botanbouhu as an active component. Such an adiponectin production-promoting agent is able to be used for prevention or treatment of hypoadiponectinemia. | 04-30-2015 |
20150125554 | METHOD FOR PREPARING GRANULES OR PILLS CONTAINING EXTRACTS IN HIGH CONCENTRATION - The present invention relates to a method for preparing a granule or a pill containing a plant, medicinal herb or traditional oriental medicine decoction extract, comprising the steps of: (a) injecting a powdered plant, medicinal herb or traditional oriental medicine decoction extract into a fluidized-bed device and spraying purified water or a solution of the same type of extract as the extract powder at the extract powder while fluidizing the same, thereby generating microgranules of the extract powder; and (b) injecting the microgranules generated at step (a) as seeds into the fluidized-bed device and spraying a solution of the extract while fluidizing the same, thereby growing the microgranules to a predetermined size of granule or pill. According to the present invention, it is possible to prepare a granule or a pill containing an extract in a high concentration. | 05-07-2015 |
20150125555 | PHARMACOLOGICAL USE OF CIMICIFUGA EXTRACT - The present invention relates to the novel use of an extract from a | 05-07-2015 |
20150125556 | POMEGRANATE EXTRACT CONTAINING LARGE AMOUNT OF ELLAGIC ACID AND USE OF THE POMEGRANATE EXTRACT - A pomegranate pulp extract is disclosed. The pomegranate pulp extract is effective in treating women's menopausal symptoms, due to the presence of a large amount of ellagic acid. Further disclosed is a method for further improving the treating effect of the pomegranate extract on women's menopausal symptoms. The method includes increasing the content of ellagic acid in the pomegranate extract. | 05-07-2015 |
20150132411 | ANTI-CANCER EXTRACT AND COMPOUNDS - The present invention relates to a new approach for treating a cancer or fibrosis, such as hepatocellular carcinoma, or liver fibrosis using an extract from a plant of | 05-14-2015 |
20150140132 | MONOTERPENE GLYCOSYLTRANSFERASE ORIGINATING FROM HOP AND METHOD FOR USING SAME - The object of the present invention is to provide | 05-21-2015 |
20150140133 | IN SITU CONTROLLED RELEASE DRUG DELIVERY SYSTEM - A system is described for long-term controlled release delivery of a drug or a therapeutic agent. According to the invention, one or more drugs or therapeutic agents contained in microspheres are mixed with a temperature sensitive hydrogel which is then introduced directly to the desired situs of the drug or therapeutic agent. The temperature sensitive hydrogel may also contain a drug or a therapeutic agent, for example, a pain relieving drug, for a short-term controlled release. The temperature sensitive hydrogel is in liquid state at room temperature, but upon injection, shortly becomes gelatinous. This system is particularly suitable for treatment of diseases, disorders, or conditions, for example, tumors, discogenic back pain, or arthritis, warranting localized administration of a drug or a therapeutic agent. In addition, the specification provides a method for production of a drug- or therapeutic agent-containing microspheres. | 05-21-2015 |
20150147414 | FRUCTUS LIGUSTRI LUCIDI FOR GROWTH IN CHILDREN - The present invention relates to a non-therapeutic and therapeutic use of Fructus Ligustri Lucidi for increasing the body growth and in particular body length of young subjects. A further aspect of the invention pertains to food products comprising an alcohol extract of said Fructus as well as pet food products comprising said Fructus. | 05-28-2015 |
20150290118 | Hoya Carnosa Extracts and Methods of Use - Methods of using extracts of | 10-15-2015 |
20150290270 | SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACT - The present invention discloses synergistic nutraceutical or pharmaceutical or dietary supplement anti-inflammatory compositions comprising therapeutically effective combination of an extract selectively enriched in 3-O-acetyl-1 1-keto-β-boswellic acid (AKBA) derived from | 10-15-2015 |
20150297511 | OPHTHALMIC COMPOSITIONS WITH ALKOXYLATED NATURAL WAXES - Ophthalmic compositions comprising 0.005 wt. % to 2.0 wt. % of alkoxylated natural waxes selected from the group consisting of alkoxylated lanolin and alkoxylated jojoba, and a method of treating a patient diagnosed with dry eye syndrome, or for cleaning and disinfecting contact lenses, with the ophthalmic compositions. | 10-22-2015 |
20150297653 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING - The present invention provides for methods of obtaining an extract of | 10-22-2015 |
20150297654 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING - The present invention provides for methods of obtaining an extract of | 10-22-2015 |
20150297656 | Atractylodes Lancea extract feed additive and preparation method thereof | 10-22-2015 |
20150297657 | Portulaca oleracea L. extract feed additive and preparation method thereof | 10-22-2015 |
20150297662 | RAPAMYCIN 40-O-CYCLIC HYDROCARBON ESTERS, COMPOSITIONS AND METHODS - A new class of rapamycin 40-O-cyclic hydrocarbon esters is disclosed. The 40-O position of the rapamycin ester has the form 40-O—R, where R is C(O)—(CH | 10-22-2015 |
20150306164 | USES OF BACOPA MONNIERI EXTRACT - The present invention broadly relates to methods for acutely improving/enhancing cognitive performance in a human subject comprising administration of an extract of | 10-29-2015 |
20150313106 | Mutant tomatoes and use thereof for preventing weight gain and/or treating obesity-related conditions - The invention relates to the use of tomatoes for inhibition, amelioration or prevention of adipogenesis mediated diseases such as obesity, lipid storage disease and hyperlipemia. Provided is a tomato plant, fruit, fragment or extract thereof for use in a method for preventing weight gain, and/or inhibiting, preventing or ameliorating a disease condition associated with adipogenesis in a mammal, wherein the tomato is a ripening-impaired mutant tomato, such as a ripening inhibitor (rin), nonripening (nor), and/or never ripe (Nr) gene mutant tomato. Also provided are anti-adipogenic extracts and compositions comprising the extract. | 11-05-2015 |
20150313954 | METHOD OF ADMINISTRATING A SERIES OF COMPOSITIONS FOR DYNAMIC IMMUNE MODULATION - The present disclosure provides a series of compositions, or a single composition formulation (e.g., which includes distinct time release portions), supportive of or resulting in antipode immune system effects. A method of administrating the series of compositions or the single composition formulation to support, provide, enhance, or improve health benefit by way of modulating aspects immune system function is also provided. | 11-05-2015 |
20150313955 | Oral Gel for Relief of Tooth Pain - Disclosed herein are orally acceptable topical analgesic gels comprising a mixture of analgesic oils comprising (a) clove oil and/or eugenol, (b) a cooling agent, and (c) camphor; in an orally acceptable gel base, the gel base providing controlled release of the mixture of analgesic oils following application to a tooth; together with methods of making and using the same. | 11-05-2015 |
20150313956 | COMPOSITIONS AND METHODS FOR HAIR GROWTH - Various embodiments provide compositions for a hair loss treatment composition for promoting hair growth and/or hair thickness and methods for their manufacture. In various exemplary embodiments, the active agent may comprise a preparation of a steroid, a steroid precursor, an estrogen biomimetic, serotonin agonist, and/or an amino acid. In various embodiments, the active agent may comprise a preparation of at least part of a whole plant, a crude plant extract, an at least partially refined plant extract, and a derivative of the plant extract. Exemplary methods for producing the active agent may comprise combining effective amounts of the components of the active agent. The active agent may be for topical use and may be formulated for delivery to at least one of: a hair follicle, a hair follicle shaft, and skin surrounding the hair follicle. | 11-05-2015 |
20150320700 | Geranium oil and constituents thereof for treatment of neurodegenerative diseases - The invention relates to the use of effective amount of | 11-12-2015 |
20150320821 | COMPOSITION FOR COGNITION AND COSMESTIC PURPOSES - The present invention relates to a composition containing an extract from the | 11-12-2015 |
20150329554 | COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS - The present invention provides compounds of formula I: | 11-19-2015 |
20150335613 | C-TERMINAL HSP90 INHIBITORS TO TREAT PITUITARY ADENOMAS - The present invention relates to C-terminal HSP90 inhibitors, like silibinin, novobiocin and derivatives thereof, stereoisomeric forms, prodrugs, solvates, hydrates and/or pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said compounds and its compositions have been identified as useful for the treatment of pituitary adenomas such as corticotroph adenomas, lactotroph adenomas, somatotroph adenomas and thyrotroph adenomas. | 11-26-2015 |
20150366787 | SESBANIA ACULEATA EXTRACTS AND METHODS OF USE - Methods of using extracts of | 12-24-2015 |
20150366922 | Method of Processing Rhinacanthus nastutus (L.) Kurz - The invention discloses a method of processing | 12-24-2015 |
20150366925 | Therapeutic Compounds - The invention features therapeutic compounds useful for the treatment of skin diseases (e.g., psoriasis and eczema), infections (microbial, viral, and fungal), and wounds (e.g., cuts and burns). The compounds of the invention include therapeutically-effective amounts of L-Arginine, undecylenic acid, and | 12-24-2015 |
20150366929 | USE OF ELICITED IRIDACEAE PLANT CELLS IN THE TREATMENT OF SENSITIVE SKIN - This invention relates to the use of | 12-24-2015 |
20150374619 | ABUTILON INDICUM EXTRACTS AND METHODS OF USE - Methods of using extracts of | 12-31-2015 |
20150374769 | TOPICAL SKIN CARE FORMULATIONS - Disclosed is a topical skin composition comprising an effective amount of | 12-31-2015 |
20150374770 | BUCCAL AND SUBLINGUAL CANNABINOID FORMULATIONS AND METHOD OF MAKING THE SAME - A cannabinoid troche including polyethylene glycol (or other base ingredients such as gelatin and/or pectin) and oils of peppermint, ginger, citrus, mango, etc., that is administered buccally and/or sublingually. This dosage form demonstrates an improved efficacy with reduced side effects when compared to formulations of cannabinoids in capsules, oral solutions, tinctures, sprays and edibles. The troches avoid harmful preservatives (e.g., BHT, BHA), heavy metals and stabilizers while addressing sub-therapeutic dosing and optimizing the synergistic qualities of the ratios of the individual cannabinoids, terpenes and flavonoids. The use of peppermint oil (and others) in the troche shows improved efficacy above and beyond that which is expected or seen without its use. The troches further allow for accurate and reproducible therapeutic effects with ease of dosage adjustments. | 12-31-2015 |
20160000847 | METHOD OF USING CISTANCHE TUBULOSA EXTRACT FOR PREPARING DRUGS OR FOOD TO PROTECT EYE CELLS - This invention provides a method of using of extract of | 01-07-2016 |
20160008280 | Dripless Olive Oil for Topical Use | 01-14-2016 |
20160008414 | PHARMACEUTICAL COMPOSITION CONTAINING SCEPTRIDIUM JAPONICUM EXTRACT FOR PREVENTING OR TREATING STROKE OR DEGENERATIVE BRAIN DISEASES | 01-14-2016 |
20160008415 | STABILIZED CREAM FORMULATIONS COMPRISING SANDALWOOD OIL | 01-14-2016 |
20160015657 | USE OF EUGENOL TO TREAT BLISTERS - Implementations of a method for treating an affected area of an epidermis having a blister or rash caused by shingles, psoriasis, acne, eczema, bug bits, bee stings, and poison oak comprising applying topically to the affected area of an epidermis a composition comprises eugenol and sesame oil. | 01-21-2016 |
20160015682 | TETRAHYDROCANNABIVARIN (THCV) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS - The present invention relates to the phytocannabinoid tetrahydrocannabivarin (THCV) for use in the protection of pancreatic islet cells. Preferably the pancreatic islet cells to be protected are beta cells. More preferably the protection of the pancreatic islet cells maintains insulin production at levels which are able to substantially control or improve control of blood glucose levels in a patient. | 01-21-2016 |
20160022753 | COMPOSITIONS DERIVED FROM SWEET POTATO GREENS AND METHODS OF PREPARATION AND USE - The present invention includes methods of identifying a fraction of a sweet potato greens extract (SPGE) that is useful in reducing the risk of or treating, cancer, hypertension, diabetes, or a wound; compositions including the identified fraction(s); methods of administering SPGEs or fractions thereof; and uses of the compositions described herein in the preparation of a medicament. | 01-28-2016 |
20160029643 | Methods, Compounds and Compositions for Repelling Insects and/or Arachnids - The present specification discloses natural repellent compounds, and isomeric forms, structural analogues and derivatives of the said compounds, having repellent activity against mosquitoes and other blood-sucking arthropods, compositions comprising such repellent compounds, methods of screening for such repellent compounds, methods of reducing mosquito bites on an individual and methods of reducing mosquito infestation to a location. | 02-04-2016 |
20160038551 | STABILIZED MESEMBRINE COMPOSITIONS - A composition comprises as active ingredient an extract of a plant or plants from the Mesembryanthemaceae family, such as | 02-11-2016 |
20160044934 | METHOD FOR MAKING COFFEE PRODUCTS CONTAINING CANNABIS INGREDIENTS - The present disclosure is directed to methods of making a coffee products containing cannabinoids that are extracted from Cannabis plant. According to one embodiment, the method includes the steps of (a) extracting cannabinoids from Cannabis plant; and (b) admixing the cannabinoids into a coffee product. The disclosed methods produce coffee products that possesses the benefits of both coffee and Cannabis plant. The methods can be used to produce different coffee products including single-serve coffee pods, ground coffee, and espresso. The methods are used to make coffee products with desired and consistent amount of tetrahydrocannabinol (THC). | 02-18-2016 |
20160045471 | Cannabis Conversion Process - A method for preparing an ingestible cannabis composition is provided. Also provided is the ingestible cannabis composition and a kit including the ingestible cannabis composition. | 02-18-2016 |
20160045558 | COMPOSITION FOR PREVENTING OR TREATING HEARING LOSS - A composition including | 02-18-2016 |
20160045559 | COMPOSITIONS AND METHODS FOR MANAGING OR IMPROVING BONE DISORDERS, CARTILAGE DISORDERS, OR BOTH - The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of useful for promoting, managing or improving bone health, cartilage health or both, or for preventing or treating a bone disorder, cartilage disorder or both. Such a mixture of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both can optionally be used in combination with other bone and cartilage management agents, such as calcium, magnesium, zinc, boron, vitamin D, vitamin K, glucosamine and/or chondroitin compounds, non-steroidal anti-inflammatory agents/analgesics, COX/LOX inhibiting agents, neuropathic pain relief agents, or the like. | 02-18-2016 |
20160051463 | HERBAL SKIN CARE COMPOSITION - Described herein is a method of treating aging skin in a subject, the method comprising applying a topical skin care composition to a surface of the skin of the subject in need thereof, the composition containing a whole plant extract solution of | 02-25-2016 |
20160051608 | ANTI-CANCER EXTRACT AND COMPOUNDS - The present invention relates to a new approach for treating a cancer or fibrosis, such as hepatocellular carcinoma, or liver fibrosis using an extract from a plant of | 02-25-2016 |
20160067292 | BIOACTIVE APOLAR EXTRACT CONTAINING PLANT GENETIC MATERIAL FOR TREATMENT OF MAMMALIAN DISEASES - Bioactive apolar extract of plant material containing plant genetic material to treat mammalian diseases and disorders. | 03-10-2016 |
20160067294 | COMPOSITION COMPRISING SUAEDA JAPONICA FOR PREVENTING OR ALLEVIATING DIABETES - The present invention relates to a food composition comprising | 03-10-2016 |
20160074450 | Essential Element Management - The invention extends the utility of apparatus used to extract medicinal cannabis compounds into an eluate by separating a portion of medicinal cannabis compounds contained within a portion of eluate at a first extraction target level providing enough clean solvent to continue extraction operations. A high efficiency concentrator such as a rotary evaporator or a wiped film evaporator processes eluate from one or more tanks or extraction vessels creating clean solvent when extraction targets are met or when clean solvent is exhausted. This manages eluate concentration levels and limits the quantity of concentrated medicinal cannabis compounds on site at any moment in time. The invention enables a business model for keeping medicinal cannabis compounds within a legal system, and reduces pollution because law enforcement would no longer have to burn large quantities of cannabis plant matter. | 03-17-2016 |
20160074451 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING - The present invention provides for methods of obtaining an extract of | 03-17-2016 |
20160081911 | Nano Freeze Dry Process of Preparation of Highly Bioactive Agent and Its Method of Use - A nano freeze dry process of preparation for a cosmetic composition having a bioactive agent for providing an anti-aging effect on a skin, comprising the steps of: placing the cosmetic composition having a bioactive agent into a capsule container; and nano freeze drying the cosmetic composition by: freezing the cosmetic composition in the capsule container at −170° C.; increasing the temperature to −85° C. and allowing sublimation under vacuum condition; then increasing the temperature to 35° C.; and vacuum drying to obtain a final product, wherein a volume of the cosmetic composition remains unchanged after the process, a water content of less than 5% is inside the final, at least 80% of bioactivity of the cosmetic composition is retained, and significant anti-aging effect is observed after a two-day treatment. | 03-24-2016 |
20160082062 | THERMO-MODIFIED NUTSHELLS AND METHODS OF TREATING DIARRHEA, ADSORBING TOXINS, PROMOTING GROWTH AND IMPROVING THE OVERALL HEALTH - Compositions comprising thermo-modified nutshells, for example hazelnut shells, are described herein. The compositions can also comprise one or more feed additives, pharmaceutically acceptable diluents and/or excipients. Also included are methods for producing the thermo-modified nutshell compositions, and methods for using the compositions to treat diarrhea and adsorb toxins as well as promote growth and improve the overall health in humans and other animals. | 03-24-2016 |
20160085941 | Method of Discovery of Effective Components in Herbals Based on Evidences by Reversed-directed Analysis - A method of proving safety and efficacy of herbal compounds by clinical information obtained by physicians in daily practice by implementation of network technology, chemical analysis, statistics, and clinical trials. Data for potential therapeutic compounds are directly obtained from human being in daily practice setting, application of the invention will tremendously reduce the time and costs involved in research and development of drugs. | 03-24-2016 |
20160089410 | COMPOSITION FOR NOURISHING INJURED HUMAN TROPHOBLAST CELLS AND INHIBITING APOPTOSIS THEREIN - Composition useful in treating and/or preventing spontaneous abortions derived from a traditional recipe of herbal medicine. The composition contains active components from three herbal medicines: total flavonoids of | 03-31-2016 |
20160095893 | PLANT-DERIVED FORMULATIONS FOR TREATMENT OF HIV - Disclosed herein are methods for treating mammals with HIV/AIDS comprising administering a therapeutically effective amount of a composition comprising an extract of | 04-07-2016 |
20160101117 | Use of Megestrol Acetate for Improving Heart Function and the Treatment of Heart Insufficiency - The present invention relates to improving the heart function, the survival and/or the treatment of heart insufficiency using megestrol acetate (Megace®; MA) in patients with heart insufficiency and after a myocardial infarction. | 04-14-2016 |
20160101142 | METHOD FOR OBTAINING A PLANT EXTRACT AND ASSOCIATED COMPOSITIONS - The invention relates to a method for obtaining a composition from a plant extract, to assist in the treatment or prevention of disorders or diseases related to neovascularisation. | 04-14-2016 |
20160113886 | Methods of Feeding Animals Liquid Feed with Soluble Fiber and Sugar Alcohol - An animal feed such as a milk replacer includes a soluble fiber and a sugar alcohol. The milk replacer enhances weight gain, starter intake and reduces weaning time. The method of feeding the animal includes feeding a mixture of a soluble fiber and sugar alcohol. The animal feed may be used as a method of weaning young ruminants such as calves. | 04-28-2016 |
20160120926 | MELALEUCA QUINQUENERVIA EXTRACTS AND USES OF THE SAME | 05-05-2016 |
20160129060 | Composition for the treatment of neurobehavioral disorders - The invention relates to a composition for use in the treatment of neurobehavioral disorders, a Cannabis plant extract comprising Cannabinol preferably with other constituents of this plant for such use and a method for the extraction of plants. The plants or plant parts may for instance be derived from | 05-12-2016 |
20160136216 | Molecular and Herbal Combinations for Treating Psoriasis - A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including emodin and digoxin, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of emodin, digoxin, Sheng Di Huang, Da Huang, Jin Yin Hua, Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi. | 05-19-2016 |
20160136218 | Molecular and Herbal Combinations for Disease Therapy - A method and medicine for treating leukemia or other cancer includes administering to a patient diagnosed with leukemia or other cancer a treatment regimen that includes periodic doses of a combination including emodin or digoxin, or both, with Sheng Di Huang or Da Huang, or both, and/or Jin Yin Hua. | 05-19-2016 |
20160136541 | EXTRACTION DEVICES, SYSTEMS, AND METHODS - Extraction devices, methods, and systems are disclosed. Example devices have a solvent chamber, a plant material chamber, a collection chamber, and a solvent return that create a sealed, closed-cycle extraction and/or solvent purification process. Any extractable plant material can be used in the disclosed devices, methods, and systems although in some examples some form of the cannabis plant is used. | 05-19-2016 |
20160143334 | EDIBLE COMPOSITION SUITABLE FOR LOWERING SERUM CHOLESTEROL - The present invention relates to an edible composition comprising plant sterol ester and/or plant stanol ester and triglyceride fat usable for lowering serum LDL cholesterol. The composition further comprises oligosaccharides and sugars. The composition can preferably be used in dietary supplements, fillings and toppings. | 05-26-2016 |
20160152803 | Process for producing cellulosic shaped articles, cellulosic shaped articles and the use thereof | 06-02-2016 |
20160158299 | Cannabidiol (CBD) Enriched Alcohol - A cannabinoid enriched alcohol composition for human consumption and method of manufacture for the composition are disclosed. The composition includes by weight about ninety-nine point nine-two percent (99.92%) ethanol in a liquid state and by weight about zero point zero eight percent (0.08%) cannabinoid in a liquid state. The composition is made by providing the ethanol in a liquid state and by providing the cannabinoid in the form of a cannabidiol oil in a liquid state, further a next step of combining the ethanol and the cannabidiol oil forming an initial mixture and agitating the initial mixture until the cannabidiol oil and the ethanol are in a substantially emulsified state with one another in a liquid state forming a completed mixture. | 06-09-2016 |
20160166625 | PHARMACEUTICAL METHOD FOR CANNABIS DISTRIBUTION AND AN AILMENT-TARGETED CANNABIS COMPOSITION | 06-16-2016 |
20160175373 | COMPOSITION FOR TREATING DIABETES AND DYSLIPIDEMIA OBTAINED FROM THE EXTRACT OF COSTUS PICTUS D.DON PLANT AND A METHOD OF PREPARING THE SAME | 06-23-2016 |
20160175376 | ANTIMICROBIAL AND ANTI-INFLAMMATORY ACTIVITY OF SWITCHGRASS-DERIVED EXTRACTIVES | 06-23-2016 |
20160183581 | POST-VAPORIZATION PLANT MATTER INFUSED SUBSTRATE FORMULATION - A process is provided for producing a substrate formulation comprising post-vaporization plant matter infused therein. The post-vaporization plant matter is gathered and saturated in a solvent to form a saturated mixture. The solvent is evaporated from the saturated mixture to form a reduced compound which is infused into a substrate thereby producing the post-vaporization plant matter infused substrate formulation. | 06-30-2016 |
20160184216 | ANTI-DANDRUFF COMPOSITIONS, AND METHODS OF USE THEREOF - An anti-dandruff composition comprising an | 06-30-2016 |
20160184338 | Bioactive Alkaloid Compositions and Their Medical Uses - The present invention relates to a novel alkaloid and novel bioactive alkaloid fractions derivable from | 06-30-2016 |
20160184379 | Molecular Combinations for Cancer or Other Disease Treatment - A method and medicine for treating leukemia or other cancer or disease condition including administering periodic doses of a combination of one or more of emodin, rhein or rhapontin with one or more of aucubin, digoxin or beta-sitosterol, and/or one or more of carvacrol, vanillic acid or sitosterol. | 06-30-2016 |
20160184385 | NOVEL PEPTIDE HAVING ABILITY TO SYNTHESIZE COLLAGEN AND USE THEREOF - Provided are a cosmetic composition and pharmaceutical composition for wound healing capable of efficiently performing collagen synthesis in skin, wherein the compositions contain, as an active ingredient, YIGSR peptide having the amino acid sequence of SEQ ID NO: 1 or a peptide derivative having a palmitoyl group added to an N-terminal of the peptide. | 06-30-2016 |
20160193268 | ANDROGRAPHIS PANICULATA EXTRACT | 07-07-2016 |
20160193269 | ANTI-DIABETIC COMPOSITION | 07-07-2016 |
20160193273 | DIETARY SUPPLEMENT COMPOSITIONS | 07-07-2016 |
20160250271 | HERBAL COMPOSITION FOR DIABETIC RETINOPATHY | 09-01-2016 |
20160250272 | ANTIANGIOGENIC USE OF LIQUID PHYTOCOMPLEXES FROM OLIVE | 09-01-2016 |
20160375077 | Herbal Combinations for Treating Eczema - A shampoo, conditioner, cream, ointment or other topical treatment includes an active herbal combination of Sheng Di Huang, Da Huang and Jin Yin Hua for treating eczema, and/or another skin or scalp disorder. | 12-29-2016 |
20160375080 | COMPOSITIONS - The present invention relates to the use of a fruit extract and optionally other specific nutrients for preventing, reducing or minimising exercise-induced systemic inflammation and/or for promoting recovery from intense exercise. The invention also relates to compositions comprising such fruit extracts. | 12-29-2016 |
20180021438 | MEDICATION DISPENSING SYSTEM | 01-25-2018 |
20190142732 | HUMAN BODY CLEANER AND MANUFACTURING METHOD THEREOF | 05-16-2019 |
20190142884 | METHOD OF REDUCING STRESS AND ANXIETY IN EQUINES | 05-16-2019 |
20190142888 | PHYTOCANNABINOID TOPICAL COMPOSITIONS FOR RELEIVING PAIN | 05-16-2019 |
20190142889 | METHOD FOR IMPROVING MITOCHONDRIA AND METHOD FOR PROMOTING CELL DIVISION OF STEM CELL | 05-16-2019 |
20190142890 | DIETARY SUPPLEMENT DERIVED FROM THE SENEGALIA PLANT | 05-16-2019 |
20220133827 | HERBAL COMPOSITION FOR PREVENTING OR TREATING BENIGN PROSTATIC HYPERPLASIA DISEASE - The present invention relates to a composition for preventing or treating benign prostatic hyperplasia disease, the composition comprising, as active ingredients, extracts of | 05-05-2022 |